Background  ||| S:24 E:43 ||| NNP
Wound  ||| S:43 E:49 ||| NNP
healing  ||| S:49 E:57 ||| NN
involves  ||| S:57 E:66 ||| VBZ
reepithelialization ||| S:66 E:85 ||| VBN
,  ||| S:85 E:87 ||| ,
granulation  ||| S:87 E:107 ||| JJ
tissue  ||| S:107 E:114 ||| NN
formation  ||| S:114 E:124 ||| NN
and  ||| S:124 E:128 ||| CC
contraction  ||| S:128 E:140 ||| NN
( ||| S:140 E:141 ||| -LRB-
reviewed  ||| S:141 E:150 ||| VBN
in  ||| S:150 E:153 ||| IN
refs.  ||| S:153 E:159 ||| NNP
[  ||| S:159 E:161 ||| -LRB-
1  ||| S:161 E:163 ||| CD
2  ||| S:163 E:165 ||| CD
]  ||| S:165 E:175 ||| CD
) ||| S:175 E:176 ||| -RRB-
.  ||| S:176 E:178 ||| .
Reepithelialization  ||| S:178 E:198 ||| NNP
and  ||| S:198 E:202 ||| CC
granulation  ||| S:202 E:214 ||| JJ
tissue  ||| S:214 E:221 ||| NN
formation  ||| S:221 E:231 ||| NN
in  ||| S:231 E:242 ||| IN
turn  ||| S:242 E:247 ||| NN
involve  ||| S:247 E:255 ||| NN
proliferation  ||| S:255 E:269 ||| NN
and  ||| S:269 E:273 ||| CC
migration  ||| S:273 E:283 ||| NN
of  ||| S:283 E:286 ||| IN
cells  ||| S:286 E:292 ||| NNS
from  ||| S:292 E:297 ||| IN
the  ||| S:297 E:309 ||| DT
wound  ||| S:309 E:315 ||| JJ
edge  ||| S:315 E:320 ||| NN
to  ||| S:320 E:323 ||| TO
fill  ||| S:323 E:328 ||| VB
the  ||| S:328 E:332 ||| DT
wound  ||| S:332 E:338 ||| JJ
site ||| S:338 E:342 ||| NN
.  ||| S:342 E:344 ||| .
In  ||| S:344 E:347 ||| IN
higher  ||| S:347 E:354 ||| JJR
vertebrate  ||| S:354 E:373 ||| JJ
adult  ||| S:373 E:379 ||| NN
animals ||| S:379 E:386 ||| NNS
,  ||| S:386 E:388 ||| ,
reepithelialization  ||| S:388 E:408 ||| VBG
of  ||| S:408 E:411 ||| IN
a  ||| S:411 E:413 ||| DT
wound  ||| S:413 E:419 ||| NN
begins  ||| S:419 E:426 ||| VBZ
within  ||| S:426 E:441 ||| IN
hours  ||| S:441 E:447 ||| NNS
after  ||| S:447 E:453 ||| IN
injury  ||| S:453 E:460 ||| NN
while  ||| S:460 E:466 ||| IN
granulation  ||| S:466 E:478 ||| JJ
tissue  ||| S:478 E:485 ||| NN
begins  ||| S:485 E:492 ||| VBZ
to  ||| S:492 E:495 ||| TO
form  ||| S:495 E:508 ||| VB
approximately  ||| S:508 E:522 ||| RB
4  ||| S:522 E:524 ||| CD
days  ||| S:524 E:529 ||| NNS
after  ||| S:529 E:535 ||| IN
injury ||| S:535 E:541 ||| NN
.  ||| S:541 E:543 ||| .
Besides  ||| S:543 E:551 ||| IN
fibroblasts ||| S:551 E:562 ||| NN
,  ||| S:562 E:572 ||| ,
granulation  ||| S:572 E:584 ||| JJ
tissue  ||| S:584 E:591 ||| NN
consists  ||| S:591 E:600 ||| VBZ
of  ||| S:600 E:603 ||| IN
macrophages ||| S:603 E:614 ||| NN
,  ||| S:614 E:616 ||| ,
blood  ||| S:616 E:622 ||| NN
vessels ||| S:622 E:629 ||| NNS
,  ||| S:629 E:639 ||| ,
and  ||| S:639 E:643 ||| CC
extracellular  ||| S:643 E:657 ||| JJ
matrix  ||| S:657 E:664 ||| NNS
( ||| S:664 E:665 ||| -LRB-
ECM ||| S:665 E:668 ||| NNP
)  ||| S:668 E:670 ||| -RRB-
produced  ||| S:670 E:679 ||| VBN
by  ||| S:679 E:682 ||| IN
fibroblasts ||| S:682 E:693 ||| NN
.  ||| S:693 E:703 ||| .
Once  ||| S:703 E:708 ||| IN
the  ||| S:708 E:712 ||| DT
wound  ||| S:712 E:718 ||| NN
is  ||| S:718 E:721 ||| VBZ
filled  ||| S:721 E:728 ||| VBN
with  ||| S:728 E:733 ||| IN
granulation  ||| S:733 E:745 ||| JJ
tissue  ||| S:745 E:752 ||| NN
and  ||| S:752 E:764 ||| CC
covered  ||| S:764 E:772 ||| VBN
with  ||| S:772 E:777 ||| IN
a  ||| S:777 E:779 ||| DT
neoepidermis ||| S:779 E:791 ||| NN
,  ||| S:791 E:793 ||| ,
a  ||| S:793 E:795 ||| DT
portion  ||| S:795 E:803 ||| NN
of  ||| S:803 E:806 ||| IN
the  ||| S:806 E:810 ||| DT
wound  ||| S:810 E:824 ||| JJ
fibroblasts  ||| S:824 E:836 ||| NN
transforms  ||| S:836 E:847 ||| VBZ
into  ||| S:847 E:852 ||| IN
myofibroblasts ||| S:852 E:866 ||| NN
,  ||| S:866 E:868 ||| ,
which  ||| S:868 E:874 ||| WDT
contract  ||| S:874 E:891 ||| VBP
the  ||| S:891 E:895 ||| DT
wound  ||| S:895 E:901 ||| NN
to  ||| S:901 E:904 ||| TO
reduce  ||| S:904 E:911 ||| VB
and  ||| S:911 E:915 ||| CC
strengthen  ||| S:915 E:926 ||| VB
the  ||| S:926 E:930 ||| DT
defect ||| S:930 E:936 ||| NN
.  ||| S:936 E:946 ||| .
Myofibroblasts  ||| S:946 E:961 ||| NNS
are  ||| S:961 E:965 ||| VBP
rich  ||| S:965 E:970 ||| JJ
in  ||| S:970 E:973 ||| IN
F-actin  ||| S:973 E:981 ||| JJ
bundles ||| S:981 E:988 ||| NNS
,  ||| S:988 E:990 ||| ,
which  ||| S:990 E:996 ||| WDT
establish  ||| S:996 E:1014 ||| VB
cell-cell  ||| S:1014 E:1024 ||| JJ
and  ||| S:1024 E:1028 ||| CC
cell-matrix  ||| S:1028 E:1040 ||| JJ
linkages  ||| S:1040 E:1049 ||| NNS
and  ||| S:1049 E:1053 ||| CC
thus  ||| S:1053 E:1058 ||| RB
generate  ||| S:1058 E:1067 ||| VB
the  ||| S:1067 E:1079 ||| DT
force  ||| S:1079 E:1085 ||| NN
for  ||| S:1085 E:1089 ||| IN
wound  ||| S:1089 E:1095 ||| JJ
contraction ||| S:1095 E:1106 ||| NN
.  ||| S:1106 E:1116 ||| .
SPARC  ||| S:1116 E:1122 ||| NNP
( ||| S:1122 E:1123 ||| -LRB-
secreted  ||| S:1123 E:1132 ||| JJ
protein  ||| S:1132 E:1140 ||| NN
acidic  ||| S:1140 E:1147 ||| NNS
and  ||| S:1147 E:1151 ||| CC
rich  ||| S:1151 E:1156 ||| JJ
in  ||| S:1156 E:1159 ||| IN
cysteine ||| S:1159 E:1167 ||| CD
)  ||| S:1167 E:1169 ||| -RRB-
is  ||| S:1169 E:1180 ||| VBZ
an  ||| S:1180 E:1183 ||| DT
extracellular  ||| S:1183 E:1197 ||| JJ
glycoprotein  ||| S:1197 E:1210 ||| NN
expressed  ||| S:1210 E:1220 ||| VBD
in  ||| S:1220 E:1223 ||| IN
elevated  ||| S:1223 E:1232 ||| JJ
levels  ||| S:1232 E:1247 ||| NNS
in  ||| S:1247 E:1250 ||| IN
actively  ||| S:1250 E:1259 ||| RB
proliferating  ||| S:1259 E:1273 ||| VBG
cells  ||| S:1273 E:1279 ||| NNS
and  ||| S:1279 E:1283 ||| CC
organs  ||| S:1283 E:1290 ||| JJ
such  ||| S:1290 E:1295 ||| JJ
as  ||| S:1295 E:1306 ||| IN
developing  ||| S:1306 E:1317 ||| VBG
embryos  ||| S:1317 E:1325 ||| NNS
and  ||| S:1325 E:1329 ||| CC
adult  ||| S:1329 E:1335 ||| NN
tissues  ||| S:1335 E:1343 ||| NNS
associated  ||| S:1343 E:1354 ||| VBN
with  ||| S:1354 E:1367 ||| IN
remodeling  ||| S:1367 E:1378 ||| NN
( ||| S:1378 E:1379 ||| -LRB-
bone  ||| S:1379 E:1384 ||| NN
and  ||| S:1384 E:1388 ||| CC
gut ||| S:1388 E:1391 ||| NN
) ||| S:1391 E:1392 ||| -RRB-
,  ||| S:1392 E:1394 ||| ,
wound  ||| S:1394 E:1400 ||| JJ
healing ||| S:1400 E:1407 ||| NN
,  ||| S:1407 E:1409 ||| ,
angiogenesis  ||| S:1409 E:1430 ||| NNS
( ||| S:1430 E:1431 ||| -LRB-
reviewed  ||| S:1431 E:1440 ||| VBN
in  ||| S:1440 E:1443 ||| IN
refs.  ||| S:1443 E:1449 ||| NNP
[  ||| S:1449 E:1451 ||| -LRB-
3  ||| S:1451 E:1453 ||| CD
4  ||| S:1453 E:1455 ||| CD
]  ||| S:1455 E:1457 ||| CD
) ||| S:1457 E:1458 ||| -RRB-
,  ||| S:1458 E:1460 ||| ,
and  ||| S:1460 E:1464 ||| CC
tumorigenesis  ||| S:1464 E:1478 ||| NNS
[  ||| S:1478 E:1480 ||| -LRB-
5  ||| S:1480 E:1482 ||| CD
6  ||| S:1482 E:1484 ||| CD
]  ||| S:1484 E:1486 ||| -RRB-
.  ||| S:1486 E:1496 ||| .
SPARC  ||| S:1496 E:1502 ||| NNP
belongs  ||| S:1502 E:1510 ||| VBZ
to  ||| S:1510 E:1513 ||| TO
a  ||| S:1513 E:1515 ||| DT
class  ||| S:1515 E:1521 ||| NN
of  ||| S:1521 E:1524 ||| IN
recently  ||| S:1524 E:1533 ||| RB
denoted  ||| S:1533 E:1541 ||| JJ
matricellular  ||| S:1541 E:1563 ||| JJ
proteins  ||| S:1563 E:1572 ||| NNS
that  ||| S:1572 E:1577 ||| WDT
are  ||| S:1577 E:1581 ||| VBP
involved  ||| S:1581 E:1590 ||| VBN
in  ||| S:1590 E:1593 ||| IN
cell-ECM  ||| S:1593 E:1602 ||| JJ
interactions ||| S:1602 E:1614 ||| NNS
.  ||| S:1614 E:1616 ||| .
It  ||| S:1616 E:1627 ||| PRP
binds  ||| S:1627 E:1633 ||| VBP
to  ||| S:1633 E:1636 ||| TO
ECM  ||| S:1636 E:1640 ||| NNP
proteins  ||| S:1640 E:1649 ||| NNS
and  ||| S:1649 E:1653 ||| CC
interacts  ||| S:1653 E:1663 ||| NN
with  ||| S:1663 E:1668 ||| IN
cells ||| S:1668 E:1673 ||| NNS
.  ||| S:1673 E:1675 ||| .
SPARC  ||| S:1675 E:1681 ||| NNP
has  ||| S:1681 E:1693 ||| VBZ
been  ||| S:1693 E:1698 ||| VBN
postulated  ||| S:1698 E:1709 ||| VBN
to  ||| S:1709 E:1712 ||| TO
modulate  ||| S:1712 E:1721 ||| VB
cell  ||| S:1721 E:1726 ||| NN
shape  ||| S:1726 E:1732 ||| NN
[  ||| S:1732 E:1734 ||| -LRB-
3  ||| S:1734 E:1736 ||| CD
4  ||| S:1736 E:1738 ||| CD
]  ||| S:1738 E:1740 ||| -RRB-
and  ||| S:1740 E:1744 ||| CC
cell  ||| S:1744 E:1757 ||| NN
adhesions  ||| S:1757 E:1767 ||| NNS
[  ||| S:1767 E:1769 ||| -LRB-
4  ||| S:1769 E:1771 ||| CD
7  ||| S:1771 E:1773 ||| CD
8  ||| S:1773 E:1775 ||| CD
]  ||| S:1775 E:1777 ||| -RRB-
,  ||| S:1777 E:1779 ||| ,
to  ||| S:1779 E:1782 ||| TO
regulate  ||| S:1782 E:1791 ||| VB
cell  ||| S:1791 E:1796 ||| NN
proliferation  ||| S:1796 E:1810 ||| NN
[  ||| S:1810 E:1812 ||| -LRB-
3  ||| S:1812 E:1814 ||| CD
4  ||| S:1814 E:1824 ||| CD
]  ||| S:1824 E:1826 ||| -RRB-
and  ||| S:1826 E:1830 ||| CC
migration  ||| S:1830 E:1840 ||| NNS
[  ||| S:1840 E:1842 ||| -LRB-
9  ||| S:1842 E:1844 ||| CD
10  ||| S:1844 E:1847 ||| CD
]  ||| S:1847 E:1849 ||| -RRB-
,  ||| S:1849 E:1851 ||| ,
and  ||| S:1851 E:1855 ||| CC
to  ||| S:1855 E:1858 ||| TO
influence  ||| S:1858 E:1868 ||| VB
matrix  ||| S:1868 E:1883 ||| JJ
contraction  ||| S:1883 E:1895 ||| NN
[  ||| S:1895 E:1897 ||| -LRB-
11  ||| S:1897 E:1900 ||| CD
]  ||| S:1900 E:1902 ||| -RRB-
.  ||| S:1902 E:1904 ||| .
In  ||| S:1904 E:1907 ||| IN
addition ||| S:1907 E:1915 ||| NN
,  ||| S:1915 E:1917 ||| ,
SPARC  ||| S:1917 E:1923 ||| NNP
is  ||| S:1923 E:1926 ||| VBZ
known  ||| S:1926 E:1932 ||| VBN
to  ||| S:1932 E:1935 ||| TO
bind  ||| S:1935 E:1940 ||| VB
to  ||| S:1940 E:1951 ||| TO
certain  ||| S:1951 E:1959 ||| JJ
growth  ||| S:1959 E:1966 ||| NN
factors  ||| S:1966 E:1974 ||| NNS
[  ||| S:1974 E:1976 ||| -LRB-
12  ||| S:1976 E:1979 ||| CD
]  ||| S:1979 E:1981 ||| -RRB-
and  ||| S:1981 E:1985 ||| CC
to  ||| S:1985 E:1988 ||| TO
modulate  ||| S:1988 E:1997 ||| VB
expression  ||| S:1997 E:2008 ||| NN
of  ||| S:2008 E:2019 ||| IN
ECM  ||| S:2019 E:2023 ||| NNP
components  ||| S:2023 E:2034 ||| NNS
[  ||| S:2034 E:2036 ||| -LRB-
13  ||| S:2036 E:2039 ||| CD
]  ||| S:2039 E:2041 ||| -RRB-
.  ||| S:2041 E:2043 ||| .
Many  ||| S:2043 E:2048 ||| JJ
of  ||| S:2048 E:2051 ||| IN
these  ||| S:2051 E:2057 ||| DT
functions  ||| S:2057 E:2067 ||| NNS
are  ||| S:2067 E:2079 ||| VBP
requisite  ||| S:2079 E:2089 ||| VBN
to  ||| S:2089 E:2092 ||| TO
wound  ||| S:2092 E:2098 ||| VB
repair ||| S:2098 E:2104 ||| NN
.  ||| S:2104 E:2114 ||| .
To  ||| S:2114 E:2117 ||| TO
further  ||| S:2117 E:2125 ||| RB
investigate  ||| S:2125 E:2137 ||| VB
the  ||| S:2137 E:2141 ||| DT
role  ||| S:2141 E:2146 ||| NN
of  ||| S:2146 E:2149 ||| IN
SPARC  ||| S:2149 E:2155 ||| NNP
in  ||| S:2155 E:2158 ||| IN
wound  ||| S:2158 E:2172 ||| JJ
healing ||| S:2172 E:2179 ||| NN
,  ||| S:2179 E:2181 ||| ,
we  ||| S:2181 E:2184 ||| PRP
used  ||| S:2184 E:2189 ||| VBD
cells  ||| S:2189 E:2195 ||| NNS
from  ||| S:2195 E:2200 ||| IN
our  ||| S:2200 E:2204 ||| PRP$
recently  ||| S:2204 E:2213 ||| RB
generated  ||| S:2213 E:2231 ||| VBN
SPARC-null  ||| S:2231 E:2242 ||| JJ
mice  ||| S:2242 E:2247 ||| NNS
[  ||| S:2247 E:2249 ||| -LRB-
14  ||| S:2249 E:2252 ||| CD
]  ||| S:2252 E:2254 ||| -RRB-
.  ||| S:2254 E:2256 ||| .
As  ||| S:2256 E:2259 ||| IN
we  ||| S:2259 E:2262 ||| PRP
reported  ||| S:2262 E:2271 ||| VBD
previously  ||| S:2271 E:2282 ||| RB
SPARC  ||| S:2282 E:2296 ||| NNP
plays  ||| S:2296 E:2302 ||| VBZ
a  ||| S:2302 E:2304 ||| DT
role  ||| S:2304 E:2309 ||| NN
in  ||| S:2309 E:2312 ||| IN
regulating  ||| S:2312 E:2323 ||| VBG
expression  ||| S:2323 E:2334 ||| NN
of  ||| S:2334 E:2337 ||| IN
growth  ||| S:2337 E:2344 ||| NN
factors ||| S:2344 E:2351 ||| NNS
,  ||| S:2351 E:2361 ||| ,
growth  ||| S:2361 E:2368 ||| NN
factor  ||| S:2368 E:2375 ||| NN
receptors ||| S:2375 E:2384 ||| NNS
,  ||| S:2384 E:2386 ||| ,
and  ||| S:2386 E:2390 ||| CC
ECM  ||| S:2390 E:2394 ||| NNP
proteins  ||| S:2394 E:2403 ||| NNS
and  ||| S:2403 E:2407 ||| CC
in  ||| S:2407 E:2410 ||| IN
modulating  ||| S:2410 E:2429 ||| JJ
cell  ||| S:2429 E:2434 ||| NN
proliferation ||| S:2434 E:2447 ||| NN
.  ||| S:2447 E:2449 ||| .
In  ||| S:2449 E:2452 ||| IN
the  ||| S:2452 E:2456 ||| DT
absence  ||| S:2456 E:2464 ||| NN
of  ||| S:2464 E:2467 ||| IN
SPARC ||| S:2467 E:2472 ||| NNP
,  ||| S:2472 E:2474 ||| ,
expression  ||| S:2474 E:2485 ||| NN
of  ||| S:2485 E:2496 ||| IN
transforming  ||| S:2496 E:2509 ||| VBG
growth  ||| S:2509 E:2516 ||| NN
factor-β1  ||| S:2516 E:2526 ||| NN
and  ||| S:2526 E:2530 ||| CC
type  ||| S:2530 E:2535 ||| NN
I  ||| S:2535 E:2537 ||| PRP
collagen  ||| S:2537 E:2546 ||| RB
is  ||| S:2546 E:2557 ||| VBZ
down-regulated  ||| S:2557 E:2572 ||| JJ
in  ||| S:2572 E:2575 ||| IN
kidney  ||| S:2575 E:2582 ||| NN
mesangial  ||| S:2582 E:2592 ||| NN
cells  ||| S:2592 E:2598 ||| NNS
[  ||| S:2598 E:2600 ||| -LRB-
15  ||| S:2600 E:2603 ||| CD
]  ||| S:2603 E:2605 ||| -RRB-
.  ||| S:2605 E:2607 ||| .
The  ||| S:2607 E:2619 ||| DT
expression  ||| S:2619 E:2630 ||| NN
of  ||| S:2630 E:2633 ||| IN
cell  ||| S:2633 E:2638 ||| NN
surface  ||| S:2638 E:2646 ||| NN
receptor  ||| S:2646 E:2655 ||| NN
for  ||| S:2655 E:2659 ||| IN
insulin-like  ||| S:2659 E:2672 ||| JJ
growth  ||| S:2672 E:2687 ||| NN
factor  ||| S:2687 E:2694 ||| NN
I  ||| S:2694 E:2696 ||| PRP
in  ||| S:2696 E:2699 ||| IN
SPARC-null  ||| S:2699 E:2710 ||| JJ
embryonic  ||| S:2710 E:2720 ||| JJ
fibroblasts  ||| S:2720 E:2732 ||| NN
is  ||| S:2732 E:2735 ||| VBZ
also  ||| S:2735 E:2748 ||| RB
diminished  ||| S:2748 E:2759 ||| VBN
[  ||| S:2759 E:2761 ||| -LRB-
16  ||| S:2761 E:2764 ||| CD
]  ||| S:2764 E:2766 ||| -RRB-
.  ||| S:2766 E:2768 ||| .
Studies  ||| S:2768 E:2776 ||| NNS
with  ||| S:2776 E:2781 ||| IN
SPARC-null  ||| S:2781 E:2792 ||| JJ
cells  ||| S:2792 E:2798 ||| NNS
have  ||| S:2798 E:2811 ||| VBP
confirmed  ||| S:2811 E:2821 ||| VBN
that  ||| S:2821 E:2826 ||| IN
SPARC  ||| S:2826 E:2832 ||| NNP
functions  ||| S:2832 E:2842 ||| NNS
in  ||| S:2842 E:2845 ||| IN
cell  ||| S:2845 E:2850 ||| NN
proliferation ||| S:2850 E:2863 ||| NN
.  ||| S:2863 E:2873 ||| .
Mesangial  ||| S:2873 E:2883 ||| JJ
cells ||| S:2883 E:2888 ||| NNS
,  ||| S:2888 E:2890 ||| ,
adult  ||| S:2890 E:2896 ||| NN
skin  ||| S:2896 E:2901 ||| NN
fibroblasts  ||| S:2901 E:2913 ||| NNS
and  ||| S:2913 E:2917 ||| CC
smooth  ||| S:2917 E:2924 ||| JJ
muscle  ||| S:2924 E:2939 ||| NN
cells  ||| S:2939 E:2945 ||| NNS
from  ||| S:2945 E:2950 ||| IN
SPARC-null  ||| S:2950 E:2961 ||| JJ
mice  ||| S:2961 E:2966 ||| NNS
proliferate  ||| S:2966 E:2978 ||| VBP
faster  ||| S:2978 E:2985 ||| RBR
than  ||| S:2985 E:2990 ||| IN
their  ||| S:2990 E:3004 ||| PRP$
respective  ||| S:3004 E:3015 ||| JJ
wild-type  ||| S:3015 E:3025 ||| JJ
counterparts  ||| S:3025 E:3038 ||| NNS
in  ||| S:3038 E:3041 ||| IN
media  ||| S:3041 E:3047 ||| NNS
containing  ||| S:3047 E:3058 ||| VBG
fetal  ||| S:3058 E:3072 ||| JJ
bovine  ||| S:3072 E:3079 ||| JJ
serum  ||| S:3079 E:3085 ||| NNS
( ||| S:3085 E:3086 ||| -LRB-
FBS ||| S:3086 E:3089 ||| NNP
)  ||| S:3089 E:3091 ||| -RRB-
[  ||| S:3091 E:3093 ||| -LRB-
17  ||| S:3093 E:3096 ||| CD
]  ||| S:3096 E:3098 ||| -RRB-
.  ||| S:3098 E:3100 ||| .
Although  ||| S:3100 E:3109 ||| IN
embryonic  ||| S:3109 E:3119 ||| JJ
fibroblasts  ||| S:3119 E:3139 ||| NN
from  ||| S:3139 E:3144 ||| IN
the  ||| S:3144 E:3148 ||| DT
SPARC-null  ||| S:3148 E:3159 ||| JJ
mice  ||| S:3159 E:3164 ||| NNS
grow  ||| S:3164 E:3169 ||| VBP
at  ||| S:3169 E:3172 ||| IN
the  ||| S:3172 E:3176 ||| DT
same  ||| S:3176 E:3181 ||| JJ
rate  ||| S:3181 E:3186 ||| NN
as  ||| S:3186 E:3189 ||| IN
the  ||| S:3189 E:3201 ||| DT
wild-type  ||| S:3201 E:3211 ||| JJ
cells  ||| S:3211 E:3217 ||| NNS
when  ||| S:3217 E:3222 ||| WRB
they  ||| S:3222 E:3227 ||| PRP
are  ||| S:3227 E:3231 ||| VBP
cultured  ||| S:3231 E:3240 ||| VBN
in  ||| S:3240 E:3243 ||| IN
FBS ||| S:3243 E:3246 ||| NNP
,  ||| S:3246 E:3248 ||| ,
the  ||| S:3248 E:3260 ||| DT
SPARC-null  ||| S:3260 E:3271 ||| JJ
embryonic  ||| S:3271 E:3281 ||| JJ
fibroblasts  ||| S:3281 E:3293 ||| JJ
exhibit  ||| S:3293 E:3301 ||| NN
down-regulated  ||| S:3301 E:3324 ||| JJ
proliferation  ||| S:3324 E:3338 ||| NN
as  ||| S:3338 E:3341 ||| IN
compared  ||| S:3341 E:3350 ||| VBN
to  ||| S:3350 E:3353 ||| TO
the  ||| S:3353 E:3357 ||| DT
wild-type  ||| S:3357 E:3367 ||| JJ
cells  ||| S:3367 E:3373 ||| NNS
when  ||| S:3373 E:3378 ||| WRB
the  ||| S:3378 E:3390 ||| DT
fibroblasts  ||| S:3390 E:3402 ||| NNS
are  ||| S:3402 E:3406 ||| VBP
cultured  ||| S:3406 E:3415 ||| VBN
in  ||| S:3415 E:3418 ||| IN
serum-free  ||| S:3418 E:3429 ||| JJ
medium  ||| S:3429 E:3436 ||| NN
containing  ||| S:3436 E:3455 ||| VBG
insulin  ||| S:3455 E:3463 ||| NN
as  ||| S:3463 E:3466 ||| IN
the  ||| S:3466 E:3470 ||| DT
sole  ||| S:3470 E:3475 ||| JJ
mitogenic  ||| S:3475 E:3485 ||| JJ
factor  ||| S:3485 E:3492 ||| NN
[  ||| S:3492 E:3494 ||| -LRB-
16  ||| S:3494 E:3497 ||| CD
]  ||| S:3497 E:3499 ||| -RRB-
.  ||| S:3499 E:3501 ||| .
Thus ||| S:3501 E:3505 ||| RB
,  ||| S:3505 E:3507 ||| ,
it  ||| S:3507 E:3518 ||| PRP
appears  ||| S:3518 E:3526 ||| VBZ
that  ||| S:3526 E:3531 ||| IN
the  ||| S:3531 E:3535 ||| DT
role  ||| S:3535 E:3540 ||| NN
of  ||| S:3540 E:3543 ||| IN
SPARC  ||| S:3543 E:3549 ||| NNP
in  ||| S:3549 E:3552 ||| IN
cell  ||| S:3552 E:3557 ||| NN
proliferation  ||| S:3557 E:3571 ||| NN
is  ||| S:3571 E:3582 ||| VBZ
cell  ||| S:3582 E:3587 ||| NN
type  ||| S:3587 E:3592 ||| NN
and  ||| S:3592 E:3596 ||| CC
environment  ||| S:3596 E:3608 ||| NN
dependent ||| S:3608 E:3617 ||| NN
.  ||| S:3617 E:3627 ||| .
Although  ||| S:3627 E:3636 ||| IN
SPARC  ||| S:3636 E:3642 ||| NNP
is  ||| S:3642 E:3645 ||| VBZ
expressed  ||| S:3645 E:3655 ||| VBN
in  ||| S:3655 E:3658 ||| IN
fibroblasts  ||| S:3658 E:3670 ||| NN
and  ||| S:3670 E:3682 ||| CC
macrophages  ||| S:3682 E:3694 ||| NN
at  ||| S:3694 E:3697 ||| IN
wound  ||| S:3697 E:3703 ||| JJ
sites  ||| S:3703 E:3709 ||| NNS
[  ||| S:3709 E:3711 ||| -LRB-
18  ||| S:3711 E:3714 ||| CD
]  ||| S:3714 E:3716 ||| -RRB-
and  ||| S:3716 E:3720 ||| CC
functions  ||| S:3720 E:3730 ||| NNS
in  ||| S:3730 E:3733 ||| IN
many  ||| S:3733 E:3746 ||| JJ
processes  ||| S:3746 E:3756 ||| NNS
important  ||| S:3756 E:3766 ||| JJ
to  ||| S:3766 E:3769 ||| TO
wound  ||| S:3769 E:3775 ||| VB
repair ||| S:3775 E:3781 ||| NN
,  ||| S:3781 E:3783 ||| ,
the  ||| S:3783 E:3787 ||| DT
role  ||| S:3787 E:3792 ||| NN
of  ||| S:3792 E:3795 ||| IN
SPARC  ||| S:3795 E:3801 ||| NNP
in  ||| S:3801 E:3812 ||| IN
wound  ||| S:3812 E:3818 ||| JJ
healing  ||| S:3818 E:3826 ||| NN
in  ||| S:3826 E:3829 ||| IN
a  ||| S:3829 E:3831 ||| DT
whole  ||| S:3831 E:3837 ||| JJ
animal  ||| S:3837 E:3844 ||| NN
has  ||| S:3844 E:3848 ||| VBZ
not  ||| S:3848 E:3852 ||| RB
yet  ||| S:3852 E:3856 ||| RB
been  ||| S:3856 E:3861 ||| VBN
studied ||| S:3861 E:3868 ||| VBN
.  ||| S:3868 E:3878 ||| .
Previously ||| S:3878 E:3888 ||| RB
,  ||| S:3888 E:3890 ||| ,
studies  ||| S:3890 E:3898 ||| NNS
of  ||| S:3898 E:3901 ||| IN
phenotypes  ||| S:3901 E:3912 ||| NN
in  ||| S:3912 E:3915 ||| IN
this  ||| S:3915 E:3920 ||| DT
laboratory  ||| S:3920 E:3931 ||| NN
have  ||| S:3931 E:3944 ||| VBP
shown  ||| S:3944 E:3950 ||| VBN
that  ||| S:3950 E:3955 ||| IN
SPARC-null  ||| S:3955 E:3966 ||| JJ
mice  ||| S:3966 E:3971 ||| NNS
develop  ||| S:3971 E:3979 ||| VBP
osteopenia  ||| S:3979 E:3990 ||| VBN
around  ||| S:3990 E:3997 ||| IN
2.5  ||| S:3997 E:4009 ||| CD
months  ||| S:4009 E:4016 ||| NNS
of  ||| S:4016 E:4019 ||| IN
age  ||| S:4019 E:4023 ||| NN
[  ||| S:4023 E:4025 ||| -LRB-
19  ||| S:4025 E:4028 ||| CD
]  ||| S:4028 E:4030 ||| -RRB-
in  ||| S:4030 E:4033 ||| IN
bones  ||| S:4033 E:4039 ||| NNS
where  ||| S:4039 E:4045 ||| WRB
SPARC  ||| S:4045 E:4051 ||| NNP
is  ||| S:4051 E:4054 ||| VBZ
normally  ||| S:4054 E:4063 ||| RB
the  ||| S:4063 E:4075 ||| DT
most  ||| S:4075 E:4080 ||| RBS
abundant  ||| S:4080 E:4089 ||| JJ
non-collagenous  ||| S:4089 E:4105 ||| JJ
glycoprotein  ||| S:4105 E:4118 ||| NNS
[  ||| S:4118 E:4120 ||| -LRB-
3  ||| S:4120 E:4122 ||| LS
]  ||| S:4122 E:4124 ||| -RRB-
.  ||| S:4124 E:4126 ||| .
The  ||| S:4126 E:4138 ||| DT
second  ||| S:4138 E:4145 ||| JJ
phenotype  ||| S:4145 E:4155 ||| NNS
thus  ||| S:4155 E:4160 ||| RB
far  ||| S:4160 E:4164 ||| RB
uncovered  ||| S:4164 E:4174 ||| VBN
is  ||| S:4174 E:4177 ||| VBZ
in  ||| S:4177 E:4180 ||| IN
the  ||| S:4180 E:4184 ||| DT
lens  ||| S:4184 E:4189 ||| NN
where  ||| S:4189 E:4203 ||| WRB
SPARC  ||| S:4203 E:4209 ||| NNP
is  ||| S:4209 E:4212 ||| VBZ
normally  ||| S:4212 E:4221 ||| RB
produced  ||| S:4221 E:4230 ||| VBN
by  ||| S:4230 E:4233 ||| IN
lens  ||| S:4233 E:4238 ||| NN
epithelial  ||| S:4238 E:4249 ||| NN
cells  ||| S:4249 E:4255 ||| NNS
[  ||| S:4255 E:4257 ||| -LRB-
20  ||| S:4257 E:4260 ||| CD
21  ||| S:4260 E:4271 ||| CD
]  ||| S:4271 E:4273 ||| -RRB-
and  ||| S:4273 E:4277 ||| CC
is  ||| S:4277 E:4280 ||| VBZ
a  ||| S:4280 E:4282 ||| DT
component  ||| S:4282 E:4292 ||| NN
of  ||| S:4292 E:4295 ||| IN
the  ||| S:4295 E:4299 ||| DT
lens  ||| S:4299 E:4304 ||| NN
capsule  ||| S:4304 E:4312 ||| NNS
[  ||| S:4312 E:4314 ||| -LRB-
20  ||| S:4314 E:4317 ||| CD
22  ||| S:4317 E:4320 ||| CD
]  ||| S:4320 E:4322 ||| -RRB-
.  ||| S:4322 E:4332 ||| .
SPARC-null  ||| S:4332 E:4343 ||| JJ
mice  ||| S:4343 E:4348 ||| NNS
show  ||| S:4348 E:4353 ||| VBP
progressive  ||| S:4353 E:4365 ||| JJ
cataract  ||| S:4365 E:4374 ||| NN
formation  ||| S:4374 E:4392 ||| NN
beginning  ||| S:4392 E:4402 ||| VBG
approximately  ||| S:4402 E:4416 ||| RB
1.5  ||| S:4416 E:4420 ||| CD
months  ||| S:4420 E:4427 ||| NNS
after  ||| S:4427 E:4433 ||| IN
birth  ||| S:4433 E:4439 ||| NN
[  ||| S:4439 E:4441 ||| -LRB-
14  ||| S:4441 E:4444 ||| CD
21  ||| S:4444 E:4447 ||| CD
]  ||| S:4447 E:4449 ||| -RRB-
.  ||| S:4449 E:4459 ||| .
Electron  ||| S:4459 E:4468 ||| NNP
microscopy  ||| S:4468 E:4479 ||| NN
of  ||| S:4479 E:4482 ||| IN
the  ||| S:4482 E:4486 ||| DT
SPARC-null  ||| S:4486 E:4497 ||| JJ
lens  ||| S:4497 E:4502 ||| NN
revealed  ||| S:4502 E:4519 ||| VBD
abnormality  ||| S:4519 E:4531 ||| VBN
at  ||| S:4531 E:4534 ||| IN
the  ||| S:4534 E:4538 ||| DT
lens  ||| S:4538 E:4543 ||| NN
cell-ECM  ||| S:4543 E:4552 ||| NNS
( ||| S:4552 E:4553 ||| -LRB-
capsule ||| S:4553 E:4560 ||| LS
)  ||| S:4560 E:4562 ||| -RRB-
interface  ||| S:4562 E:4572 ||| NN
with  ||| S:4572 E:4585 ||| IN
an  ||| S:4585 E:4588 ||| DT
intrusion  ||| S:4588 E:4598 ||| NN
of  ||| S:4598 E:4601 ||| IN
cellular  ||| S:4601 E:4610 ||| JJ
processes  ||| S:4610 E:4620 ||| NNS
into  ||| S:4620 E:4625 ||| IN
the  ||| S:4625 E:4629 ||| DT
basement  ||| S:4629 E:4646 ||| NN
membrane  ||| S:4646 E:4655 ||| NN
of  ||| S:4655 E:4658 ||| IN
the  ||| S:4658 E:4662 ||| DT
lens  ||| S:4662 E:4667 ||| NN
capsule ||| S:4667 E:4674 ||| NN
,  ||| S:4674 E:4676 ||| ,
whereas  ||| S:4676 E:4684 ||| IN
wild-type  ||| S:4684 E:4694 ||| JJ
lens  ||| S:4694 E:4707 ||| NN
exhibited  ||| S:4707 E:4717 ||| VBD
a  ||| S:4717 E:4719 ||| DT
precise  ||| S:4719 E:4727 ||| JJ
border  ||| S:4727 E:4734 ||| NN
at  ||| S:4734 E:4737 ||| IN
the  ||| S:4737 E:4741 ||| DT
cell-matrix  ||| S:4741 E:4753 ||| JJ
interface  ||| S:4753 E:4763 ||| NNS
[  ||| S:4763 E:4773 ||| -LRB-
23  ||| S:4773 E:4776 ||| CD
]  ||| S:4776 E:4778 ||| -RRB-
.  ||| S:4778 E:4780 ||| .
In  ||| S:4780 E:4783 ||| IN
the  ||| S:4783 E:4787 ||| DT
present  ||| S:4787 E:4795 ||| JJ
study ||| S:4795 E:4800 ||| NN
,  ||| S:4800 E:4802 ||| ,
we  ||| S:4802 E:4805 ||| PRP
show  ||| S:4805 E:4810 ||| VBP
for  ||| S:4810 E:4814 ||| IN
the  ||| S:4814 E:4818 ||| DT
first  ||| S:4818 E:4824 ||| JJ
time  ||| S:4824 E:4837 ||| NN
that  ||| S:4837 E:4842 ||| IN
SPARC  ||| S:4842 E:4848 ||| NNP
plays  ||| S:4848 E:4854 ||| VBZ
a  ||| S:4854 E:4856 ||| DT
role  ||| S:4856 E:4861 ||| NN
in  ||| S:4861 E:4864 ||| IN
wound  ||| S:4864 E:4870 ||| JJ
repair  ||| S:4870 E:4877 ||| NN
in  ||| S:4877 E:4880 ||| IN
vivo  ||| S:4880 E:4885 ||| NN
and  ||| S:4885 E:4889 ||| CC
in  ||| S:4889 E:4900 ||| IN
vitro ||| S:4900 E:4905 ||| NN
.  ||| S:4905 E:4907 ||| .
Wound  ||| S:4907 E:4913 ||| JJ
healing  ||| S:4913 E:4921 ||| NN
in  ||| S:4921 E:4924 ||| IN
SPARC-null  ||| S:4924 E:4935 ||| JJ
mice  ||| S:4935 E:4940 ||| NNS
is  ||| S:4940 E:4943 ||| VBZ
retarded  ||| S:4943 E:4952 ||| JJ
due  ||| S:4952 E:4956 ||| JJ
to  ||| S:4956 E:4967 ||| TO
delayed  ||| S:4967 E:4975 ||| VB
granulation  ||| S:4975 E:4987 ||| JJ
tissue  ||| S:4987 E:4994 ||| NN
formation ||| S:4994 E:5003 ||| NN
.  ||| S:5003 E:5005 ||| .
Repair  ||| S:5005 E:5012 ||| NN
of  ||| S:5012 E:5015 ||| IN
a  ||| S:5015 E:5017 ||| DT
wound  ||| S:5017 E:5023 ||| NN
in  ||| S:5023 E:5034 ||| IN
vitro  ||| S:5034 E:5040 ||| NN
by  ||| S:5040 E:5043 ||| IN
dermal  ||| S:5043 E:5050 ||| JJ
fibroblasts  ||| S:5050 E:5062 ||| NN
is  ||| S:5062 E:5065 ||| VBZ
impaired  ||| S:5065 E:5074 ||| VBN
due  ||| S:5074 E:5078 ||| JJ
to  ||| S:5078 E:5081 ||| TO
defect  ||| S:5081 E:5088 ||| VB
in  ||| S:5088 E:5099 ||| IN
cell  ||| S:5099 E:5104 ||| NN
migration ||| S:5104 E:5113 ||| NN
.  ||| S:5113 E:5137 ||| .
Results  ||| S:5137 E:5164 ||| NNS
Delayed  ||| S:5164 E:5172 ||| JJ
wound  ||| S:5172 E:5178 ||| NN
healing  ||| S:5178 E:5186 ||| NN
in  ||| S:5186 E:5189 ||| IN
SPARC-deficient  ||| S:5189 E:5215 ||| JJ
mice  ||| S:5215 E:5230 ||| NNS
Two  ||| S:5230 E:5234 ||| CD
independent  ||| S:5234 E:5246 ||| JJ
experiments  ||| S:5246 E:5258 ||| NNS
with  ||| S:5258 E:5263 ||| IN
25  ||| S:5263 E:5266 ||| CD
mm  ||| S:5266 E:5269 ||| NNS
oblong  ||| S:5269 E:5286 ||| VBP
full-thickness  ||| S:5286 E:5301 ||| JJ
excision  ||| S:5301 E:5310 ||| NN
wounds  ||| S:5310 E:5317 ||| NNS
( ||| S:5317 E:5318 ||| -LRB-
6  ||| S:5318 E:5320 ||| CD
mice  ||| S:5320 E:5325 ||| NNS
of  ||| S:5325 E:5328 ||| IN
each  ||| S:5328 E:5333 ||| DT
type  ||| S:5333 E:5338 ||| NN
per  ||| S:5338 E:5352 ||| IN
experiment ||| S:5352 E:5362 ||| NN
) ||| S:5362 E:5363 ||| -RRB-
,  ||| S:5363 E:5365 ||| ,
including  ||| S:5365 E:5375 ||| VBG
the  ||| S:5375 E:5379 ||| DT
striated  ||| S:5379 E:5388 ||| JJ
muscle  ||| S:5388 E:5395 ||| NN
layer  ||| S:5395 E:5411 ||| NN
( ||| S:5411 E:5412 ||| -LRB-
panniculus  ||| S:5412 E:5423 ||| FW
carnosus ||| S:5423 E:5431 ||| FW
) ||| S:5431 E:5432 ||| -RRB-
,  ||| S:5432 E:5434 ||| ,
on  ||| S:5434 E:5437 ||| IN
the  ||| S:5437 E:5441 ||| DT
dorsal  ||| S:5441 E:5448 ||| JJ
skin  ||| S:5448 E:5453 ||| NN
of  ||| S:5453 E:5456 ||| IN
wild-type  ||| S:5456 E:5476 ||| JJ
and  ||| S:5476 E:5480 ||| CC
SPARC-null  ||| S:5480 E:5491 ||| JJ
mice  ||| S:5491 E:5496 ||| NNS
indicated  ||| S:5496 E:5506 ||| VBD
that  ||| S:5506 E:5511 ||| IN
the  ||| S:5511 E:5515 ||| DT
absence  ||| S:5515 E:5523 ||| NN
of  ||| S:5523 E:5526 ||| IN
SPARC  ||| S:5526 E:5542 ||| NNP
impeded  ||| S:5542 E:5550 ||| JJ
healing  ||| S:5550 E:5558 ||| NN
of  ||| S:5558 E:5561 ||| IN
skin  ||| S:5561 E:5566 ||| NN
wounds ||| S:5566 E:5572 ||| NNS
.  ||| S:5572 E:5574 ||| .
One  ||| S:5574 E:5578 ||| CD
day  ||| S:5578 E:5582 ||| NN
after  ||| S:5582 E:5588 ||| IN
surgery  ||| S:5588 E:5596 ||| NN
a  ||| S:5596 E:5608 ||| DT
clear  ||| S:5608 E:5614 ||| JJ
thin  ||| S:5614 E:5619 ||| JJ
film  ||| S:5619 E:5624 ||| NN
of  ||| S:5624 E:5627 ||| IN
dried  ||| S:5627 E:5633 ||| NNS
exudate  ||| S:5633 E:5641 ||| VBP
covered  ||| S:5641 E:5649 ||| VBN
the  ||| S:5649 E:5653 ||| DT
wounds  ||| S:5653 E:5660 ||| NNS
in  ||| S:5660 E:5673 ||| IN
the  ||| S:5673 E:5677 ||| DT
wild-type  ||| S:5677 E:5687 ||| JJ
and  ||| S:5687 E:5691 ||| CC
SPARC-null  ||| S:5691 E:5702 ||| JJ
mice ||| S:5702 E:5706 ||| NNS
.  ||| S:5706 E:5708 ||| .
Build-up  ||| S:5708 E:5717 ||| NN
of  ||| S:5717 E:5720 ||| IN
dehydrated  ||| S:5720 E:5741 ||| JJ
wound  ||| S:5741 E:5747 ||| NN
crusts  ||| S:5747 E:5754 ||| NNS
or  ||| S:5754 E:5757 ||| CC
scabs  ||| S:5757 E:5763 ||| NNS
began  ||| S:5763 E:5769 ||| VBD
at  ||| S:5769 E:5772 ||| IN
day  ||| S:5772 E:5776 ||| NN
3  ||| S:5776 E:5778 ||| CD
and  ||| S:5778 E:5782 ||| CC
became  ||| S:5782 E:5799 ||| VBD
subsequently  ||| S:5799 E:5812 ||| RB
more  ||| S:5812 E:5817 ||| RBR
extensive ||| S:5817 E:5826 ||| JJ
.  ||| S:5826 E:5828 ||| .
In  ||| S:5828 E:5831 ||| IN
the  ||| S:5831 E:5835 ||| DT
SPARC-null  ||| S:5835 E:5846 ||| JJ
mice  ||| S:5846 E:5851 ||| JJ
scabs  ||| S:5851 E:5867 ||| NNS
were  ||| S:5867 E:5872 ||| VBD
thicker  ||| S:5872 E:5880 ||| JJR
and  ||| S:5880 E:5884 ||| CC
extravasation  ||| S:5884 E:5898 ||| NN
of  ||| S:5898 E:5901 ||| IN
blood ||| S:5901 E:5906 ||| NN
,  ||| S:5906 E:5908 ||| ,
visible  ||| S:5908 E:5916 ||| JJ
in  ||| S:5916 E:5919 ||| IN
the  ||| S:5919 E:5933 ||| DT
gaps  ||| S:5933 E:5938 ||| NN
within  ||| S:5938 E:5945 ||| IN
the  ||| S:5945 E:5949 ||| DT
scabs ||| S:5949 E:5954 ||| NN
,  ||| S:5954 E:5956 ||| ,
was  ||| S:5956 E:5960 ||| VBD
more  ||| S:5960 E:5965 ||| RBR
frequent  ||| S:5965 E:5974 ||| JJ
and  ||| S:5974 E:5978 ||| CC
extensive  ||| S:5978 E:5998 ||| JJ
than  ||| S:5998 E:6003 ||| IN
that  ||| S:6003 E:6008 ||| DT
in  ||| S:6008 E:6011 ||| IN
the  ||| S:6011 E:6015 ||| DT
control  ||| S:6015 E:6023 ||| NN
mice ||| S:6023 E:6027 ||| NNS
.  ||| S:6027 E:6029 ||| .
In  ||| S:6029 E:6032 ||| IN
control  ||| S:6032 E:6040 ||| NN
wild-type  ||| S:6040 E:6050 ||| JJ
mice ||| S:6050 E:6054 ||| NNS
,  ||| S:6054 E:6066 ||| ,
loss  ||| S:6066 E:6071 ||| NN
of  ||| S:6071 E:6074 ||| IN
wound  ||| S:6074 E:6080 ||| JJ
scabs  ||| S:6080 E:6086 ||| NNS
began  ||| S:6086 E:6092 ||| VBD
at  ||| S:6092 E:6095 ||| IN
day  ||| S:6095 E:6099 ||| NN
17  ||| S:6099 E:6102 ||| CD
and  ||| S:6102 E:6106 ||| CC
was  ||| S:6106 E:6110 ||| VBD
complete  ||| S:6110 E:6119 ||| JJ
in  ||| S:6119 E:6132 ||| IN
all  ||| S:6132 E:6136 ||| DT
mice  ||| S:6136 E:6141 ||| NNS
by  ||| S:6141 E:6144 ||| IN
day  ||| S:6144 E:6148 ||| NN
24  ||| S:6148 E:6151 ||| CD
( ||| S:6151 E:6152 ||| -LRB-
Fig.  ||| S:6152 E:6157 ||| NNP
1A ||| S:6157 E:6159 ||| NNP
,  ||| S:6159 E:6161 ||| ,
lower  ||| S:6161 E:6167 ||| JJR
panel ||| S:6167 E:6172 ||| NN
)  ||| S:6172 E:6174 ||| -RRB-
with  ||| S:6174 E:6179 ||| IN
wounds  ||| S:6179 E:6196 ||| JJ
well-healed  ||| S:6196 E:6208 ||| JJ
and  ||| S:6208 E:6212 ||| CC
epithelial  ||| S:6212 E:6223 ||| VBP
covering  ||| S:6223 E:6232 ||| VBG
restored  ||| S:6232 E:6241 ||| VBN
( ||| S:6241 E:6242 ||| -LRB-
Fig.  ||| S:6242 E:6247 ||| NNP
1A ||| S:6247 E:6249 ||| NNP
,  ||| S:6249 E:6261 ||| ,
upper  ||| S:6261 E:6267 ||| JJ
panel ||| S:6267 E:6272 ||| NN
) ||| S:6272 E:6273 ||| -RRB-
.  ||| S:6273 E:6275 ||| .
In  ||| S:6275 E:6278 ||| IN
contrast ||| S:6278 E:6286 ||| NN
,  ||| S:6286 E:6288 ||| ,
the  ||| S:6288 E:6292 ||| DT
scabs  ||| S:6292 E:6298 ||| NN
in  ||| S:6298 E:6301 ||| IN
SPARC-null  ||| S:6301 E:6312 ||| JJ
mice  ||| S:6312 E:6327 ||| NNS
started  ||| S:6327 E:6335 ||| VBD
to  ||| S:6335 E:6338 ||| TO
come  ||| S:6338 E:6343 ||| VB
off  ||| S:6343 E:6347 ||| RP
partially  ||| S:6347 E:6357 ||| RB
around  ||| S:6357 E:6364 ||| IN
day  ||| S:6364 E:6368 ||| NN
14 ||| S:6368 E:6370 ||| CD
,  ||| S:6370 E:6372 ||| ,
resulting  ||| S:6372 E:6382 ||| VBG
in  ||| S:6382 E:6395 ||| IN
a  ||| S:6395 E:6397 ||| DT
scab  ||| S:6397 E:6402 ||| NN
with  ||| S:6402 E:6407 ||| IN
a  ||| S:6407 E:6409 ||| DT
gaping  ||| S:6409 E:6416 ||| JJ
red  ||| S:6416 E:6420 ||| JJ
wound  ||| S:6420 E:6426 ||| NN
field ||| S:6426 E:6431 ||| NN
,  ||| S:6431 E:6433 ||| ,
which  ||| S:6433 E:6439 ||| WDT
was  ||| S:6439 E:6443 ||| VBD
evident  ||| S:6443 E:6461 ||| JJ
even  ||| S:6461 E:6466 ||| RB
at  ||| S:6466 E:6469 ||| IN
22  ||| S:6469 E:6472 ||| CD
days  ||| S:6472 E:6477 ||| NNS
( ||| S:6477 E:6478 ||| -LRB-
Fig.  ||| S:6478 E:6483 ||| NNP
1A ||| S:6483 E:6485 ||| NNP
,  ||| S:6485 E:6487 ||| ,
upper  ||| S:6487 E:6493 ||| JJ
panel ||| S:6493 E:6498 ||| NN
) ||| S:6498 E:6499 ||| -RRB-
.  ||| S:6499 E:6501 ||| .
Healing  ||| S:6501 E:6509 ||| NN
of  ||| S:6509 E:6522 ||| IN
SPARC-null  ||| S:6522 E:6533 ||| JJ
wounds  ||| S:6533 E:6540 ||| NNS
remained  ||| S:6540 E:6549 ||| VBD
incomplete  ||| S:6549 E:6560 ||| JJ
on  ||| S:6560 E:6563 ||| IN
day  ||| S:6563 E:6567 ||| NN
24 ||| S:6567 E:6569 ||| CD
,  ||| S:6569 E:6571 ||| ,
and  ||| S:6571 E:6585 ||| CC
complete  ||| S:6585 E:6594 ||| JJ
healing  ||| S:6594 E:6602 ||| NN
in  ||| S:6602 E:6605 ||| IN
all  ||| S:6605 E:6609 ||| DT
mice  ||| S:6609 E:6614 ||| NNS
was  ||| S:6614 E:6618 ||| VBD
observed  ||| S:6618 E:6627 ||| VBN
between  ||| S:6627 E:6635 ||| IN
25  ||| S:6635 E:6638 ||| CD
and  ||| S:6638 E:6652 ||| CC
31  ||| S:6652 E:6655 ||| CD
days  ||| S:6655 E:6660 ||| NNS
( ||| S:6660 E:6661 ||| -LRB-
Fig.  ||| S:6661 E:6666 ||| NNP
1A ||| S:6666 E:6668 ||| NNP
,  ||| S:6668 E:6670 ||| ,
lower  ||| S:6670 E:6676 ||| JJR
panel ||| S:6676 E:6681 ||| NN
) ||| S:6681 E:6682 ||| -RRB-
.  ||| S:6682 E:6684 ||| .
Similar  ||| S:6684 E:6692 ||| JJ
results  ||| S:6692 E:6700 ||| NNS
were  ||| S:6700 E:6705 ||| VBD
seen  ||| S:6705 E:6720 ||| VBN
with  ||| S:6720 E:6725 ||| IN
30-mm  ||| S:6725 E:6731 ||| CD
circular  ||| S:6731 E:6740 ||| JJ
excision  ||| S:6740 E:6749 ||| NN
wounds  ||| S:6749 E:6756 ||| NNS
( ||| S:6756 E:6757 ||| -LRB-
not  ||| S:6757 E:6761 ||| RB
shown ||| S:6761 E:6766 ||| VBN
) ||| S:6766 E:6767 ||| -RRB-
.  ||| S:6767 E:6779 ||| .
Although  ||| S:6779 E:6788 ||| IN
the  ||| S:6788 E:6792 ||| DT
larger  ||| S:6792 E:6799 ||| JJR
25  ||| S:6799 E:6802 ||| CD
mm  ||| S:6802 E:6805 ||| JJ
oblong ||| S:6805 E:6811 ||| NN
,  ||| S:6811 E:6813 ||| ,
full  ||| S:6813 E:6818 ||| JJ
thickness  ||| S:6818 E:6838 ||| NN
excisions  ||| S:6838 E:6848 ||| NNS
allowed  ||| S:6848 E:6856 ||| VBD
us  ||| S:6856 E:6859 ||| PRP
to  ||| S:6859 E:6862 ||| TO
observe  ||| S:6862 E:6870 ||| VB
visible  ||| S:6870 E:6878 ||| JJ
differences  ||| S:6878 E:6890 ||| NNS
in  ||| S:6890 E:6903 ||| IN
wound  ||| S:6903 E:6909 ||| JJ
healing  ||| S:6909 E:6917 ||| NN
progression ||| S:6917 E:6928 ||| NN
,  ||| S:6928 E:6930 ||| ,
the  ||| S:6930 E:6934 ||| DT
wound  ||| S:6934 E:6940 ||| JJ
sites  ||| S:6940 E:6946 ||| NNS
were  ||| S:6946 E:6951 ||| VBD
too  ||| S:6951 E:6965 ||| RB
fragile  ||| S:6965 E:6973 ||| JJ
to  ||| S:6973 E:6976 ||| TO
be  ||| S:6976 E:6979 ||| VB
isolated  ||| S:6979 E:6988 ||| VBN
for  ||| S:6988 E:6992 ||| IN
histological  ||| S:6992 E:7005 ||| JJ
examination ||| S:7005 E:7016 ||| NN
.  ||| S:7016 E:7018 ||| .
We  ||| S:7018 E:7031 ||| PRP
therefore  ||| S:7031 E:7041 ||| RB
made  ||| S:7041 E:7046 ||| VBD
6  ||| S:7046 E:7048 ||| CD
mm  ||| S:7048 E:7051 ||| CD
full  ||| S:7051 E:7056 ||| JJ
thickness  ||| S:7056 E:7066 ||| NN
circular  ||| S:7066 E:7075 ||| NN
lesions  ||| S:7075 E:7083 ||| NNS
and  ||| S:7083 E:7097 ||| CC
examined  ||| S:7097 E:7106 ||| VBD
the  ||| S:7106 E:7110 ||| DT
gross  ||| S:7110 E:7116 ||| JJ
and  ||| S:7116 E:7120 ||| CC
microscopic  ||| S:7120 E:7132 ||| JJ
appearance  ||| S:7132 E:7143 ||| NN
of  ||| S:7143 E:7146 ||| IN
skin  ||| S:7146 E:7161 ||| NN
wounds  ||| S:7161 E:7168 ||| NNS
at  ||| S:7168 E:7171 ||| IN
various  ||| S:7171 E:7179 ||| JJ
time  ||| S:7179 E:7184 ||| NN
points ||| S:7184 E:7190 ||| NNS
,  ||| S:7190 E:7192 ||| ,
with  ||| S:7192 E:7197 ||| IN
four  ||| S:7197 E:7202 ||| CD
wild-type  ||| S:7202 E:7212 ||| JJ
and  ||| S:7212 E:7226 ||| CC
four  ||| S:7226 E:7231 ||| CD
SPARC-null  ||| S:7231 E:7242 ||| JJ
mice  ||| S:7242 E:7247 ||| NNS
at  ||| S:7247 E:7250 ||| IN
each  ||| S:7250 E:7255 ||| DT
time  ||| S:7255 E:7260 ||| NN
point ||| S:7260 E:7265 ||| NN
.  ||| S:7265 E:7267 ||| .
Examination  ||| S:7267 E:7279 ||| NN
of  ||| S:7279 E:7292 ||| IN
the  ||| S:7292 E:7296 ||| DT
gross  ||| S:7296 E:7302 ||| JJ
appearance  ||| S:7302 E:7313 ||| NN
of  ||| S:7313 E:7316 ||| IN
wounds  ||| S:7316 E:7323 ||| NNS
showed  ||| S:7323 E:7330 ||| VBD
no  ||| S:7330 E:7333 ||| DT
apparent  ||| S:7333 E:7352 ||| JJ
difference  ||| S:7352 E:7363 ||| NN
in  ||| S:7363 E:7366 ||| IN
healing  ||| S:7366 E:7374 ||| JJ
progression  ||| S:7374 E:7386 ||| NN
between  ||| S:7386 E:7394 ||| IN
wild-type  ||| S:7394 E:7404 ||| JJ
and  ||| S:7404 E:7418 ||| CC
SPARC-null  ||| S:7418 E:7429 ||| JJ
mice ||| S:7429 E:7433 ||| NNS
,  ||| S:7433 E:7435 ||| ,
with  ||| S:7435 E:7440 ||| IN
build  ||| S:7440 E:7446 ||| VB
up  ||| S:7446 E:7449 ||| RP
of  ||| S:7449 E:7452 ||| IN
scab  ||| S:7452 E:7457 ||| NN
at  ||| S:7457 E:7460 ||| IN
day  ||| S:7460 E:7464 ||| NN
1  ||| S:7464 E:7466 ||| CD
and  ||| S:7466 E:7470 ||| CC
loss  ||| S:7470 E:7485 ||| NN
of  ||| S:7485 E:7488 ||| IN
scab  ||| S:7488 E:7493 ||| NN
by  ||| S:7493 E:7496 ||| IN
day  ||| S:7496 E:7500 ||| NN
10 ||| S:7500 E:7502 ||| CD
.  ||| S:7502 E:7504 ||| .
However ||| S:7504 E:7511 ||| RB
,  ||| S:7511 E:7513 ||| ,
we  ||| S:7513 E:7516 ||| PRP
detected  ||| S:7516 E:7525 ||| VBD
histological  ||| S:7525 E:7548 ||| JJ
differences  ||| S:7548 E:7560 ||| NNS
between  ||| S:7560 E:7568 ||| IN
wild-type  ||| S:7568 E:7578 ||| JJ
and  ||| S:7578 E:7582 ||| CC
SPARC-null  ||| S:7582 E:7593 ||| JJ
mice ||| S:7593 E:7597 ||| NNS
.  ||| S:7597 E:7609 ||| .
Histology  ||| S:7609 E:7619 ||| NNP
of  ||| S:7619 E:7622 ||| IN
6  ||| S:7622 E:7624 ||| CD
mm  ||| S:7624 E:7627 ||| JJ
wound  ||| S:7627 E:7633 ||| NN
tissues  ||| S:7633 E:7641 ||| NNS
showed  ||| S:7641 E:7648 ||| VBD
that  ||| S:7648 E:7653 ||| IN
at  ||| S:7653 E:7656 ||| IN
day  ||| S:7656 E:7660 ||| NN
2  ||| S:7660 E:7672 ||| CD
after  ||| S:7672 E:7678 ||| IN
wounding  ||| S:7678 E:7687 ||| VBG
the  ||| S:7687 E:7691 ||| DT
epidermis  ||| S:7691 E:7701 ||| NN
at  ||| S:7701 E:7704 ||| IN
wound  ||| S:7704 E:7710 ||| JJ
edges  ||| S:7710 E:7716 ||| NNS
had  ||| S:7716 E:7720 ||| VBD
grown  ||| S:7720 E:7736 ||| VBN
thicker  ||| S:7736 E:7744 ||| JJR
in  ||| S:7744 E:7747 ||| IN
both  ||| S:7747 E:7752 ||| DT
wild-type  ||| S:7752 E:7762 ||| JJ
and  ||| S:7762 E:7766 ||| CC
SPARC-null  ||| S:7766 E:7777 ||| JJ
mice ||| S:7777 E:7781 ||| NNS
,  ||| S:7781 E:7783 ||| ,
indicating  ||| S:7783 E:7804 ||| VBG
that  ||| S:7804 E:7809 ||| DT
proliferation  ||| S:7809 E:7823 ||| NN
of  ||| S:7823 E:7826 ||| IN
keratinocytes  ||| S:7826 E:7840 ||| NN
had  ||| S:7840 E:7844 ||| VBD
began ||| S:7844 E:7849 ||| VBD
.  ||| S:7849 E:7851 ||| .
However ||| S:7851 E:7858 ||| RB
,  ||| S:7858 E:7870 ||| ,
no  ||| S:7870 E:7873 ||| DT
granulation  ||| S:7873 E:7885 ||| JJ
tissue  ||| S:7885 E:7892 ||| NN
formation  ||| S:7892 E:7902 ||| NN
was  ||| S:7902 E:7906 ||| VBD
visible  ||| S:7906 E:7914 ||| JJ
at  ||| S:7914 E:7917 ||| IN
this  ||| S:7917 E:7922 ||| DT
stage  ||| S:7922 E:7938 ||| NN
of  ||| S:7938 E:7941 ||| IN
healing  ||| S:7941 E:7949 ||| NN
in  ||| S:7949 E:7952 ||| IN
either  ||| S:7952 E:7959 ||| DT
wild-type  ||| S:7959 E:7969 ||| JJ
or  ||| S:7969 E:7972 ||| CC
SPARC-null  ||| S:7972 E:7983 ||| JJ
mice  ||| S:7983 E:7998 ||| NNS
( ||| S:7998 E:7999 ||| -LRB-
results  ||| S:7999 E:8007 ||| NNS
not  ||| S:8007 E:8011 ||| RB
shown ||| S:8011 E:8016 ||| VBN
) ||| S:8016 E:8017 ||| -RRB-
.  ||| S:8017 E:8019 ||| .
At  ||| S:8019 E:8022 ||| IN
day  ||| S:8022 E:8026 ||| NN
4  ||| S:8026 E:8028 ||| CD
reepithelialization  ||| S:8028 E:8048 ||| NNS
and  ||| S:8048 E:8062 ||| CC
granulation  ||| S:8062 E:8074 ||| JJ
tissue  ||| S:8074 E:8081 ||| NN
growth  ||| S:8081 E:8088 ||| NN
had  ||| S:8088 E:8092 ||| VBD
begun  ||| S:8092 E:8098 ||| VBN
as  ||| S:8098 E:8101 ||| RB
shown  ||| S:8101 E:8107 ||| VBN
in  ||| S:8107 E:8110 ||| IN
the  ||| S:8110 E:8114 ||| DT
6  ||| S:8114 E:8116 ||| CD
mm  ||| S:8116 E:8129 ||| CD
biopsies  ||| S:8129 E:8138 ||| NNS
in  ||| S:8138 E:8141 ||| IN
figure  ||| S:8141 E:8148 ||| NN
1B ||| S:8148 E:8150 ||| NN
.  ||| S:8150 E:8152 ||| .
The  ||| S:8152 E:8156 ||| DT
epidermis  ||| S:8156 E:8166 ||| NN
had  ||| S:8166 E:8170 ||| VBD
begun  ||| S:8170 E:8176 ||| VBN
to  ||| S:8176 E:8179 ||| TO
migrate  ||| S:8179 E:8197 ||| VB
centrally  ||| S:8197 E:8207 ||| VBN
to  ||| S:8207 E:8210 ||| TO
cover  ||| S:8210 E:8216 ||| VB
the  ||| S:8216 E:8220 ||| DT
wound  ||| S:8220 E:8226 ||| JJ
edge  ||| S:8226 E:8231 ||| NN
and  ||| S:8231 E:8235 ||| CC
reepithelialization  ||| S:8235 E:8265 ||| NN
at  ||| S:8265 E:8268 ||| IN
this  ||| S:8268 E:8273 ||| DT
early  ||| S:8273 E:8279 ||| JJ
stage  ||| S:8279 E:8285 ||| NN
of  ||| S:8285 E:8288 ||| IN
wound  ||| S:8288 E:8294 ||| JJ
healing  ||| S:8294 E:8302 ||| NN
in  ||| S:8302 E:8305 ||| IN
a  ||| S:8305 E:8307 ||| DT
small  ||| S:8307 E:8313 ||| JJ
biopsy  ||| S:8313 E:8330 ||| NN
appeared  ||| S:8330 E:8339 ||| VBD
to  ||| S:8339 E:8342 ||| TO
be  ||| S:8342 E:8345 ||| VB
as  ||| S:8345 E:8348 ||| IN
efficient  ||| S:8348 E:8358 ||| JJ
in  ||| S:8358 E:8361 ||| IN
SPARC-null  ||| S:8361 E:8372 ||| JJ
mice  ||| S:8372 E:8377 ||| NNS
as  ||| S:8377 E:8380 ||| IN
in  ||| S:8380 E:8383 ||| IN
the  ||| S:8383 E:8397 ||| DT
wild-type  ||| S:8397 E:8407 ||| JJ
mice  ||| S:8407 E:8412 ||| NNS
except  ||| S:8412 E:8419 ||| IN
for  ||| S:8419 E:8423 ||| IN
the  ||| S:8423 E:8427 ||| DT
more  ||| S:8427 E:8432 ||| RBR
extensive  ||| S:8432 E:8442 ||| JJ
granulation  ||| S:8442 E:8464 ||| JJ
tissue  ||| S:8464 E:8471 ||| NN
formation  ||| S:8471 E:8481 ||| NN
in  ||| S:8481 E:8484 ||| IN
the  ||| S:8484 E:8488 ||| DT
wild-type  ||| S:8488 E:8498 ||| JJ
than  ||| S:8498 E:8503 ||| IN
in  ||| S:8503 E:8506 ||| IN
the  ||| S:8506 E:8510 ||| DT
SPARC-null  ||| S:8510 E:8531 ||| JJ
mice ||| S:8531 E:8535 ||| NNS
.  ||| S:8535 E:8537 ||| .
In  ||| S:8537 E:8540 ||| IN
wild-type  ||| S:8540 E:8550 ||| JJ
mice ||| S:8550 E:8554 ||| NNS
,  ||| S:8554 E:8556 ||| ,
the  ||| S:8556 E:8560 ||| DT
granulation  ||| S:8560 E:8572 ||| JJ
tissue  ||| S:8572 E:8579 ||| NN
had  ||| S:8579 E:8593 ||| VBD
formed  ||| S:8593 E:8600 ||| VBN
at  ||| S:8600 E:8603 ||| IN
the  ||| S:8603 E:8607 ||| DT
edge  ||| S:8607 E:8612 ||| NN
and  ||| S:8612 E:8616 ||| CC
base  ||| S:8616 E:8621 ||| NN
of  ||| S:8621 E:8624 ||| IN
the  ||| S:8624 E:8628 ||| DT
wound ||| S:8628 E:8633 ||| NN
.  ||| S:8633 E:8635 ||| .
In  ||| S:8635 E:8638 ||| IN
SPARC-null  ||| S:8638 E:8659 ||| JJ
mice ||| S:8659 E:8663 ||| NNS
,  ||| S:8663 E:8665 ||| ,
the  ||| S:8665 E:8669 ||| DT
granulation  ||| S:8669 E:8681 ||| JJ
tissue  ||| S:8681 E:8688 ||| NN
covered  ||| S:8688 E:8696 ||| VBD
the  ||| S:8696 E:8700 ||| DT
edge  ||| S:8700 E:8705 ||| NN
of  ||| S:8705 E:8708 ||| IN
the  ||| S:8708 E:8722 ||| DT
wound  ||| S:8722 E:8728 ||| NN
but  ||| S:8728 E:8732 ||| CC
did  ||| S:8732 E:8736 ||| VBD
not  ||| S:8736 E:8740 ||| RB
extend  ||| S:8740 E:8747 ||| VB
to  ||| S:8747 E:8750 ||| TO
the  ||| S:8750 E:8754 ||| DT
base  ||| S:8754 E:8759 ||| NN
of  ||| S:8759 E:8762 ||| IN
the  ||| S:8762 E:8766 ||| DT
wound  ||| S:8766 E:8772 ||| NN
( ||| S:8772 E:8773 ||| -LRB-
Fig.  ||| S:8773 E:8788 ||| NNP
1B ||| S:8788 E:8790 ||| NNP
) ||| S:8790 E:8791 ||| -RRB-
.  ||| S:8791 E:8793 ||| .
At  ||| S:8793 E:8796 ||| IN
day  ||| S:8796 E:8800 ||| NN
6 ||| S:8800 E:8801 ||| CD
,  ||| S:8801 E:8803 ||| ,
reepithelialization  ||| S:8803 E:8823 ||| NN
and  ||| S:8823 E:8827 ||| CC
granulation  ||| S:8827 E:8839 ||| JJ
tissue  ||| S:8839 E:8856 ||| NN
formation  ||| S:8856 E:8866 ||| NN
appeared  ||| S:8866 E:8875 ||| VBD
as  ||| S:8875 E:8878 ||| RB
elaborate  ||| S:8878 E:8888 ||| VB
in  ||| S:8888 E:8891 ||| IN
SPARC-null  ||| S:8891 E:8902 ||| JJ
mice  ||| S:8902 E:8907 ||| NNS
as  ||| S:8907 E:8910 ||| IN
in  ||| S:8910 E:8923 ||| IN
wild-type  ||| S:8923 E:8933 ||| JJ
mice  ||| S:8933 E:8938 ||| NNS
with  ||| S:8938 E:8943 ||| IN
the  ||| S:8943 E:8947 ||| DT
neoepidermis  ||| S:8947 E:8960 ||| NN
and  ||| S:8960 E:8964 ||| CC
granulation  ||| S:8964 E:8986 ||| JJ
tissue  ||| S:8986 E:8993 ||| NN
filling  ||| S:8993 E:9001 ||| VBG
two  ||| S:9001 E:9005 ||| CD
third  ||| S:9005 E:9011 ||| JJ
of  ||| S:9011 E:9014 ||| IN
the  ||| S:9014 E:9018 ||| DT
wound  ||| S:9018 E:9024 ||| JJ
beds  ||| S:9024 E:9029 ||| NNS
( ||| S:9029 E:9030 ||| -LRB-
not  ||| S:9030 E:9034 ||| RB
shown ||| S:9034 E:9039 ||| VBN
) ||| S:9039 E:9040 ||| -RRB-
.  ||| S:9040 E:9052 ||| .
By  ||| S:9052 E:9055 ||| IN
day  ||| S:9055 E:9059 ||| NN
10 ||| S:9059 E:9061 ||| CD
,  ||| S:9061 E:9063 ||| ,
the  ||| S:9063 E:9067 ||| DT
wound  ||| S:9067 E:9073 ||| JJ
areas  ||| S:9073 E:9079 ||| NNS
in  ||| S:9079 E:9082 ||| IN
both  ||| S:9082 E:9087 ||| DT
control  ||| S:9087 E:9095 ||| NN
and  ||| S:9095 E:9099 ||| CC
mutant  ||| S:9099 E:9116 ||| JJ
mice  ||| S:9116 E:9121 ||| NNS
were  ||| S:9121 E:9126 ||| VBD
smaller ||| S:9126 E:9133 ||| JJR
,  ||| S:9133 E:9135 ||| ,
reflecting  ||| S:9135 E:9146 ||| VBG
some  ||| S:9146 E:9151 ||| DT
degree  ||| S:9151 E:9158 ||| NN
of  ||| S:9158 E:9161 ||| IN
wound  ||| S:9161 E:9177 ||| JJ
contraction ||| S:9177 E:9188 ||| NN
,  ||| S:9188 E:9190 ||| ,
and  ||| S:9190 E:9194 ||| CC
in  ||| S:9194 E:9197 ||| IN
addition ||| S:9197 E:9205 ||| NN
,  ||| S:9205 E:9207 ||| ,
the  ||| S:9207 E:9211 ||| DT
wounds  ||| S:9211 E:9218 ||| NNS
were  ||| S:9218 E:9223 ||| VBD
now  ||| S:9223 E:9227 ||| RB
closed ||| S:9227 E:9233 ||| VBD
,  ||| S:9233 E:9245 ||| ,
being  ||| S:9245 E:9251 ||| VBG
completely  ||| S:9251 E:9262 ||| RB
covered  ||| S:9262 E:9270 ||| VBN
by  ||| S:9270 E:9273 ||| IN
epidermal  ||| S:9273 E:9283 ||| JJ
cells  ||| S:9283 E:9289 ||| NNS
and  ||| S:9289 E:9303 ||| CC
underlying  ||| S:9303 E:9314 ||| JJ
granulation  ||| S:9314 E:9326 ||| JJ
tissue  ||| S:9326 E:9333 ||| NN
( ||| S:9333 E:9334 ||| -LRB-
results  ||| S:9334 E:9342 ||| NNS
not  ||| S:9342 E:9346 ||| RB
shown ||| S:9346 E:9351 ||| VBN
) ||| S:9351 E:9352 ||| -RRB-
.  ||| S:9352 E:9364 ||| .
Northern  ||| S:9364 E:9373 ||| JJ
analysis  ||| S:9373 E:9382 ||| NN
of  ||| S:9382 E:9385 ||| IN
6  ||| S:9385 E:9387 ||| CD
mm  ||| S:9387 E:9390 ||| CD
circular  ||| S:9390 E:9399 ||| JJ
wound  ||| S:9399 E:9405 ||| NN
tissues  ||| S:9405 E:9423 ||| NNS
isolated  ||| S:9423 E:9432 ||| VBN
during  ||| S:9432 E:9439 ||| IN
a  ||| S:9439 E:9441 ||| DT
6  ||| S:9441 E:9443 ||| CD
day  ||| S:9443 E:9447 ||| NN
healing  ||| S:9447 E:9455 ||| NN
period  ||| S:9455 E:9462 ||| NN
showed  ||| S:9462 E:9469 ||| VBD
similar  ||| S:9469 E:9487 ||| JJ
patterns  ||| S:9487 E:9496 ||| NNS
of  ||| S:9496 E:9499 ||| IN
cytokeratin  ||| S:9499 E:9511 ||| CD
14  ||| S:9511 E:9514 ||| CD
expression  ||| S:9514 E:9525 ||| NN
in  ||| S:9525 E:9528 ||| IN
SPARC-null  ||| S:9528 E:9539 ||| JJ
mice  ||| S:9539 E:9554 ||| NNS
and  ||| S:9554 E:9558 ||| CC
wild-type  ||| S:9558 E:9568 ||| JJ
mice  ||| S:9568 E:9573 ||| NNS
( ||| S:9573 E:9574 ||| -LRB-
Fig.  ||| S:9574 E:9579 ||| CD
2 ||| S:9579 E:9580 ||| CD
) ||| S:9580 E:9581 ||| -RRB-
.  ||| S:9581 E:9583 ||| .
Cytokeratin  ||| S:9583 E:9595 ||| NNP
14  ||| S:9595 E:9598 ||| CD
expression  ||| S:9598 E:9609 ||| NN
is  ||| S:9609 E:9622 ||| VBZ
associated  ||| S:9622 E:9633 ||| VBN
with  ||| S:9633 E:9638 ||| IN
proliferative  ||| S:9638 E:9652 ||| JJ
epidermal  ||| S:9652 E:9662 ||| JJ
keratinocytes  ||| S:9662 E:9676 ||| NN
at  ||| S:9676 E:9689 ||| IN
wound  ||| S:9689 E:9695 ||| JJ
sites  ||| S:9695 E:9701 ||| NNS
[  ||| S:9701 E:9703 ||| -LRB-
24  ||| S:9703 E:9706 ||| CD
]  ||| S:9706 E:9708 ||| -RRB-
.  ||| S:9708 E:9710 ||| .
Such  ||| S:9710 E:9715 ||| JJ
expression  ||| S:9715 E:9726 ||| NN
in  ||| S:9726 E:9729 ||| IN
control  ||| S:9729 E:9737 ||| NN
unwounded  ||| S:9737 E:9757 ||| NN
skin  ||| S:9757 E:9762 ||| NN
( ||| S:9762 E:9763 ||| -LRB-
0  ||| S:9763 E:9765 ||| CD
day ||| S:9765 E:9768 ||| NN
)  ||| S:9768 E:9770 ||| -RRB-
is ||| S:9770 E:9772 ||| VBZ
,  ||| S:9772 E:9774 ||| ,
as  ||| S:9774 E:9777 ||| RB
expected ||| S:9777 E:9785 ||| VBN
,  ||| S:9785 E:9787 ||| ,
very  ||| S:9787 E:9792 ||| RB
low  ||| S:9792 E:9796 ||| JJ
but  ||| S:9796 E:9800 ||| CC
increased  ||| S:9800 E:9820 ||| VBD
appreciably  ||| S:9820 E:9832 ||| RB
by  ||| S:9832 E:9835 ||| IN
day  ||| S:9835 E:9839 ||| NN
2  ||| S:9839 E:9841 ||| CD
after  ||| S:9841 E:9847 ||| IN
wounding  ||| S:9847 E:9856 ||| NN
with  ||| S:9856 E:9861 ||| IN
peak  ||| S:9861 E:9866 ||| JJ
expression  ||| S:9866 E:9887 ||| NN
at  ||| S:9887 E:9890 ||| IN
day  ||| S:9890 E:9894 ||| NN
4 ||| S:9894 E:9895 ||| CD
.  ||| S:9895 E:9897 ||| .
Interestingly ||| S:9897 E:9910 ||| RB
,  ||| S:9910 E:9912 ||| ,
expression  ||| S:9912 E:9923 ||| NN
of  ||| S:9923 E:9926 ||| IN
cytokeratin  ||| S:9926 E:9938 ||| CD
14  ||| S:9938 E:9941 ||| CD
was  ||| S:9941 E:9955 ||| VBD
up-regulated  ||| S:9955 E:9968 ||| JJ
in  ||| S:9968 E:9971 ||| IN
the  ||| S:9971 E:9975 ||| DT
normal  ||| S:9975 E:9982 ||| JJ
epidermis  ||| S:9982 E:9992 ||| NN
and  ||| S:9992 E:9996 ||| CC
neoepidermis  ||| S:9996 E:10009 ||| NN
of  ||| S:10009 E:10022 ||| IN
SPARC-null  ||| S:10022 E:10033 ||| JJ
mice  ||| S:10033 E:10038 ||| NNS
relative  ||| S:10038 E:10047 ||| JJ
to  ||| S:10047 E:10050 ||| TO
those  ||| S:10050 E:10056 ||| DT
of  ||| S:10056 E:10059 ||| IN
wild-type  ||| S:10059 E:10069 ||| JJ
mice  ||| S:10069 E:10074 ||| NNS
( ||| S:10074 E:10075 ||| -LRB-
Fig.  ||| S:10075 E:10090 ||| CD
2 ||| S:10090 E:10091 ||| CD
) ||| S:10091 E:10092 ||| -RRB-
,  ||| S:10092 E:10094 ||| ,
although  ||| S:10094 E:10103 ||| IN
histologically  ||| S:10103 E:10118 ||| VBG
no  ||| S:10118 E:10121 ||| DT
differences  ||| S:10121 E:10133 ||| NNS
in  ||| S:10133 E:10146 ||| IN
reepithelialization  ||| S:10146 E:10166 ||| NN
between  ||| S:10166 E:10174 ||| IN
the  ||| S:10174 E:10178 ||| DT
SPARC-null  ||| S:10178 E:10189 ||| JJ
and  ||| S:10189 E:10193 ||| CC
wild-type  ||| S:10193 E:10213 ||| JJ
wounds  ||| S:10213 E:10220 ||| NNS
were  ||| S:10220 E:10225 ||| VBD
apparent  ||| S:10225 E:10234 ||| JJ
( ||| S:10234 E:10235 ||| -LRB-
Fig.  ||| S:10235 E:10240 ||| NNP
1B ||| S:10240 E:10242 ||| NNP
) ||| S:10242 E:10243 ||| -RRB-
.  ||| S:10243 E:10245 ||| .
Analysis  ||| S:10245 E:10254 ||| NN
of  ||| S:10254 E:10257 ||| IN
α1 ||| S:10257 E:10259 ||| NNP
( ||| S:10259 E:10260 ||| -LRB-
I ||| S:10260 E:10261 ||| PRP
)  ||| S:10261 E:10273 ||| -RRB-
collagen  ||| S:10273 E:10282 ||| NN
and  ||| S:10282 E:10286 ||| CC
fibronectin  ||| S:10286 E:10298 ||| JJ
transcripts ||| S:10298 E:10309 ||| NNS
,  ||| S:10309 E:10311 ||| ,
which  ||| S:10311 E:10317 ||| WDT
are  ||| S:10317 E:10331 ||| VBP
synthesized  ||| S:10331 E:10343 ||| VBN
by  ||| S:10343 E:10346 ||| IN
fibroblasts  ||| S:10346 E:10358 ||| NN
of  ||| S:10358 E:10361 ||| IN
dermal  ||| S:10361 E:10368 ||| JJ
granulation  ||| S:10368 E:10380 ||| JJ
tissue  ||| S:10380 E:10387 ||| NN
[  ||| S:10387 E:10399 ||| -LRB-
25  ||| S:10399 E:10402 ||| CD
26  ||| S:10402 E:10405 ||| CD
27  ||| S:10405 E:10408 ||| CD
]  ||| S:10408 E:10410 ||| -RRB-
,  ||| S:10410 E:10412 ||| ,
revealed  ||| S:10412 E:10421 ||| VBD
that  ||| S:10421 E:10426 ||| DT
expression  ||| S:10426 E:10437 ||| NN
of  ||| S:10437 E:10440 ||| IN
both  ||| S:10440 E:10445 ||| DT
transcripts  ||| S:10445 E:10467 ||| NNS
was  ||| S:10467 E:10471 ||| VBD
delayed  ||| S:10471 E:10479 ||| VBN
in  ||| S:10479 E:10482 ||| IN
the  ||| S:10482 E:10486 ||| DT
wounds  ||| S:10486 E:10493 ||| NNS
of  ||| S:10493 E:10496 ||| IN
SPARC-null  ||| S:10496 E:10507 ||| JJ
mice  ||| S:10507 E:10512 ||| NNS
relative  ||| S:10512 E:10521 ||| JJ
to  ||| S:10521 E:10534 ||| TO
those  ||| S:10534 E:10540 ||| DT
of  ||| S:10540 E:10543 ||| IN
wild-type  ||| S:10543 E:10553 ||| JJ
mice  ||| S:10553 E:10558 ||| NNS
( ||| S:10558 E:10559 ||| -LRB-
Fig.  ||| S:10559 E:10564 ||| CD
2 ||| S:10564 E:10565 ||| CD
) ||| S:10565 E:10566 ||| -RRB-
.  ||| S:10566 E:10568 ||| .
In  ||| S:10568 E:10571 ||| IN
wild-type  ||| S:10571 E:10581 ||| JJ
mice ||| S:10581 E:10585 ||| NNS
,  ||| S:10585 E:10587 ||| ,
both  ||| S:10587 E:10602 ||| DT
transcripts  ||| S:10602 E:10614 ||| NNS
were  ||| S:10614 E:10619 ||| VBD
expressed  ||| S:10619 E:10629 ||| VBN
in  ||| S:10629 E:10632 ||| IN
the  ||| S:10632 E:10636 ||| DT
unwounded  ||| S:10636 E:10646 ||| JJ
skin  ||| S:10646 E:10651 ||| NN
( ||| S:10651 E:10652 ||| -LRB-
0  ||| S:10652 E:10654 ||| CD
day ||| S:10654 E:10657 ||| NN
)  ||| S:10657 E:10669 ||| -RRB-
used  ||| S:10669 E:10674 ||| VBN
as  ||| S:10674 E:10677 ||| IN
controls ||| S:10677 E:10685 ||| NNS
.  ||| S:10685 E:10687 ||| .
At  ||| S:10687 E:10690 ||| IN
day  ||| S:10690 E:10694 ||| NN
2 ||| S:10694 E:10695 ||| CD
,  ||| S:10695 E:10697 ||| ,
the  ||| S:10697 E:10701 ||| DT
levels  ||| S:10701 E:10708 ||| NNS
of  ||| S:10708 E:10711 ||| IN
the  ||| S:10711 E:10715 ||| DT
two  ||| S:10715 E:10729 ||| CD
transcripts  ||| S:10729 E:10741 ||| NNS
decreased  ||| S:10741 E:10751 ||| VBD
appreciably  ||| S:10751 E:10763 ||| RB
below  ||| S:10763 E:10769 ||| IN
the  ||| S:10769 E:10773 ||| DT
levels  ||| S:10773 E:10780 ||| NNS
of  ||| S:10780 E:10783 ||| IN
the  ||| S:10783 E:10797 ||| DT
control  ||| S:10797 E:10805 ||| NN
skin  ||| S:10805 E:10810 ||| NN
followed  ||| S:10810 E:10819 ||| VBN
by  ||| S:10819 E:10822 ||| IN
an  ||| S:10822 E:10825 ||| DT
increase  ||| S:10825 E:10834 ||| NN
in  ||| S:10834 E:10837 ||| IN
expression  ||| S:10837 E:10858 ||| NN
between  ||| S:10858 E:10866 ||| IN
day  ||| S:10866 E:10870 ||| NN
2  ||| S:10870 E:10872 ||| CD
and  ||| S:10872 E:10876 ||| CC
day  ||| S:10876 E:10880 ||| NN
4 ||| S:10880 E:10881 ||| CD
.  ||| S:10881 E:10883 ||| .
In  ||| S:10883 E:10886 ||| IN
the  ||| S:10886 E:10890 ||| DT
case  ||| S:10890 E:10895 ||| NN
of  ||| S:10895 E:10898 ||| IN
SPARC-null  ||| S:10898 E:10909 ||| JJ
mice ||| S:10909 E:10913 ||| NNS
,  ||| S:10913 E:10925 ||| ,
expression  ||| S:10925 E:10936 ||| NN
of  ||| S:10936 E:10939 ||| IN
the  ||| S:10939 E:10943 ||| DT
two  ||| S:10943 E:10947 ||| CD
transcripts  ||| S:10947 E:10959 ||| NNS
remained  ||| S:10959 E:10968 ||| VBD
below  ||| S:10968 E:10974 ||| IN
the  ||| S:10974 E:10988 ||| DT
control  ||| S:10988 E:10996 ||| NN
unwounded  ||| S:10996 E:11006 ||| NN
skin  ||| S:11006 E:11011 ||| NN
at  ||| S:11011 E:11014 ||| IN
day  ||| S:11014 E:11018 ||| NN
2  ||| S:11018 E:11020 ||| CD
and  ||| S:11020 E:11024 ||| CC
day  ||| S:11024 E:11028 ||| NN
4  ||| S:11028 E:11030 ||| CD
and  ||| S:11030 E:11034 ||| CC
did  ||| S:11034 E:11038 ||| VBD
not  ||| S:11038 E:11052 ||| RB
begin  ||| S:11052 E:11058 ||| VB
to  ||| S:11058 E:11061 ||| TO
increase  ||| S:11061 E:11070 ||| VB
until  ||| S:11070 E:11076 ||| IN
between  ||| S:11076 E:11084 ||| IN
day  ||| S:11084 E:11088 ||| NN
4  ||| S:11088 E:11090 ||| CD
and  ||| S:11090 E:11094 ||| CC
day  ||| S:11094 E:11098 ||| NN
6  ||| S:11098 E:11100 ||| CD
( ||| S:11100 E:11101 ||| -LRB-
Fig.  ||| S:11101 E:11106 ||| CD
2 ||| S:11106 E:11107 ||| CD
) ||| S:11107 E:11108 ||| -RRB-
.  ||| S:11108 E:11120 ||| .
Thus ||| S:11120 E:11124 ||| RB
,  ||| S:11124 E:11126 ||| ,
we  ||| S:11126 E:11129 ||| PRP
conclude  ||| S:11129 E:11138 ||| VBP
that  ||| S:11138 E:11143 ||| IN
SPARC  ||| S:11143 E:11149 ||| NNP
deficiency  ||| S:11149 E:11160 ||| NN
compromises  ||| S:11160 E:11182 ||| VBZ
granulation  ||| S:11182 E:11194 ||| JJ
tissue  ||| S:11194 E:11201 ||| NN
formation  ||| S:11201 E:11211 ||| NN
that  ||| S:11211 E:11216 ||| WDT
involves  ||| S:11216 E:11225 ||| VBZ
fibroblast  ||| S:11225 E:11246 ||| JJ
ingrowth  ||| S:11246 E:11255 ||| NN
and  ||| S:11255 E:11259 ||| CC
ECM  ||| S:11259 E:11263 ||| NNP
protein  ||| S:11263 E:11271 ||| NN
deposition ||| S:11271 E:11281 ||| NN
.  ||| S:11281 E:11311 ||| .
Impaired  ||| S:11311 E:11320 ||| JJ
wound  ||| S:11320 E:11326 ||| NN
repair  ||| S:11326 E:11333 ||| NN
by  ||| S:11333 E:11336 ||| IN
cultured  ||| S:11336 E:11345 ||| JJ
SPARC-null  ||| S:11345 E:11366 ||| JJ
fibroblasts  ||| S:11366 E:11388 ||| JJ
Granulation  ||| S:11388 E:11400 ||| JJ
tissue  ||| S:11400 E:11407 ||| NN
formation  ||| S:11407 E:11417 ||| NN
after  ||| S:11417 E:11423 ||| IN
cutaneous  ||| S:11423 E:11433 ||| JJ
wounding  ||| S:11433 E:11452 ||| NN
involves  ||| S:11452 E:11461 ||| VBZ
both  ||| S:11461 E:11466 ||| DT
cell  ||| S:11466 E:11471 ||| NN
proliferation  ||| S:11471 E:11485 ||| NN
and  ||| S:11485 E:11489 ||| CC
migration  ||| S:11489 E:11499 ||| NNS
[  ||| S:11499 E:11501 ||| -LRB-
1  ||| S:11501 E:11503 ||| LS
]  ||| S:11503 E:11505 ||| -RRB-
.  ||| S:11505 E:11517 ||| .
However ||| S:11517 E:11524 ||| RB
,  ||| S:11524 E:11526 ||| ,
these  ||| S:11526 E:11532 ||| DT
two  ||| S:11532 E:11536 ||| CD
processes  ||| S:11536 E:11546 ||| NNS
are  ||| S:11546 E:11550 ||| VBP
difficult  ||| S:11550 E:11560 ||| JJ
to  ||| S:11560 E:11563 ||| TO
analyze  ||| S:11563 E:11571 ||| VB
in  ||| S:11571 E:11584 ||| IN
vivo ||| S:11584 E:11588 ||| NN
.  ||| S:11588 E:11590 ||| .
To  ||| S:11590 E:11593 ||| TO
investigate  ||| S:11593 E:11605 ||| VB
these  ||| S:11605 E:11611 ||| DT
two  ||| S:11611 E:11615 ||| CD
processes ||| S:11615 E:11624 ||| NNS
,  ||| S:11624 E:11626 ||| ,
a  ||| S:11626 E:11628 ||| DT
small  ||| S:11628 E:11634 ||| JJ
scrape  ||| S:11634 E:11651 ||| JJ
wound  ||| S:11651 E:11657 ||| NN
was  ||| S:11657 E:11661 ||| VBD
made  ||| S:11661 E:11666 ||| VBN
across  ||| S:11666 E:11673 ||| IN
a  ||| S:11673 E:11675 ||| DT
confluent  ||| S:11675 E:11685 ||| JJ
monolayer  ||| S:11685 E:11695 ||| NN
of  ||| S:11695 E:11698 ||| IN
primary  ||| S:11698 E:11716 ||| JJ
dermal  ||| S:11716 E:11723 ||| JJ
fibroblasts  ||| S:11723 E:11735 ||| NN
and  ||| S:11735 E:11739 ||| CC
the  ||| S:11739 E:11743 ||| DT
process  ||| S:11743 E:11751 ||| NN
of  ||| S:11751 E:11754 ||| IN
wound  ||| S:11754 E:11760 ||| JJ
closure  ||| S:11760 E:11768 ||| NN
was  ||| S:11768 E:11782 ||| VBD
monitored  ||| S:11782 E:11792 ||| VBN
( ||| S:11792 E:11793 ||| -LRB-
Fig.  ||| S:11793 E:11798 ||| NNP
3A ||| S:11798 E:11800 ||| NNP
) ||| S:11800 E:11801 ||| -RRB-
.  ||| S:11801 E:11803 ||| .
In  ||| S:11803 E:11806 ||| IN
wild-type  ||| S:11806 E:11816 ||| JJ
cells ||| S:11816 E:11821 ||| NNS
,  ||| S:11821 E:11823 ||| ,
at  ||| S:11823 E:11826 ||| IN
11  ||| S:11826 E:11829 ||| CD
hours  ||| S:11829 E:11845 ||| NNS
after  ||| S:11845 E:11851 ||| IN
wounding ||| S:11851 E:11859 ||| NN
,  ||| S:11859 E:11861 ||| ,
repair  ||| S:11861 E:11868 ||| NN
of  ||| S:11868 E:11871 ||| IN
the  ||| S:11871 E:11875 ||| DT
wound  ||| S:11875 E:11881 ||| NN
was  ||| S:11881 E:11885 ||| VBD
essentially  ||| S:11885 E:11907 ||| RB
complete  ||| S:11907 E:11916 ||| VB
with  ||| S:11916 E:11921 ||| IN
the  ||| S:11921 E:11925 ||| DT
denuded  ||| S:11925 E:11933 ||| JJ
area  ||| S:11933 E:11938 ||| NN
covered  ||| S:11938 E:11946 ||| VBN
with  ||| S:11946 E:11951 ||| IN
fibroblasts  ||| S:11951 E:11973 ||| NNS
( ||| S:11973 E:11974 ||| -LRB-
Fig.  ||| S:11974 E:11979 ||| NNP
3A ||| S:11979 E:11981 ||| NNP
,  ||| S:11981 E:11983 ||| ,
upper  ||| S:11983 E:11989 ||| JJ
panel ||| S:11989 E:11994 ||| NN
) ||| S:11994 E:11995 ||| -RRB-
.  ||| S:11995 E:11997 ||| .
In  ||| S:11997 E:12000 ||| IN
comparison ||| S:12000 E:12010 ||| NN
,  ||| S:12010 E:12012 ||| ,
repair  ||| S:12012 E:12019 ||| NN
of  ||| S:12019 E:12022 ||| IN
the  ||| S:12022 E:12036 ||| DT
wounded  ||| S:12036 E:12044 ||| JJ
SPARC-null  ||| S:12044 E:12055 ||| JJ
fibroblast  ||| S:12055 E:12066 ||| JJ
monolayer  ||| S:12066 E:12076 ||| NN
was  ||| S:12076 E:12080 ||| VBD
retarded  ||| S:12080 E:12099 ||| JJ
( ||| S:12099 E:12100 ||| -LRB-
Fig.  ||| S:12100 E:12105 ||| NNP
3A ||| S:12105 E:12107 ||| NNP
,  ||| S:12107 E:12109 ||| ,
lower  ||| S:12109 E:12115 ||| JJR
panel ||| S:12115 E:12120 ||| NN
) ||| S:12120 E:12121 ||| -RRB-
.  ||| S:12121 E:12123 ||| .
The  ||| S:12123 E:12127 ||| DT
denuded  ||| S:12127 E:12135 ||| JJ
area  ||| S:12135 E:12140 ||| NN
remained  ||| S:12140 E:12159 ||| VBD
unpopulated  ||| S:12159 E:12171 ||| VBN
through  ||| S:12171 E:12179 ||| IN
11  ||| S:12179 E:12182 ||| CD
to  ||| S:12182 E:12185 ||| TO
15  ||| S:12185 E:12188 ||| CD
hours ||| S:12188 E:12193 ||| NNS
,  ||| S:12193 E:12195 ||| ,
even  ||| S:12195 E:12200 ||| RB
though  ||| S:12200 E:12207 ||| IN
cells  ||| S:12207 E:12213 ||| NNS
at  ||| S:12213 E:12226 ||| IN
the  ||| S:12226 E:12230 ||| DT
edge  ||| S:12230 E:12235 ||| NN
of  ||| S:12235 E:12238 ||| IN
the  ||| S:12238 E:12242 ||| DT
wound  ||| S:12242 E:12248 ||| NN
showed  ||| S:12248 E:12255 ||| VBD
forward  ||| S:12255 E:12263 ||| RP
movement ||| S:12263 E:12271 ||| NN
.  ||| S:12271 E:12273 ||| .
The  ||| S:12273 E:12277 ||| DT
first  ||| S:12277 E:12293 ||| JJ
evidence  ||| S:12293 E:12302 ||| NN
of  ||| S:12302 E:12305 ||| IN
cell  ||| S:12305 E:12310 ||| NN
ingrowth  ||| S:12310 E:12319 ||| NNS
did  ||| S:12319 E:12323 ||| VBD
not  ||| S:12323 E:12327 ||| RB
appear  ||| S:12327 E:12334 ||| VB
until  ||| S:12334 E:12340 ||| IN
around  ||| S:12340 E:12347 ||| IN
24  ||| S:12347 E:12360 ||| CD
hours  ||| S:12360 E:12366 ||| NNS
and  ||| S:12366 E:12370 ||| CC
wound  ||| S:12370 E:12376 ||| JJ
repair  ||| S:12376 E:12383 ||| NN
was  ||| S:12383 E:12387 ||| VBD
not  ||| S:12387 E:12391 ||| RB
complete  ||| S:12391 E:12400 ||| VB
until  ||| S:12400 E:12406 ||| IN
some  ||| S:12406 E:12411 ||| DT
time  ||| S:12411 E:12426 ||| NN
between  ||| S:12426 E:12434 ||| IN
31  ||| S:12434 E:12437 ||| CD
and  ||| S:12437 E:12441 ||| CC
48  ||| S:12441 E:12444 ||| CD
hours  ||| S:12444 E:12450 ||| NNS
after  ||| S:12450 E:12456 ||| IN
wounding ||| S:12456 E:12464 ||| NN
.  ||| S:12464 E:12466 ||| .
Since  ||| S:12466 E:12472 ||| IN
the  ||| S:12472 E:12486 ||| DT
doubling  ||| S:12486 E:12495 ||| NN
time  ||| S:12495 E:12500 ||| NN
for  ||| S:12500 E:12504 ||| IN
these  ||| S:12504 E:12510 ||| DT
dermal  ||| S:12510 E:12517 ||| JJ
fibroblasts  ||| S:12517 E:12529 ||| NN
was  ||| S:12529 E:12533 ||| VBD
about  ||| S:12533 E:12539 ||| IN
20  ||| S:12539 E:12552 ||| CD
hours  ||| S:12552 E:12558 ||| NNS
( ||| S:12558 E:12559 ||| -LRB-
our  ||| S:12559 E:12563 ||| PRP$
unpublished  ||| S:12563 E:12575 ||| JJ
observation ||| S:12575 E:12586 ||| NN
) ||| S:12586 E:12587 ||| -RRB-
,  ||| S:12587 E:12589 ||| ,
the  ||| S:12589 E:12593 ||| DT
healing  ||| S:12593 E:12601 ||| NN
in  ||| S:12601 E:12614 ||| IN
wild-type  ||| S:12614 E:12624 ||| JJ
cells  ||| S:12624 E:12630 ||| NNS
at  ||| S:12630 E:12633 ||| IN
11  ||| S:12633 E:12636 ||| CD
hours  ||| S:12636 E:12642 ||| NNS
implied  ||| S:12642 E:12650 ||| VBN
that  ||| S:12650 E:12655 ||| IN
wild-type  ||| S:12655 E:12675 ||| JJ
fibroblasts  ||| S:12675 E:12687 ||| NN
had  ||| S:12687 E:12691 ||| VBD
extensively  ||| S:12691 E:12703 ||| RB
migrated  ||| S:12703 E:12712 ||| VBN
from  ||| S:12712 E:12717 ||| IN
the  ||| S:12717 E:12721 ||| DT
edge  ||| S:12721 E:12726 ||| NN
of  ||| S:12726 E:12729 ||| IN
the  ||| S:12729 E:12743 ||| DT
wound  ||| S:12743 E:12749 ||| NN
into  ||| S:12749 E:12754 ||| IN
the  ||| S:12754 E:12758 ||| DT
wound  ||| S:12758 E:12764 ||| JJ
site  ||| S:12764 E:12769 ||| NN
prior  ||| S:12769 E:12775 ||| RB
to  ||| S:12775 E:12778 ||| TO
the  ||| S:12778 E:12782 ||| DT
onset  ||| S:12782 E:12788 ||| NN
of  ||| S:12788 E:12791 ||| IN
cell  ||| S:12791 E:12806 ||| NN
proliferation ||| S:12806 E:12819 ||| NN
.  ||| S:12819 E:12821 ||| .
However  ||| S:12821 E:12829 ||| RB
SPARC-null  ||| S:12829 E:12840 ||| JJ
cells  ||| S:12840 E:12846 ||| NNS
did  ||| S:12846 E:12850 ||| VBD
not  ||| S:12850 E:12854 ||| RB
show  ||| S:12854 E:12859 ||| VB
any  ||| S:12859 E:12873 ||| DT
migration  ||| S:12873 E:12883 ||| JJ
prior  ||| S:12883 E:12889 ||| JJ
to  ||| S:12889 E:12892 ||| TO
the  ||| S:12892 E:12896 ||| DT
onset  ||| S:12896 E:12902 ||| NN
of  ||| S:12902 E:12905 ||| IN
cell  ||| S:12905 E:12910 ||| NN
proliferation  ||| S:12910 E:12924 ||| NN
and  ||| S:12924 E:12938 ||| CC
ingrowth  ||| S:12938 E:12947 ||| NNS
was  ||| S:12947 E:12951 ||| VBD
retarded  ||| S:12951 E:12960 ||| VBN
even  ||| S:12960 E:12965 ||| RB
after  ||| S:12965 E:12971 ||| IN
the  ||| S:12971 E:12975 ||| DT
onset  ||| S:12975 E:12981 ||| NN
of  ||| S:12981 E:12984 ||| IN
cell  ||| S:12984 E:12999 ||| NN
proliferation ||| S:12999 E:13012 ||| NN
.  ||| S:13012 E:13014 ||| .
This  ||| S:13014 E:13019 ||| DT
defect  ||| S:13019 E:13026 ||| NN
in  ||| S:13026 E:13029 ||| IN
cell  ||| S:13029 E:13034 ||| NN
motility  ||| S:13034 E:13043 ||| NNS
was  ||| S:13043 E:13047 ||| VBD
rescued  ||| S:13047 E:13065 ||| VBN
to  ||| S:13065 E:13068 ||| TO
the  ||| S:13068 E:13072 ||| DT
level  ||| S:13072 E:13078 ||| NN
of  ||| S:13078 E:13081 ||| IN
wild-type  ||| S:13081 E:13091 ||| JJ
cells  ||| S:13091 E:13097 ||| NNS
by  ||| S:13097 E:13100 ||| IN
the  ||| S:13100 E:13104 ||| DT
addition  ||| S:13104 E:13113 ||| NN
of  ||| S:13113 E:13126 ||| IN
purified  ||| S:13126 E:13135 ||| JJ
SPARC  ||| S:13135 E:13141 ||| NNP
( ||| S:13141 E:13142 ||| -LRB-
Fig.  ||| S:13142 E:13147 ||| NNP
3B ||| S:13147 E:13149 ||| NNP
) ||| S:13149 E:13150 ||| -RRB-
.  ||| S:13150 E:13152 ||| .
The  ||| S:13152 E:13156 ||| DT
denuded  ||| S:13156 E:13164 ||| JJ
area  ||| S:13164 E:13169 ||| NN
was  ||| S:13169 E:13183 ||| VBD
repopulated  ||| S:13183 E:13195 ||| VBN
by  ||| S:13195 E:13198 ||| IN
the  ||| S:13198 E:13202 ||| DT
SPARC-null  ||| S:13202 E:13213 ||| JJ
cells  ||| S:13213 E:13219 ||| NNS
by  ||| S:13219 E:13222 ||| IN
11  ||| S:13222 E:13225 ||| CD
hours  ||| S:13225 E:13231 ||| NNS
in  ||| S:13231 E:13234 ||| IN
the  ||| S:13234 E:13248 ||| DT
presence  ||| S:13248 E:13257 ||| NN
of  ||| S:13257 E:13260 ||| IN
added  ||| S:13260 E:13266 ||| JJ
SPARC  ||| S:13266 E:13272 ||| NNP
( ||| S:13272 E:13273 ||| -LRB-
Fig.  ||| S:13273 E:13278 ||| NNP
3B ||| S:13278 E:13280 ||| NNP
,  ||| S:13280 E:13282 ||| ,
lower  ||| S:13282 E:13288 ||| JJR
panel ||| S:13288 E:13293 ||| NN
)  ||| S:13293 E:13295 ||| -RRB-
as  ||| S:13295 E:13308 ||| RB
compared  ||| S:13308 E:13317 ||| VBN
to  ||| S:13317 E:13320 ||| TO
48  ||| S:13320 E:13323 ||| CD
hours  ||| S:13323 E:13329 ||| NNS
in  ||| S:13329 E:13332 ||| IN
its  ||| S:13332 E:13336 ||| PRP$
absence  ||| S:13336 E:13344 ||| NN
( ||| S:13344 E:13345 ||| -LRB-
Fig.  ||| S:13345 E:13350 ||| NNP
3A ||| S:13350 E:13352 ||| NNP
,  ||| S:13352 E:13354 ||| ,
lower  ||| S:13354 E:13370 ||| JJR
panel ||| S:13370 E:13375 ||| NN
) ||| S:13375 E:13376 ||| -RRB-
.  ||| S:13376 E:13378 ||| .
The  ||| S:13378 E:13382 ||| DT
repair  ||| S:13382 E:13389 ||| NN
of  ||| S:13389 E:13392 ||| IN
wild-type  ||| S:13392 E:13402 ||| JJ
fibroblasts  ||| S:13402 E:13414 ||| NN
was  ||| S:13414 E:13418 ||| VBD
not  ||| S:13418 E:13432 ||| RB
affected  ||| S:13432 E:13441 ||| VBN
by  ||| S:13441 E:13444 ||| IN
the  ||| S:13444 E:13448 ||| DT
addition  ||| S:13448 E:13457 ||| NN
of  ||| S:13457 E:13460 ||| IN
SPARC  ||| S:13460 E:13466 ||| NNP
and  ||| S:13466 E:13470 ||| CC
was  ||| S:13470 E:13474 ||| VBD
complete  ||| S:13474 E:13483 ||| JJ
by  ||| S:13483 E:13486 ||| IN
11  ||| S:13486 E:13499 ||| CD
hours  ||| S:13499 E:13505 ||| NNS
in  ||| S:13505 E:13508 ||| IN
the  ||| S:13508 E:13512 ||| DT
presence  ||| S:13512 E:13521 ||| NN
of  ||| S:13521 E:13524 ||| IN
exogenous  ||| S:13524 E:13534 ||| JJ
SPARC  ||| S:13534 E:13540 ||| NNP
( ||| S:13540 E:13541 ||| -LRB-
Fig.  ||| S:13541 E:13546 ||| NNP
3B ||| S:13546 E:13548 ||| NNP
,  ||| S:13548 E:13550 ||| ,
upper  ||| S:13550 E:13566 ||| JJ
panel ||| S:13566 E:13571 ||| NN
)  ||| S:13571 E:13573 ||| -RRB-
or  ||| S:13573 E:13576 ||| CC
in  ||| S:13576 E:13579 ||| IN
its  ||| S:13579 E:13583 ||| PRP$
absence  ||| S:13583 E:13591 ||| NN
( ||| S:13591 E:13592 ||| -LRB-
Fig.  ||| S:13592 E:13597 ||| NNP
3A ||| S:13597 E:13599 ||| NNP
,  ||| S:13599 E:13601 ||| ,
upper  ||| S:13601 E:13607 ||| JJ
panel ||| S:13607 E:13612 ||| NN
) ||| S:13612 E:13613 ||| -RRB-
.  ||| S:13613 E:13615 ||| .
The  ||| S:13615 E:13629 ||| DT
results  ||| S:13629 E:13637 ||| NNS
indicate  ||| S:13637 E:13646 ||| VBP
that  ||| S:13646 E:13651 ||| IN
SPARC  ||| S:13651 E:13657 ||| NNP
regulates  ||| S:13657 E:13667 ||| VBZ
wound  ||| S:13667 E:13673 ||| VBN
healing  ||| S:13673 E:13691 ||| VBG
directly  ||| S:13691 E:13700 ||| RB
through  ||| S:13700 E:13708 ||| IN
cell  ||| S:13708 E:13713 ||| NN
migration ||| S:13713 E:13722 ||| NN
.  ||| S:13722 E:13724 ||| .
Although  ||| S:13724 E:13733 ||| IN
the  ||| S:13733 E:13737 ||| DT
long  ||| S:13737 E:13742 ||| JJ
period  ||| S:13742 E:13759 ||| NN
of  ||| S:13759 E:13762 ||| IN
impeded  ||| S:13762 E:13770 ||| JJ
ingrowth  ||| S:13770 E:13779 ||| NN
of  ||| S:13779 E:13782 ||| IN
SPARC-null  ||| S:13782 E:13793 ||| JJ
cells  ||| S:13793 E:13799 ||| NNS
after  ||| S:13799 E:13805 ||| IN
wounding  ||| S:13805 E:13824 ||| VBG
already  ||| S:13824 E:13832 ||| RB
suggested  ||| S:13832 E:13842 ||| VBD
defect  ||| S:13842 E:13849 ||| VBN
in  ||| S:13849 E:13852 ||| IN
cell  ||| S:13852 E:13857 ||| NN
migration  ||| S:13857 E:13867 ||| VBZ
rather  ||| S:13867 E:13874 ||| RB
than  ||| S:13874 E:13889 ||| IN
cell  ||| S:13889 E:13894 ||| NN
proliferation ||| S:13894 E:13907 ||| NN
,  ||| S:13907 E:13909 ||| ,
we  ||| S:13909 E:13912 ||| PRP
determined  ||| S:13912 E:13923 ||| VBD
cell  ||| S:13923 E:13928 ||| NN
migration  ||| S:13928 E:13938 ||| NN
in  ||| S:13938 E:13941 ||| IN
the  ||| S:13941 E:13955 ||| DT
absence  ||| S:13955 E:13963 ||| NN
of  ||| S:13963 E:13966 ||| IN
cell  ||| S:13966 E:13971 ||| NN
proliferation ||| S:13971 E:13984 ||| NN
.  ||| S:13984 E:13986 ||| .
Mitomycin  ||| S:13986 E:13996 ||| NNP
C  ||| S:13996 E:13998 ||| NNP
blocks  ||| S:13998 E:14005 ||| NNS
mitosis  ||| S:14005 E:14023 ||| NN
and  ||| S:14023 E:14027 ||| CC
thus  ||| S:14027 E:14032 ||| RB
allows  ||| S:14032 E:14039 ||| VBZ
analysis  ||| S:14039 E:14048 ||| NN
of  ||| S:14048 E:14051 ||| IN
cell  ||| S:14051 E:14056 ||| NN
migration  ||| S:14056 E:14066 ||| NN
in  ||| S:14066 E:14069 ||| IN
the  ||| S:14069 E:14073 ||| DT
absence  ||| S:14073 E:14091 ||| NN
of  ||| S:14091 E:14094 ||| IN
cell  ||| S:14094 E:14099 ||| NN
proliferation ||| S:14099 E:14112 ||| NN
.  ||| S:14112 E:14114 ||| .
Treatment  ||| S:14114 E:14124 ||| NN
with  ||| S:14124 E:14129 ||| IN
mitomycin  ||| S:14129 E:14139 ||| JJ
C  ||| S:14139 E:14141 ||| NNP
did  ||| S:14141 E:14145 ||| VBD
not  ||| S:14145 E:14159 ||| RB
affect  ||| S:14159 E:14166 ||| VB
the  ||| S:14166 E:14170 ||| DT
time  ||| S:14170 E:14175 ||| NN
course  ||| S:14175 E:14182 ||| NN
of  ||| S:14182 E:14185 ||| IN
wound  ||| S:14185 E:14191 ||| JJ
closure  ||| S:14191 E:14199 ||| NN
of  ||| S:14199 E:14202 ||| IN
either  ||| S:14202 E:14209 ||| RB
the  ||| S:14209 E:14223 ||| DT
wild-type  ||| S:14223 E:14233 ||| JJ
or  ||| S:14233 E:14236 ||| CC
SPARC-null  ||| S:14236 E:14247 ||| JJ
cells  ||| S:14247 E:14253 ||| NNS
( ||| S:14253 E:14254 ||| -LRB-
Fig.  ||| S:14254 E:14259 ||| CD
4 ||| S:14259 E:14260 ||| CD
) ||| S:14260 E:14261 ||| -RRB-
.  ||| S:14261 E:14263 ||| .
The  ||| S:14263 E:14267 ||| DT
wound  ||| S:14267 E:14273 ||| NN
in  ||| S:14273 E:14276 ||| IN
a  ||| S:14276 E:14288 ||| DT
monolayer  ||| S:14288 E:14298 ||| NN
of  ||| S:14298 E:14301 ||| IN
wild-type  ||| S:14301 E:14311 ||| JJ
fibroblasts  ||| S:14311 E:14323 ||| JJ
cultured  ||| S:14323 E:14332 ||| NN
in  ||| S:14332 E:14335 ||| IN
the  ||| S:14335 E:14349 ||| DT
absence  ||| S:14349 E:14357 ||| NN
or  ||| S:14357 E:14360 ||| CC
presence  ||| S:14360 E:14369 ||| NN
of  ||| S:14369 E:14372 ||| IN
mitomycin  ||| S:14372 E:14382 ||| JJ
C  ||| S:14382 E:14384 ||| NNP
healed  ||| S:14384 E:14391 ||| NN
by  ||| S:14391 E:14394 ||| IN
15  ||| S:14394 E:14397 ||| CD
hours  ||| S:14397 E:14413 ||| NNS
after  ||| S:14413 E:14419 ||| IN
wounding  ||| S:14419 E:14428 ||| NNS
( ||| S:14428 E:14429 ||| -LRB-
Fig.  ||| S:14429 E:14434 ||| NNP
4A ||| S:14434 E:14436 ||| NNP
) ||| S:14436 E:14437 ||| -RRB-
.  ||| S:14437 E:14439 ||| .
The  ||| S:14439 E:14443 ||| DT
wound  ||| S:14443 E:14449 ||| NN
in  ||| S:14449 E:14452 ||| IN
a  ||| S:14452 E:14454 ||| DT
monolayer  ||| S:14454 E:14464 ||| NN
of  ||| S:14464 E:14477 ||| IN
SPARC-null  ||| S:14477 E:14488 ||| JJ
fibroblasts ||| S:14488 E:14499 ||| NN
,  ||| S:14499 E:14501 ||| ,
whether  ||| S:14501 E:14509 ||| IN
cultured  ||| S:14509 E:14518 ||| NN
in  ||| S:14518 E:14521 ||| IN
the  ||| S:14521 E:14525 ||| DT
presence  ||| S:14525 E:14544 ||| NN
of  ||| S:14544 E:14547 ||| IN
mitomycin  ||| S:14547 E:14557 ||| JJ
C  ||| S:14557 E:14559 ||| NNP
or  ||| S:14559 E:14562 ||| CC
in  ||| S:14562 E:14565 ||| IN
its  ||| S:14565 E:14569 ||| PRP$
absence ||| S:14569 E:14576 ||| NN
,  ||| S:14576 E:14578 ||| ,
remained  ||| S:14578 E:14587 ||| VBD
unrepaired  ||| S:14587 E:14598 ||| VBN
at  ||| S:14598 E:14611 ||| IN
15  ||| S:14611 E:14614 ||| CD
hours ||| S:14614 E:14619 ||| NNS
,  ||| S:14619 E:14621 ||| ,
began  ||| S:14621 E:14627 ||| VBD
to  ||| S:14627 E:14630 ||| TO
show  ||| S:14630 E:14635 ||| VB
slight  ||| S:14635 E:14642 ||| JJ
closure  ||| S:14642 E:14650 ||| NN
at  ||| S:14650 E:14653 ||| IN
24  ||| S:14653 E:14656 ||| CD
hours  ||| S:14656 E:14662 ||| NNS
and  ||| S:14662 E:14676 ||| CC
healed  ||| S:14676 E:14683 ||| VBN
by  ||| S:14683 E:14686 ||| IN
48  ||| S:14686 E:14689 ||| CD
hours  ||| S:14689 E:14695 ||| NNS
( ||| S:14695 E:14696 ||| -LRB-
Fig.  ||| S:14696 E:14701 ||| NNP
4B ||| S:14701 E:14703 ||| NNP
) ||| S:14703 E:14704 ||| -RRB-
.  ||| S:14704 E:14706 ||| .
These  ||| S:14706 E:14712 ||| DT
results  ||| S:14712 E:14720 ||| NNS
confirm  ||| S:14720 E:14728 ||| VBP
that  ||| S:14728 E:14743 ||| DT
cell  ||| S:14743 E:14748 ||| NN
migration  ||| S:14748 E:14758 ||| NN
is  ||| S:14758 E:14761 ||| VBZ
a  ||| S:14761 E:14763 ||| DT
key  ||| S:14763 E:14767 ||| JJ
step  ||| S:14767 E:14772 ||| NN
affecting  ||| S:14772 E:14782 ||| VBG
the  ||| S:14782 E:14786 ||| DT
rate  ||| S:14786 E:14791 ||| NN
of  ||| S:14791 E:14794 ||| IN
wound  ||| S:14794 E:14810 ||| JJ
healing  ||| S:14810 E:14818 ||| NN
and  ||| S:14818 E:14822 ||| CC
that  ||| S:14822 E:14827 ||| IN
this  ||| S:14827 E:14832 ||| DT
process  ||| S:14832 E:14840 ||| NN
is  ||| S:14840 E:14843 ||| VBZ
impaired  ||| S:14843 E:14852 ||| VBN
in  ||| S:14852 E:14855 ||| IN
SPARC-null  ||| S:14855 E:14876 ||| JJ
cells ||| S:14876 E:14881 ||| NNS
.  ||| S:14881 E:14883 ||| .
To  ||| S:14883 E:14886 ||| TO
further  ||| S:14886 E:14894 ||| RB
test  ||| S:14894 E:14899 ||| VB
our  ||| S:14899 E:14903 ||| PRP$
conclusion ||| S:14903 E:14913 ||| NN
,  ||| S:14913 E:14915 ||| ,
we  ||| S:14915 E:14918 ||| PRP
investigated  ||| S:14918 E:14941 ||| VBD
whether  ||| S:14941 E:14949 ||| IN
cell  ||| S:14949 E:14954 ||| NN
proliferation  ||| S:14954 E:14968 ||| NN
was  ||| S:14968 E:14972 ||| VBD
affected  ||| S:14972 E:14981 ||| VBN
by  ||| S:14981 E:14984 ||| IN
the  ||| S:14984 E:14988 ||| DT
lack  ||| S:14988 E:14993 ||| NN
of  ||| S:14993 E:15006 ||| IN
SPARC ||| S:15006 E:15011 ||| NNP
.  ||| S:15011 E:15013 ||| .
We  ||| S:15013 E:15016 ||| PRP
found  ||| S:15016 E:15022 ||| VBD
that  ||| S:15022 E:15027 ||| DT
SPARC-null  ||| S:15027 E:15038 ||| JJ
fibroblasts  ||| S:15038 E:15050 ||| JJ
incorporated  ||| S:15050 E:15073 ||| JJ
3H-thymidine  ||| S:15073 E:15086 ||| NN
as  ||| S:15086 E:15089 ||| IN
efficiently  ||| S:15089 E:15101 ||| RB
as  ||| S:15101 E:15104 ||| RB
control  ||| S:15104 E:15112 ||| VB
wild-type  ||| S:15112 E:15132 ||| JJ
fibroblasts  ||| S:15132 E:15144 ||| NN
over  ||| S:15144 E:15149 ||| IN
the  ||| S:15149 E:15153 ||| DT
25  ||| S:15153 E:15156 ||| CD
hour  ||| S:15156 E:15161 ||| NN
period  ||| S:15161 E:15168 ||| NN
studied  ||| S:15168 E:15176 ||| VBD
( ||| S:15176 E:15177 ||| -LRB-
Fig.  ||| S:15177 E:15182 ||| CD
5 ||| S:15182 E:15183 ||| CD
) ||| S:15183 E:15184 ||| -RRB-
.  ||| S:15184 E:15196 ||| .
These  ||| S:15196 E:15202 ||| DT
results  ||| S:15202 E:15210 ||| NNS
together  ||| S:15210 E:15219 ||| RB
show  ||| S:15219 E:15224 ||| VB
that  ||| S:15224 E:15229 ||| DT
indeed  ||| S:15229 E:15236 ||| JJ
cell  ||| S:15236 E:15241 ||| NN
motility ||| S:15241 E:15249 ||| NN
,  ||| S:15249 E:15261 ||| ,
rather  ||| S:15261 E:15268 ||| RB
than  ||| S:15268 E:15273 ||| IN
cell  ||| S:15273 E:15278 ||| NN
proliferation ||| S:15278 E:15291 ||| NN
,  ||| S:15291 E:15293 ||| ,
is  ||| S:15293 E:15296 ||| VBZ
the  ||| S:15296 E:15300 ||| DT
major  ||| S:15300 E:15306 ||| JJ
factor  ||| S:15306 E:15313 ||| NN
in  ||| S:15313 E:15326 ||| IN
the  ||| S:15326 E:15330 ||| DT
retarded  ||| S:15330 E:15339 ||| JJ
wound  ||| S:15339 E:15345 ||| NN
repair  ||| S:15345 E:15352 ||| NN
process  ||| S:15352 E:15360 ||| NN
in  ||| S:15360 E:15363 ||| IN
SPARC-null  ||| S:15363 E:15384 ||| JJ
cells ||| S:15384 E:15389 ||| NNS
.  ||| S:15389 E:15419 ||| .
Collagen-gel  ||| S:15419 E:15432 ||| JJ
contraction  ||| S:15432 E:15444 ||| NN
by  ||| S:15444 E:15447 ||| IN
SPARC-null  ||| S:15447 E:15458 ||| JJ
fibroblasts  ||| S:15458 E:15480 ||| NN
is  ||| S:15480 E:15483 ||| VBZ
not  ||| S:15483 E:15487 ||| RB
compromised  ||| S:15487 E:15509 ||| VBN
An  ||| S:15509 E:15512 ||| DT
important  ||| S:15512 E:15522 ||| JJ
event  ||| S:15522 E:15528 ||| NN
during  ||| S:15528 E:15535 ||| IN
wound  ||| S:15535 E:15541 ||| JJ
healing  ||| S:15541 E:15549 ||| NN
is  ||| S:15549 E:15552 ||| VBZ
the  ||| S:15552 E:15566 ||| DT
contraction  ||| S:15566 E:15578 ||| NN
of  ||| S:15578 E:15581 ||| IN
newly  ||| S:15581 E:15587 ||| RB
formed  ||| S:15587 E:15594 ||| VBN
granulation  ||| S:15594 E:15606 ||| JJ
tissue  ||| S:15606 E:15613 ||| NN
by  ||| S:15613 E:15626 ||| IN
fibroblasts  ||| S:15626 E:15638 ||| VBG
to  ||| S:15638 E:15641 ||| TO
bring  ||| S:15641 E:15647 ||| VB
together  ||| S:15647 E:15656 ||| RP
the  ||| S:15656 E:15660 ||| DT
edges  ||| S:15660 E:15666 ||| NN
of  ||| S:15666 E:15669 ||| IN
the  ||| S:15669 E:15673 ||| DT
wound  ||| S:15673 E:15679 ||| NN
[  ||| S:15679 E:15681 ||| -LRB-
1  ||| S:15681 E:15693 ||| LS
]  ||| S:15693 E:15695 ||| -RRB-
.  ||| S:15695 E:15697 ||| .
It  ||| S:15697 E:15700 ||| PRP
has  ||| S:15700 E:15704 ||| VBZ
been  ||| S:15704 E:15709 ||| VBN
reported  ||| S:15709 E:15718 ||| VBN
[  ||| S:15718 E:15720 ||| -LRB-
28  ||| S:15720 E:15723 ||| CD
]  ||| S:15723 E:15725 ||| -RRB-
that  ||| S:15725 E:15730 ||| WDT
fibroblasts  ||| S:15730 E:15752 ||| VBZ
incorporated  ||| S:15752 E:15765 ||| VBN
in  ||| S:15765 E:15768 ||| IN
a  ||| S:15768 E:15770 ||| DT
collagen  ||| S:15770 E:15779 ||| NN
gel  ||| S:15779 E:15783 ||| RB
induce  ||| S:15783 E:15790 ||| VB
progressive  ||| S:15790 E:15812 ||| JJ
contraction  ||| S:15812 E:15824 ||| NN
of  ||| S:15824 E:15827 ||| IN
the  ||| S:15827 E:15831 ||| DT
gel ||| S:15831 E:15834 ||| NN
,  ||| S:15834 E:15836 ||| ,
resulting  ||| S:15836 E:15846 ||| VBG
in  ||| S:15846 E:15849 ||| IN
the  ||| S:15849 E:15853 ||| DT
formation  ||| S:15853 E:15863 ||| NN
of  ||| S:15863 E:15866 ||| IN
a  ||| S:15866 E:15878 ||| DT
dense  ||| S:15878 E:15884 ||| JJ
collagen  ||| S:15884 E:15893 ||| NN
disc  ||| S:15893 E:15898 ||| NN
of  ||| S:15898 E:15901 ||| IN
greatly  ||| S:15901 E:15909 ||| RB
reduced  ||| S:15909 E:15917 ||| VBN
diameter ||| S:15917 E:15925 ||| NN
.  ||| S:15925 E:15927 ||| .
This  ||| S:15927 E:15942 ||| DT
phenomenon  ||| S:15942 E:15953 ||| NN
has  ||| S:15953 E:15957 ||| VBZ
been  ||| S:15957 E:15962 ||| VBN
considered  ||| S:15962 E:15973 ||| VBN
as  ||| S:15973 E:15976 ||| IN
an  ||| S:15976 E:15979 ||| DT
in  ||| S:15979 E:15982 ||| IN
vitro  ||| S:15982 E:15988 ||| JJ
equivalent  ||| S:15988 E:16009 ||| NN
of  ||| S:16009 E:16012 ||| IN
the  ||| S:16012 E:16016 ||| DT
connective-tissue  ||| S:16016 E:16034 ||| JJ
contraction  ||| S:16034 E:16046 ||| NN
that  ||| S:16046 E:16051 ||| WDT
occurs  ||| S:16051 E:16058 ||| VBZ
during  ||| S:16058 E:16075 ||| IN
wound  ||| S:16075 E:16081 ||| JJ
healing ||| S:16081 E:16088 ||| NN
.  ||| S:16088 E:16090 ||| .
We  ||| S:16090 E:16093 ||| PRP
used  ||| S:16093 E:16098 ||| VBD
this  ||| S:16098 E:16103 ||| DT
procedure  ||| S:16103 E:16113 ||| NN
to  ||| S:16113 E:16116 ||| TO
examine  ||| S:16116 E:16124 ||| VB
the  ||| S:16124 E:16138 ||| DT
contractile  ||| S:16138 E:16150 ||| JJ
ability  ||| S:16150 E:16158 ||| NN
of  ||| S:16158 E:16161 ||| IN
SPARC-null  ||| S:16161 E:16172 ||| JJ
fibroblasts ||| S:16172 E:16183 ||| NN
.  ||| S:16183 E:16185 ||| .
Gel  ||| S:16185 E:16199 ||| JJ
diameter  ||| S:16199 E:16208 ||| NN
was  ||| S:16208 E:16212 ||| VBD
measured  ||| S:16212 E:16221 ||| VBN
at  ||| S:16221 E:16224 ||| IN
various  ||| S:16224 E:16232 ||| JJ
time  ||| S:16232 E:16237 ||| NN
points  ||| S:16237 E:16244 ||| NNS
following  ||| S:16244 E:16264 ||| VBG
incorporation  ||| S:16264 E:16278 ||| NN
of  ||| S:16278 E:16281 ||| IN
fibroblasts  ||| S:16281 E:16293 ||| NN
in  ||| S:16293 E:16296 ||| IN
the  ||| S:16296 E:16300 ||| DT
collagen  ||| S:16300 E:16309 ||| JJ
gel ||| S:16309 E:16312 ||| NN
,  ||| S:16312 E:16314 ||| ,
and  ||| S:16314 E:16318 ||| CC
the  ||| S:16318 E:16332 ||| DT
area  ||| S:16332 E:16337 ||| NN
calculated  ||| S:16337 E:16348 ||| VBN
and  ||| S:16348 E:16352 ||| CC
expressed  ||| S:16352 E:16362 ||| VBN
as  ||| S:16362 E:16365 ||| IN
a  ||| S:16365 E:16367 ||| DT
percentage  ||| S:16367 E:16378 ||| NN
of  ||| S:16378 E:16381 ||| IN
the  ||| S:16381 E:16395 ||| DT
initial  ||| S:16395 E:16403 ||| JJ
area ||| S:16403 E:16407 ||| NN
.  ||| S:16407 E:16409 ||| .
Primary  ||| S:16409 E:16417 ||| JJ
dermal  ||| S:16417 E:16424 ||| JJ
fibroblasts  ||| S:16424 E:16436 ||| NN
from  ||| S:16436 E:16441 ||| IN
SPARC-null  ||| S:16441 E:16462 ||| JJ
mice  ||| S:16462 E:16467 ||| NNS
contracted  ||| S:16467 E:16478 ||| VBD
type  ||| S:16478 E:16483 ||| NN
I  ||| S:16483 E:16485 ||| PRP
collagen  ||| S:16485 E:16494 ||| VBP
gels  ||| S:16494 E:16499 ||| VBN
as  ||| S:16499 E:16502 ||| IN
efficiently  ||| S:16502 E:16514 ||| RB
as  ||| S:16514 E:16527 ||| IN
primary  ||| S:16527 E:16535 ||| JJ
dermal  ||| S:16535 E:16542 ||| JJ
fibroblasts  ||| S:16542 E:16554 ||| NN
from  ||| S:16554 E:16559 ||| IN
wild-type  ||| S:16559 E:16569 ||| JJ
mice ||| S:16569 E:16573 ||| NNS
,  ||| S:16573 E:16585 ||| ,
contracting  ||| S:16585 E:16597 ||| VBG
to  ||| S:16597 E:16600 ||| TO
30 ||| S:16600 E:16602 ||| CD
%  ||| S:16602 E:16604 ||| NN
of  ||| S:16604 E:16607 ||| IN
the  ||| S:16607 E:16611 ||| DT
initial  ||| S:16611 E:16619 ||| JJ
area  ||| S:16619 E:16624 ||| NN
at  ||| S:16624 E:16627 ||| IN
20  ||| S:16627 E:16630 ||| CD
hours  ||| S:16630 E:16636 ||| NNS
and  ||| S:16636 E:16640 ||| CC
to  ||| S:16640 E:16653 ||| TO
15 ||| S:16653 E:16655 ||| CD
%  ||| S:16655 E:16657 ||| NN
by  ||| S:16657 E:16660 ||| IN
40  ||| S:16660 E:16663 ||| CD
hours  ||| S:16663 E:16669 ||| NNS
after  ||| S:16669 E:16675 ||| IN
incubation  ||| S:16675 E:16686 ||| NN
of  ||| S:16686 E:16689 ||| IN
the  ||| S:16689 E:16693 ||| DT
fibroblasts  ||| S:16693 E:16705 ||| NN
in  ||| S:16705 E:16718 ||| IN
collagen  ||| S:16718 E:16727 ||| JJ
gels  ||| S:16727 E:16732 ||| NNS
( ||| S:16732 E:16733 ||| -LRB-
Fig.  ||| S:16733 E:16738 ||| CD
6 ||| S:16738 E:16739 ||| CD
) ||| S:16739 E:16740 ||| -RRB-
.  ||| S:16740 E:16773 ||| .
Discussion  ||| S:16773 E:16792 ||| NN
In  ||| S:16792 E:16795 ||| IN
this  ||| S:16795 E:16800 ||| DT
study ||| S:16800 E:16805 ||| NN
,  ||| S:16805 E:16807 ||| ,
we  ||| S:16807 E:16810 ||| PRP
have  ||| S:16810 E:16815 ||| VBP
shown  ||| S:16815 E:16821 ||| VBN
for  ||| S:16821 E:16825 ||| IN
the  ||| S:16825 E:16829 ||| DT
first  ||| S:16829 E:16835 ||| JJ
time  ||| S:16835 E:16840 ||| NN
that  ||| S:16840 E:16853 ||| IN
repair  ||| S:16853 E:16860 ||| NN
of  ||| S:16860 E:16863 ||| IN
excision  ||| S:16863 E:16872 ||| JJ
wounds  ||| S:16872 E:16879 ||| NNS
in  ||| S:16879 E:16882 ||| IN
SPARC-null  ||| S:16882 E:16893 ||| JJ
mice  ||| S:16893 E:16898 ||| NNS
is  ||| S:16898 E:16901 ||| VBZ
impaired ||| S:16901 E:16909 ||| VBN
.  ||| S:16909 E:16919 ||| .
Histological  ||| S:16919 E:16932 ||| JJ
examination  ||| S:16932 E:16944 ||| NN
and  ||| S:16944 E:16948 ||| CC
study  ||| S:16948 E:16954 ||| NN
of  ||| S:16954 E:16957 ||| IN
the  ||| S:16957 E:16961 ||| DT
expression  ||| S:16961 E:16980 ||| NN
patterns  ||| S:16980 E:16989 ||| NNS
of  ||| S:16989 E:16992 ||| IN
ECM  ||| S:16992 E:16996 ||| NNP
components ||| S:16996 E:17006 ||| NNS
,  ||| S:17006 E:17008 ||| ,
fibronectin  ||| S:17008 E:17020 ||| NN
and  ||| S:17020 E:17024 ||| CC
type  ||| S:17024 E:17029 ||| NN
I  ||| S:17029 E:17039 ||| PRP
collagen ||| S:17039 E:17047 ||| VBP
,  ||| S:17047 E:17049 ||| ,
at  ||| S:17049 E:17052 ||| IN
the  ||| S:17052 E:17056 ||| DT
wound  ||| S:17056 E:17062 ||| JJ
site  ||| S:17062 E:17067 ||| NN
suggested  ||| S:17067 E:17077 ||| VBD
that  ||| S:17077 E:17082 ||| DT
retarded  ||| S:17082 E:17099 ||| JJ
granulation  ||| S:17099 E:17111 ||| JJ
tissue  ||| S:17111 E:17118 ||| NN
formation  ||| S:17118 E:17128 ||| NN
caused  ||| S:17128 E:17135 ||| VBD
impaired  ||| S:17135 E:17144 ||| VBN
wound  ||| S:17144 E:17150 ||| JJ
repair ||| S:17150 E:17156 ||| NN
.  ||| S:17156 E:17166 ||| .
In  ||| S:17166 E:17169 ||| IN
vitro  ||| S:17169 E:17175 ||| JJ
studies  ||| S:17175 E:17183 ||| NNS
with  ||| S:17183 E:17188 ||| IN
dermal  ||| S:17188 E:17195 ||| NNS
fibroblasts  ||| S:17195 E:17207 ||| VBP
isolated  ||| S:17207 E:17216 ||| VBN
from  ||| S:17216 E:17229 ||| IN
SPARC-null  ||| S:17229 E:17240 ||| JJ
mice  ||| S:17240 E:17245 ||| NNS
further  ||| S:17245 E:17253 ||| RB
showed  ||| S:17253 E:17260 ||| VBD
that  ||| S:17260 E:17265 ||| IN
the  ||| S:17265 E:17269 ||| DT
ability  ||| S:17269 E:17277 ||| NN
of  ||| S:17277 E:17280 ||| IN
the  ||| S:17280 E:17292 ||| DT
cells  ||| S:17292 E:17298 ||| NNS
to  ||| S:17298 E:17301 ||| TO
restore  ||| S:17301 E:17309 ||| VB
wounded  ||| S:17309 E:17317 ||| JJ
areas  ||| S:17317 E:17323 ||| NNS
was  ||| S:17323 E:17327 ||| VBD
hindered  ||| S:17327 E:17336 ||| VBN
and  ||| S:17336 E:17340 ||| CC
that  ||| S:17340 E:17345 ||| IN
a  ||| S:17345 E:17355 ||| DT
defect  ||| S:17355 E:17362 ||| NN
in  ||| S:17362 E:17365 ||| IN
cell  ||| S:17365 E:17370 ||| NN
migration ||| S:17370 E:17379 ||| NN
,  ||| S:17379 E:17381 ||| ,
rather  ||| S:17381 E:17388 ||| RB
than  ||| S:17388 E:17393 ||| IN
cell  ||| S:17393 E:17398 ||| NN
proliferation ||| S:17398 E:17411 ||| NN
,  ||| S:17411 E:17421 ||| ,
was  ||| S:17421 E:17425 ||| VBD
the  ||| S:17425 E:17429 ||| DT
major  ||| S:17429 E:17435 ||| JJ
cause  ||| S:17435 E:17441 ||| NN
of  ||| S:17441 E:17444 ||| IN
the  ||| S:17444 E:17448 ||| DT
delay  ||| S:17448 E:17454 ||| NN
in  ||| S:17454 E:17457 ||| IN
repopulating  ||| S:17457 E:17470 ||| VBG
the  ||| S:17470 E:17482 ||| DT
denuded  ||| S:17482 E:17490 ||| JJ
area ||| S:17490 E:17494 ||| NN
.  ||| S:17494 E:17496 ||| .
The  ||| S:17496 E:17500 ||| DT
delayed  ||| S:17500 E:17508 ||| JJ
cell  ||| S:17508 E:17513 ||| NN
migration  ||| S:17513 E:17523 ||| NNS
and  ||| S:17523 E:17527 ||| CC
restoration  ||| S:17527 E:17539 ||| NN
of  ||| S:17539 E:17550 ||| IN
the  ||| S:17550 E:17554 ||| DT
wound  ||| S:17554 E:17560 ||| JJ
site  ||| S:17560 E:17565 ||| NN
were  ||| S:17565 E:17570 ||| VBD
growth  ||| S:17570 E:17577 ||| NN
factor  ||| S:17577 E:17584 ||| NN
independent  ||| S:17584 E:17596 ||| JJ
as  ||| S:17596 E:17599 ||| IN
these  ||| S:17599 E:17613 ||| DT
defects  ||| S:17613 E:17621 ||| NNS
occurred  ||| S:17621 E:17630 ||| VBD
in  ||| S:17630 E:17633 ||| IN
the  ||| S:17633 E:17637 ||| DT
presence  ||| S:17637 E:17646 ||| NN
of  ||| S:17646 E:17649 ||| IN
FBS ||| S:17649 E:17652 ||| NNP
.  ||| S:17652 E:17654 ||| .
Furthermore  ||| S:17654 E:17666 ||| RB
these  ||| S:17666 E:17680 ||| DT
defects  ||| S:17680 E:17688 ||| NNS
were  ||| S:17688 E:17693 ||| VBD
reversed  ||| S:17693 E:17702 ||| VBN
by  ||| S:17702 E:17705 ||| IN
the  ||| S:17705 E:17709 ||| DT
addition  ||| S:17709 E:17718 ||| NN
of  ||| S:17718 E:17721 ||| IN
purified  ||| S:17721 E:17730 ||| JJ
SPARC ||| S:17730 E:17735 ||| NNP
,  ||| S:17735 E:17745 ||| ,
showing  ||| S:17745 E:17753 ||| VBG
that  ||| S:17753 E:17758 ||| IN
the  ||| S:17758 E:17762 ||| DT
defect  ||| S:17762 E:17769 ||| NN
in  ||| S:17769 E:17772 ||| IN
cell  ||| S:17772 E:17777 ||| NN
migration  ||| S:17777 E:17787 ||| NNS
and  ||| S:17787 E:17791 ||| CC
wound  ||| S:17791 E:17797 ||| JJ
healing  ||| S:17797 E:17813 ||| NN
was  ||| S:17813 E:17817 ||| VBD
attributable  ||| S:17817 E:17830 ||| JJ
to  ||| S:17830 E:17833 ||| TO
the  ||| S:17833 E:17837 ||| DT
absence  ||| S:17837 E:17845 ||| NN
of  ||| S:17845 E:17848 ||| IN
SPARC ||| S:17848 E:17853 ||| NNP
.  ||| S:17853 E:17855 ||| .
The  ||| S:17855 E:17859 ||| DT
mechanism  ||| S:17859 E:17869 ||| NN
by  ||| S:17869 E:17880 ||| IN
which  ||| S:17880 E:17886 ||| WDT
SPARC  ||| S:17886 E:17892 ||| NNP
influences  ||| S:17892 E:17903 ||| VBZ
cell  ||| S:17903 E:17908 ||| NN
migration  ||| S:17908 E:17918 ||| NN
is  ||| S:17918 E:17921 ||| VBZ
not  ||| S:17921 E:17925 ||| RB
known ||| S:17925 E:17930 ||| VBN
.  ||| S:17930 E:17932 ||| .
One  ||| S:17932 E:17944 ||| CD
possibility  ||| S:17944 E:17956 ||| NN
is  ||| S:17956 E:17959 ||| VBZ
that  ||| S:17959 E:17964 ||| IN
the  ||| S:17964 E:17968 ||| DT
lack  ||| S:17968 E:17973 ||| NN
of  ||| S:17973 E:17976 ||| IN
SPARC  ||| S:17976 E:17982 ||| NNP
causes  ||| S:17982 E:17989 ||| VBZ
alteration  ||| S:17989 E:18000 ||| VBN
in  ||| S:18000 E:18011 ||| IN
ECM  ||| S:18011 E:18015 ||| NNP
with  ||| S:18015 E:18020 ||| IN
respect  ||| S:18020 E:18028 ||| NN
to  ||| S:18028 E:18031 ||| TO
structure  ||| S:18031 E:18041 ||| NN
and ||| S:18041 E:18044 ||| CC
/ ||| S:18044 E:18045 ||| NNP
or  ||| S:18045 E:18048 ||| CC
function  ||| S:18048 E:18057 ||| NN
and  ||| S:18057 E:18061 ||| CC
thus  ||| S:18061 E:18074 ||| RB
contributes  ||| S:18074 E:18086 ||| VBZ
to  ||| S:18086 E:18089 ||| TO
a  ||| S:18089 E:18091 ||| DT
decrease  ||| S:18091 E:18100 ||| NN
in  ||| S:18100 E:18103 ||| IN
cell  ||| S:18103 E:18108 ||| NN
migration ||| S:18108 E:18117 ||| NN
.  ||| S:18117 E:18119 ||| .
Although  ||| S:18119 E:18128 ||| IN
SPARC  ||| S:18128 E:18142 ||| NNP
has  ||| S:18142 E:18146 ||| VBZ
been  ||| S:18146 E:18151 ||| VBN
postulated  ||| S:18151 E:18162 ||| VBN
to  ||| S:18162 E:18165 ||| TO
be  ||| S:18165 E:18168 ||| VB
involved  ||| S:18168 E:18177 ||| VBN
in  ||| S:18177 E:18180 ||| IN
wound  ||| S:18180 E:18186 ||| JJ
healing  ||| S:18186 E:18194 ||| NN
due  ||| S:18194 E:18198 ||| JJ
to  ||| S:18198 E:18209 ||| TO
its  ||| S:18209 E:18213 ||| PRP$
elevated  ||| S:18213 E:18222 ||| JJ
expression  ||| S:18222 E:18233 ||| NN
in  ||| S:18233 E:18236 ||| IN
fibroblasts  ||| S:18236 E:18248 ||| NN
and  ||| S:18248 E:18252 ||| CC
macrophages  ||| S:18252 E:18264 ||| NN
at  ||| S:18264 E:18275 ||| IN
wound  ||| S:18275 E:18281 ||| JJ
sites  ||| S:18281 E:18287 ||| NNS
[  ||| S:18287 E:18289 ||| -LRB-
18  ||| S:18289 E:18292 ||| CD
]  ||| S:18292 E:18294 ||| -RRB-
,  ||| S:18294 E:18296 ||| ,
our  ||| S:18296 E:18300 ||| PRP$
results  ||| S:18300 E:18308 ||| NNS
are  ||| S:18308 E:18312 ||| VBP
the  ||| S:18312 E:18316 ||| DT
first  ||| S:18316 E:18322 ||| JJ
to  ||| S:18322 E:18333 ||| TO
demonstrate  ||| S:18333 E:18345 ||| VB
that  ||| S:18345 E:18350 ||| IN
SPARC  ||| S:18350 E:18356 ||| NNP
indeed  ||| S:18356 E:18363 ||| RB
plays  ||| S:18363 E:18369 ||| VBZ
a  ||| S:18369 E:18371 ||| DT
role  ||| S:18371 E:18376 ||| NN
in  ||| S:18376 E:18379 ||| IN
wound  ||| S:18379 E:18385 ||| JJ
repair  ||| S:18385 E:18400 ||| NN
and  ||| S:18400 E:18404 ||| CC
that  ||| S:18404 E:18409 ||| IN
it  ||| S:18409 E:18412 ||| PRP
does  ||| S:18412 E:18417 ||| VBZ
so  ||| S:18417 E:18420 ||| RB
by  ||| S:18420 E:18423 ||| IN
promoting  ||| S:18423 E:18433 ||| VBG
granulation  ||| S:18433 E:18445 ||| JJ
tissue  ||| S:18445 E:18460 ||| NN
formation  ||| S:18460 E:18470 ||| NN
through  ||| S:18470 E:18478 ||| IN
modulation  ||| S:18478 E:18489 ||| NN
of  ||| S:18489 E:18492 ||| IN
fibroblast  ||| S:18492 E:18503 ||| JJ
migration ||| S:18503 E:18512 ||| NN
.  ||| S:18512 E:18522 ||| .
In  ||| S:18522 E:18525 ||| IN
large  ||| S:18525 E:18531 ||| JJ
wounds  ||| S:18531 E:18538 ||| NNS
( ||| S:18538 E:18539 ||| -LRB-
25  ||| S:18539 E:18542 ||| CD
mm ||| S:18542 E:18544 ||| CD
) ||| S:18544 E:18545 ||| -RRB-
,  ||| S:18545 E:18547 ||| ,
visual  ||| S:18547 E:18554 ||| JJ
examination  ||| S:18554 E:18566 ||| NN
of  ||| S:18566 E:18569 ||| IN
wounds  ||| S:18569 E:18584 ||| NNS
showed  ||| S:18584 E:18591 ||| VBD
that  ||| S:18591 E:18596 ||| DT
loss  ||| S:18596 E:18601 ||| NN
of  ||| S:18601 E:18604 ||| IN
wound  ||| S:18604 E:18610 ||| JJ
scabs  ||| S:18610 E:18616 ||| NNS
and  ||| S:18616 E:18620 ||| CC
restoration  ||| S:18620 E:18632 ||| NN
of  ||| S:18632 E:18643 ||| IN
epidermal  ||| S:18643 E:18653 ||| JJ
covering  ||| S:18653 E:18662 ||| NN
were  ||| S:18662 E:18667 ||| VBD
delayed  ||| S:18667 E:18675 ||| VBN
in  ||| S:18675 E:18678 ||| IN
SPARC-null  ||| S:18678 E:18689 ||| JJ
mice  ||| S:18689 E:18694 ||| NNS
due  ||| S:18694 E:18698 ||| JJ
to  ||| S:18698 E:18709 ||| TO
premature ||| S:18709 E:18718 ||| JJ
,  ||| S:18718 E:18720 ||| ,
partial  ||| S:18720 E:18728 ||| JJ
loss  ||| S:18728 E:18733 ||| NN
of  ||| S:18733 E:18736 ||| IN
scabs  ||| S:18736 E:18742 ||| NNS
and  ||| S:18742 E:18746 ||| CC
neoepidermis ||| S:18746 E:18758 ||| NN
,  ||| S:18758 E:18768 ||| ,
resulting  ||| S:18768 E:18778 ||| VBG
in  ||| S:18778 E:18781 ||| IN
repeated  ||| S:18781 E:18790 ||| JJ
setbacks  ||| S:18790 E:18799 ||| NNS
in  ||| S:18799 E:18802 ||| IN
the  ||| S:18802 E:18806 ||| DT
reepithelialization  ||| S:18806 E:18834 ||| JJ
process ||| S:18834 E:18841 ||| NN
.  ||| S:18841 E:18843 ||| .
However ||| S:18843 E:18850 ||| RB
,  ||| S:18850 E:18852 ||| ,
similar  ||| S:18852 E:18860 ||| JJ
setbacks  ||| S:18860 E:18869 ||| NNS
in  ||| S:18869 E:18872 ||| IN
reepitheliallization  ||| S:18872 E:18901 ||| NN
were  ||| S:18901 E:18906 ||| VBD
not  ||| S:18906 E:18910 ||| RB
observed  ||| S:18910 E:18919 ||| VBN
in  ||| S:18919 E:18922 ||| IN
small  ||| S:18922 E:18928 ||| JJ
wounds  ||| S:18928 E:18935 ||| NNS
( ||| S:18935 E:18936 ||| -LRB-
6  ||| S:18936 E:18938 ||| CD
mm ||| S:18938 E:18940 ||| CD
) ||| S:18940 E:18941 ||| -RRB-
.  ||| S:18941 E:18943 ||| .
Furthermore ||| S:18943 E:18954 ||| RB
,  ||| S:18954 E:18964 ||| ,
histological  ||| S:18964 E:18977 ||| JJ
examination  ||| S:18977 E:18989 ||| NN
of  ||| S:18989 E:18992 ||| IN
new  ||| S:18992 E:18996 ||| JJ
epidermal  ||| S:18996 E:19006 ||| JJ
cells  ||| S:19006 E:19012 ||| NNS
in  ||| S:19012 E:19015 ||| IN
the  ||| S:19015 E:19027 ||| DT
wound  ||| S:19027 E:19033 ||| JJ
bed  ||| S:19033 E:19037 ||| NN
and  ||| S:19037 E:19041 ||| CC
Northern  ||| S:19041 E:19050 ||| JJ
analysis  ||| S:19050 E:19059 ||| NN
of  ||| S:19059 E:19062 ||| IN
expression  ||| S:19062 E:19073 ||| NN
of  ||| S:19073 E:19076 ||| IN
a  ||| S:19076 E:19078 ||| DT
wound  ||| S:19078 E:19092 ||| JJ
keratinocyte  ||| S:19092 E:19105 ||| JJ
marker ||| S:19105 E:19111 ||| NN
,  ||| S:19111 E:19113 ||| ,
cytokeratin  ||| S:19113 E:19125 ||| CD
14 ||| S:19125 E:19127 ||| CD
,  ||| S:19127 E:19129 ||| ,
in  ||| S:19129 E:19132 ||| IN
the  ||| S:19132 E:19136 ||| DT
biopsied  ||| S:19136 E:19153 ||| JJ
tissues  ||| S:19153 E:19161 ||| NNS
revealed  ||| S:19161 E:19170 ||| VBD
that  ||| S:19170 E:19175 ||| DT
reepithelialization  ||| S:19175 E:19195 ||| NN
in  ||| S:19195 E:19198 ||| IN
SPARC-null  ||| S:19198 E:19217 ||| JJ
mice  ||| S:19217 E:19222 ||| NNS
was  ||| S:19222 E:19226 ||| VBD
probably  ||| S:19226 E:19235 ||| RB
not  ||| S:19235 E:19239 ||| RB
compromised ||| S:19239 E:19250 ||| VBN
.  ||| S:19250 E:19252 ||| .
It  ||| S:19252 E:19255 ||| PRP
seems  ||| S:19255 E:19261 ||| VBZ
possible  ||| S:19261 E:19270 ||| JJ
that  ||| S:19270 E:19283 ||| IN
reepithelialization  ||| S:19283 E:19303 ||| NN
occurs  ||| S:19303 E:19310 ||| VBZ
normally  ||| S:19310 E:19319 ||| RB
in  ||| S:19319 E:19322 ||| IN
SPARC-null  ||| S:19322 E:19333 ||| JJ
mice ||| S:19333 E:19337 ||| NNS
.  ||| S:19337 E:19347 ||| .
However ||| S:19347 E:19354 ||| RB
,  ||| S:19354 E:19356 ||| ,
since  ||| S:19356 E:19362 ||| IN
SPARC  ||| S:19362 E:19368 ||| NNP
is  ||| S:19368 E:19371 ||| VBZ
a  ||| S:19371 E:19373 ||| DT
matricellular  ||| S:19373 E:19387 ||| JJ
protein  ||| S:19387 E:19395 ||| NN
involved  ||| S:19395 E:19404 ||| VBN
in  ||| S:19404 E:19415 ||| IN
cell-matrix  ||| S:19415 E:19427 ||| JJ
interaction  ||| S:19427 E:19439 ||| NNS
[  ||| S:19439 E:19441 ||| -LRB-
3  ||| S:19441 E:19443 ||| CD
4  ||| S:19443 E:19445 ||| CD
23  ||| S:19445 E:19448 ||| CD
]  ||| S:19448 E:19450 ||| -RRB-
,  ||| S:19450 E:19452 ||| ,
cell-matrix  ||| S:19452 E:19472 ||| JJ
interaction-related  ||| S:19472 E:19492 ||| JJ
defects  ||| S:19492 E:19500 ||| NNS
may  ||| S:19500 E:19504 ||| MD
exert  ||| S:19504 E:19510 ||| VB
a  ||| S:19510 E:19512 ||| DT
significant  ||| S:19512 E:19532 ||| JJ
influence  ||| S:19532 E:19542 ||| NN
in  ||| S:19542 E:19545 ||| IN
large  ||| S:19545 E:19551 ||| JJ
wounds  ||| S:19551 E:19558 ||| NNS
of  ||| S:19558 E:19561 ||| IN
SPARC-null  ||| S:19561 E:19572 ||| JJ
mice  ||| S:19572 E:19577 ||| NNS
causing  ||| S:19577 E:19593 ||| VBG
premature  ||| S:19593 E:19603 ||| JJ
loss  ||| S:19603 E:19608 ||| NN
of  ||| S:19608 E:19611 ||| IN
a  ||| S:19611 E:19613 ||| DT
part  ||| S:19613 E:19618 ||| NN
of  ||| S:19618 E:19621 ||| IN
the  ||| S:19621 E:19625 ||| DT
scabs  ||| S:19625 E:19631 ||| NN
and  ||| S:19631 E:19635 ||| CC
of  ||| S:19635 E:19638 ||| IN
the  ||| S:19638 E:19650 ||| DT
neoepidermis ||| S:19650 E:19662 ||| NN
,  ||| S:19662 E:19664 ||| ,
a  ||| S:19664 E:19666 ||| DT
pathophysiological  ||| S:19666 E:19685 ||| JJ
process  ||| S:19685 E:19693 ||| NN
requiring  ||| S:19693 E:19711 ||| VBG
repeated  ||| S:19711 E:19720 ||| VBN
healing ||| S:19720 E:19727 ||| NN
.  ||| S:19727 E:19729 ||| .
In  ||| S:19729 E:19732 ||| IN
small  ||| S:19732 E:19738 ||| JJ
wounds ||| S:19738 E:19744 ||| NNS
,  ||| S:19744 E:19746 ||| ,
the  ||| S:19746 E:19750 ||| DT
pathophysiological  ||| S:19750 E:19777 ||| JJ
process  ||| S:19777 E:19785 ||| NN
caused  ||| S:19785 E:19792 ||| VBN
by  ||| S:19792 E:19795 ||| IN
the  ||| S:19795 E:19799 ||| DT
cell-matrix  ||| S:19799 E:19811 ||| JJ
interaction-related  ||| S:19811 E:19839 ||| JJ
defects  ||| S:19839 E:19847 ||| NNS
may  ||| S:19847 E:19851 ||| MD
be  ||| S:19851 E:19854 ||| VB
too  ||| S:19854 E:19858 ||| RB
small  ||| S:19858 E:19864 ||| JJ
to  ||| S:19864 E:19867 ||| TO
affect  ||| S:19867 E:19874 ||| VB
reepithelialization  ||| S:19874 E:19902 ||| VBN
significantly  ||| S:19902 E:19916 ||| RB
with  ||| S:19916 E:19921 ||| IN
the  ||| S:19921 E:19925 ||| DT
result  ||| S:19925 E:19932 ||| NN
that  ||| S:19932 E:19937 ||| IN
restoration  ||| S:19937 E:19949 ||| NN
of  ||| S:19949 E:19952 ||| IN
epidermal  ||| S:19952 E:19970 ||| JJ
covering  ||| S:19970 E:19979 ||| NN
progresses  ||| S:19979 E:19990 ||| VBZ
as  ||| S:19990 E:19993 ||| RB
normally  ||| S:19993 E:20002 ||| RB
as  ||| S:20002 E:20005 ||| RB
in  ||| S:20005 E:20008 ||| IN
the  ||| S:20008 E:20012 ||| DT
wild-type  ||| S:20012 E:20022 ||| JJ
mice ||| S:20022 E:20026 ||| NNS
.  ||| S:20026 E:20036 ||| .
Perhaps  ||| S:20036 E:20044 ||| RB
this  ||| S:20044 E:20049 ||| DT
size-dependent  ||| S:20049 E:20064 ||| JJ
wound  ||| S:20064 E:20070 ||| NN
closure  ||| S:20070 E:20078 ||| NN
may  ||| S:20078 E:20082 ||| MD
have  ||| S:20082 E:20095 ||| VB
contributed  ||| S:20095 E:20107 ||| VBN
to  ||| S:20107 E:20110 ||| TO
the  ||| S:20110 E:20114 ||| DT
enhanced  ||| S:20114 E:20123 ||| JJ
wound  ||| S:20123 E:20129 ||| NN
healing  ||| S:20129 E:20137 ||| NN
in  ||| S:20137 E:20140 ||| IN
SPARC-null  ||| S:20140 E:20159 ||| JJ
mice  ||| S:20159 E:20164 ||| NNS
cited  ||| S:20164 E:20170 ||| VBD
recently  ||| S:20170 E:20179 ||| RB
as  ||| S:20179 E:20182 ||| IN
an  ||| S:20182 E:20185 ||| DT
unpublished  ||| S:20185 E:20197 ||| JJ
result  ||| S:20197 E:20204 ||| NN
[  ||| S:20204 E:20206 ||| -LRB-
29  ||| S:20206 E:20209 ||| CD
]  ||| S:20209 E:20211 ||| -RRB-
.  ||| S:20211 E:20221 ||| .
Although  ||| S:20221 E:20230 ||| IN
SPARC  ||| S:20230 E:20236 ||| NNP
is  ||| S:20236 E:20239 ||| VBZ
required  ||| S:20239 E:20248 ||| VBN
for  ||| S:20248 E:20252 ||| IN
migration  ||| S:20252 E:20262 ||| NN
of  ||| S:20262 E:20265 ||| IN
dermal  ||| S:20265 E:20280 ||| JJ
fibroblasts  ||| S:20280 E:20292 ||| NN
into  ||| S:20292 E:20297 ||| IN
the  ||| S:20297 E:20301 ||| DT
wound  ||| S:20301 E:20307 ||| JJ
site ||| S:20307 E:20311 ||| NN
,  ||| S:20311 E:20313 ||| ,
it  ||| S:20313 E:20316 ||| PRP
is  ||| S:20316 E:20319 ||| VBZ
apparently  ||| S:20319 E:20330 ||| RB
not  ||| S:20330 E:20342 ||| RB
essential  ||| S:20342 E:20352 ||| JJ
to  ||| S:20352 E:20355 ||| TO
the  ||| S:20355 E:20359 ||| DT
motility  ||| S:20359 E:20368 ||| NN
of  ||| S:20368 E:20371 ||| IN
keratinocytes  ||| S:20371 E:20385 ||| NN
since  ||| S:20385 E:20399 ||| IN
reepithelialization  ||| S:20399 E:20419 ||| NN
appears  ||| S:20419 E:20427 ||| VBZ
normal  ||| S:20427 E:20434 ||| JJ
in  ||| S:20434 E:20437 ||| IN
SPARC-null  ||| S:20437 E:20448 ||| JJ
mice ||| S:20448 E:20452 ||| NNS
.  ||| S:20452 E:20462 ||| .
Thus ||| S:20462 E:20466 ||| RB
,  ||| S:20466 E:20468 ||| ,
the  ||| S:20468 E:20472 ||| DT
role  ||| S:20472 E:20477 ||| NN
of  ||| S:20477 E:20480 ||| IN
SPARC  ||| S:20480 E:20486 ||| NNP
in  ||| S:20486 E:20489 ||| IN
cell  ||| S:20489 E:20494 ||| NN
migration  ||| S:20494 E:20504 ||| NNS
may  ||| S:20504 E:20508 ||| MD
be  ||| S:20508 E:20511 ||| VB
cell  ||| S:20511 E:20524 ||| NN
type-specific ||| S:20524 E:20537 ||| NN
,  ||| S:20537 E:20539 ||| ,
which  ||| S:20539 E:20545 ||| WDT
has  ||| S:20545 E:20549 ||| VBZ
been  ||| S:20549 E:20554 ||| VBN
shown  ||| S:20554 E:20560 ||| VBN
to  ||| S:20560 E:20563 ||| TO
be  ||| S:20563 E:20566 ||| VB
the  ||| S:20566 E:20570 ||| DT
case  ||| S:20570 E:20575 ||| NN
with  ||| S:20575 E:20580 ||| IN
in  ||| S:20580 E:20591 ||| IN
vitro  ||| S:20591 E:20597 ||| JJ
studies  ||| S:20597 E:20605 ||| NNS
[  ||| S:20605 E:20607 ||| -LRB-
7  ||| S:20607 E:20609 ||| CD
9  ||| S:20609 E:20611 ||| CD
10  ||| S:20611 E:20614 ||| CD
]  ||| S:20614 E:20616 ||| -RRB-
.  ||| S:20616 E:20618 ||| .
Cell  ||| S:20618 E:20623 ||| NN
motility  ||| S:20623 E:20632 ||| NN
is  ||| S:20632 E:20635 ||| VBZ
controlled  ||| S:20635 E:20646 ||| VBN
by  ||| S:20646 E:20649 ||| IN
a  ||| S:20649 E:20659 ||| DT
cycle  ||| S:20659 E:20665 ||| NN
of  ||| S:20665 E:20668 ||| IN
cell  ||| S:20668 E:20673 ||| NN
attachment  ||| S:20673 E:20684 ||| NN
and  ||| S:20684 E:20688 ||| CC
detachment ||| S:20688 E:20698 ||| NN
.  ||| S:20698 E:20700 ||| .
It  ||| S:20700 E:20703 ||| PRP
is  ||| S:20703 E:20706 ||| VBZ
generally  ||| S:20706 E:20724 ||| RB
accepted  ||| S:20724 E:20733 ||| VBN
that  ||| S:20733 E:20738 ||| IN
the  ||| S:20738 E:20742 ||| DT
driving  ||| S:20742 E:20750 ||| NN
force  ||| S:20750 E:20756 ||| NN
for  ||| S:20756 E:20760 ||| IN
cell  ||| S:20760 E:20765 ||| NN
movement  ||| S:20765 E:20774 ||| NN
is  ||| S:20774 E:20785 ||| VBZ
provided  ||| S:20785 E:20794 ||| VBN
by  ||| S:20794 E:20797 ||| IN
the  ||| S:20797 E:20801 ||| DT
dynamic  ||| S:20801 E:20809 ||| JJ
reorganization  ||| S:20809 E:20824 ||| NN
of  ||| S:20824 E:20827 ||| IN
the  ||| S:20827 E:20831 ||| DT
actin  ||| S:20831 E:20845 ||| JJ
cytoskeleton ||| S:20845 E:20857 ||| NN
,  ||| S:20857 E:20859 ||| ,
directing  ||| S:20859 E:20869 ||| VBG
protrusion  ||| S:20869 E:20880 ||| NNS
( ||| S:20880 E:20881 ||| -LRB-
lamellipodia  ||| S:20881 E:20894 ||| NN
and  ||| S:20894 E:20906 ||| CC
filopodia ||| S:20906 E:20915 ||| CD
)  ||| S:20915 E:20917 ||| -RRB-
at  ||| S:20917 E:20920 ||| IN
the  ||| S:20920 E:20924 ||| DT
front  ||| S:20924 E:20930 ||| NN
of  ||| S:20930 E:20933 ||| IN
the  ||| S:20933 E:20937 ||| DT
cell  ||| S:20937 E:20942 ||| NN
and  ||| S:20942 E:20946 ||| CC
retraction  ||| S:20946 E:20957 ||| NN
at  ||| S:20957 E:20960 ||| IN
the  ||| S:20960 E:20972 ||| DT
rear  ||| S:20972 E:20977 ||| NN
[  ||| S:20977 E:20979 ||| -LRB-
30  ||| S:20979 E:20982 ||| CD
31  ||| S:20982 E:20985 ||| CD
]  ||| S:20985 E:20987 ||| -RRB-
.  ||| S:20987 E:20989 ||| .
Although  ||| S:20989 E:20998 ||| IN
we  ||| S:20998 E:21001 ||| PRP
have  ||| S:21001 E:21006 ||| VBP
not  ||| S:21006 E:21010 ||| RB
examined  ||| S:21010 E:21019 ||| VBD
the  ||| S:21019 E:21031 ||| DT
ultrastructure  ||| S:21031 E:21046 ||| NN
of  ||| S:21046 E:21049 ||| IN
the  ||| S:21049 E:21053 ||| DT
dermal  ||| S:21053 E:21060 ||| JJ
fibroblasts  ||| S:21060 E:21072 ||| NN
at  ||| S:21072 E:21075 ||| IN
the  ||| S:21075 E:21079 ||| DT
edge  ||| S:21079 E:21084 ||| NN
of  ||| S:21084 E:21095 ||| IN
wound  ||| S:21095 E:21101 ||| JJ
sites ||| S:21101 E:21106 ||| NNS
,  ||| S:21106 E:21108 ||| ,
we  ||| S:21108 E:21111 ||| PRP
showed  ||| S:21111 E:21118 ||| VBD
previously  ||| S:21118 E:21129 ||| RB
by  ||| S:21129 E:21132 ||| IN
electron  ||| S:21132 E:21141 ||| JJ
microscopy  ||| S:21141 E:21160 ||| NN
that  ||| S:21160 E:21165 ||| IN
in  ||| S:21165 E:21168 ||| IN
the  ||| S:21168 E:21172 ||| DT
lens  ||| S:21172 E:21177 ||| NN
of  ||| S:21177 E:21180 ||| IN
SPARC-null  ||| S:21180 E:21191 ||| JJ
mice  ||| S:21191 E:21196 ||| NNS
numerous  ||| S:21196 E:21205 ||| JJ
cellular  ||| S:21205 E:21222 ||| JJ
processes  ||| S:21222 E:21232 ||| NNS
extended  ||| S:21232 E:21241 ||| VBN
into  ||| S:21241 E:21246 ||| IN
the  ||| S:21246 E:21250 ||| DT
ECM  ||| S:21250 E:21254 ||| NNP
of  ||| S:21254 E:21257 ||| IN
the  ||| S:21257 E:21261 ||| DT
lens  ||| S:21261 E:21266 ||| NN
capsule  ||| S:21266 E:21274 ||| NNS
[  ||| S:21274 E:21276 ||| -LRB-
23  ||| S:21276 E:21279 ||| CD
]  ||| S:21279 E:21289 ||| -RRB-
.  ||| S:21289 E:21291 ||| .
We  ||| S:21291 E:21294 ||| PRP
further  ||| S:21294 E:21302 ||| RB
showed  ||| S:21302 E:21309 ||| VBD
that ||| S:21309 E:21313 ||| IN
,  ||| S:21313 E:21315 ||| ,
in  ||| S:21315 E:21318 ||| IN
contrast  ||| S:21318 E:21327 ||| NN
to  ||| S:21327 E:21330 ||| TO
the  ||| S:21330 E:21334 ||| DT
abnormal  ||| S:21334 E:21351 ||| JJ
filopodial  ||| S:21351 E:21362 ||| JJ
projections  ||| S:21362 E:21374 ||| NNS
at  ||| S:21374 E:21377 ||| IN
the  ||| S:21377 E:21381 ||| DT
lens  ||| S:21381 E:21386 ||| NN
cell-ECM  ||| S:21386 E:21395 ||| JJ
interface ||| S:21395 E:21404 ||| NN
,  ||| S:21404 E:21414 ||| ,
cell-cell  ||| S:21414 E:21424 ||| JJ
contacts  ||| S:21424 E:21433 ||| NNS
between  ||| S:21433 E:21441 ||| IN
the  ||| S:21441 E:21445 ||| DT
neighboring  ||| S:21445 E:21457 ||| JJ
lens  ||| S:21457 E:21462 ||| NN
epithelial  ||| S:21462 E:21481 ||| NN
cells  ||| S:21481 E:21487 ||| NNS
and  ||| S:21487 E:21491 ||| CC
between  ||| S:21491 E:21499 ||| IN
the  ||| S:21499 E:21503 ||| DT
lens  ||| S:21503 E:21508 ||| NN
epithelial  ||| S:21508 E:21519 ||| NNS
and  ||| S:21519 E:21523 ||| CC
fiber  ||| S:21523 E:21529 ||| NN
cells  ||| S:21529 E:21535 ||| NNS
were  ||| S:21535 E:21548 ||| VBD
normal  ||| S:21548 E:21555 ||| JJ
[  ||| S:21555 E:21557 ||| -LRB-
23  ||| S:21557 E:21560 ||| CD
]  ||| S:21560 E:21562 ||| -RRB-
.  ||| S:21562 E:21564 ||| .
The  ||| S:21564 E:21568 ||| DT
results  ||| S:21568 E:21576 ||| NNS
indicate  ||| S:21576 E:21585 ||| VBP
that  ||| S:21585 E:21590 ||| DT
disassembly  ||| S:21590 E:21602 ||| NN
of  ||| S:21602 E:21613 ||| IN
cell-cell  ||| S:21613 E:21623 ||| JJ
contacts  ||| S:21623 E:21632 ||| NNS
between  ||| S:21632 E:21640 ||| IN
lens  ||| S:21640 E:21645 ||| NN
cells  ||| S:21645 E:21651 ||| NNS
is  ||| S:21651 E:21654 ||| VBZ
not  ||| S:21654 E:21658 ||| RB
taking  ||| S:21658 E:21665 ||| VBG
place ||| S:21665 E:21670 ||| NN
,  ||| S:21670 E:21680 ||| ,
despite  ||| S:21680 E:21688 ||| IN
the  ||| S:21688 E:21692 ||| DT
forward  ||| S:21692 E:21700 ||| JJ
movement  ||| S:21700 E:21709 ||| NN
of  ||| S:21709 E:21712 ||| IN
the  ||| S:21712 E:21716 ||| DT
lens  ||| S:21716 E:21721 ||| NN
cells  ||| S:21721 E:21727 ||| NNS
into  ||| S:21727 E:21732 ||| IN
the  ||| S:21732 E:21736 ||| DT
ECM  ||| S:21736 E:21748 ||| NNP
of  ||| S:21748 E:21751 ||| IN
the  ||| S:21751 E:21755 ||| DT
capsule ||| S:21755 E:21762 ||| NN
.  ||| S:21762 E:21764 ||| .
In  ||| S:21764 E:21767 ||| IN
this  ||| S:21767 E:21772 ||| DT
study ||| S:21772 E:21777 ||| NN
,  ||| S:21777 E:21779 ||| ,
the  ||| S:21779 E:21783 ||| DT
lack  ||| S:21783 E:21788 ||| NN
of  ||| S:21788 E:21791 ||| IN
ingrowth  ||| S:21791 E:21800 ||| NN
despite  ||| S:21800 E:21816 ||| IN
the  ||| S:21816 E:21820 ||| DT
forward  ||| S:21820 E:21828 ||| JJ
movement  ||| S:21828 E:21837 ||| NN
of  ||| S:21837 E:21840 ||| IN
cells  ||| S:21840 E:21846 ||| NNS
at  ||| S:21846 E:21849 ||| IN
the  ||| S:21849 E:21853 ||| DT
edge  ||| S:21853 E:21858 ||| NN
of  ||| S:21858 E:21861 ||| IN
wounded  ||| S:21861 E:21877 ||| JJ
monolayers  ||| S:21877 E:21888 ||| NN
suggests  ||| S:21888 E:21897 ||| VBZ
that  ||| S:21897 E:21902 ||| IN
a  ||| S:21902 E:21904 ||| DT
similar  ||| S:21904 E:21912 ||| JJ
failure  ||| S:21912 E:21920 ||| NN
of  ||| S:21920 E:21923 ||| IN
SPARC-null  ||| S:21923 E:21942 ||| JJ
dermal  ||| S:21942 E:21949 ||| JJ
fibroblasts  ||| S:21949 E:21961 ||| NN
to  ||| S:21961 E:21964 ||| TO
break  ||| S:21964 E:21970 ||| VB
away  ||| S:21970 E:21975 ||| RP
from  ||| S:21975 E:21980 ||| IN
its  ||| S:21980 E:21984 ||| PRP$
neighboring  ||| S:21984 E:21996 ||| JJ
cells  ||| S:21996 E:22010 ||| NNS
may  ||| S:22010 E:22014 ||| MD
account  ||| S:22014 E:22022 ||| VB
for  ||| S:22022 E:22026 ||| IN
the  ||| S:22026 E:22030 ||| DT
impaired  ||| S:22030 E:22039 ||| JJ
cell  ||| S:22039 E:22044 ||| NN
motility  ||| S:22044 E:22053 ||| NNS
observed  ||| S:22053 E:22062 ||| VBD
during  ||| S:22062 E:22077 ||| IN
wound  ||| S:22077 E:22083 ||| JJ
healing  ||| S:22083 E:22091 ||| NN
in  ||| S:22091 E:22094 ||| IN
vitro ||| S:22094 E:22099 ||| NN
.  ||| S:22099 E:22101 ||| .
Previously ||| S:22101 E:22111 ||| RB
,  ||| S:22111 E:22113 ||| ,
SPARC  ||| S:22113 E:22119 ||| NNP
has  ||| S:22119 E:22123 ||| VBZ
been  ||| S:22123 E:22128 ||| VBN
shown  ||| S:22128 E:22134 ||| VBN
to  ||| S:22134 E:22145 ||| TO
regulate  ||| S:22145 E:22154 ||| VB
cell-cell  ||| S:22154 E:22164 ||| JJ
contact  ||| S:22164 E:22172 ||| NN
through  ||| S:22172 E:22180 ||| IN
tyrosine  ||| S:22180 E:22189 ||| JJ
phosphorylation  ||| S:22189 E:22213 ||| NN
of  ||| S:22213 E:22216 ||| IN
adherens  ||| S:22216 E:22225 ||| JJ
junction  ||| S:22225 E:22234 ||| NN
proteins  ||| S:22234 E:22243 ||| NNS
[  ||| S:22243 E:22245 ||| -LRB-
32  ||| S:22245 E:22248 ||| CD
]  ||| S:22248 E:22250 ||| -RRB-
.  ||| S:22250 E:22252 ||| .
Electron  ||| S:22252 E:22261 ||| NNP
microscopy  ||| S:22261 E:22280 ||| NN
of  ||| S:22280 E:22283 ||| IN
the  ||| S:22283 E:22287 ||| DT
SPARC-null  ||| S:22287 E:22298 ||| JJ
dermal  ||| S:22298 E:22305 ||| JJ
fibroblasts  ||| S:22305 E:22317 ||| NN
at  ||| S:22317 E:22320 ||| IN
wound  ||| S:22320 E:22326 ||| JJ
sites  ||| S:22326 E:22332 ||| NNS
should  ||| S:22332 E:22347 ||| MD
not  ||| S:22347 E:22351 ||| RB
only  ||| S:22351 E:22356 ||| RB
confirm  ||| S:22356 E:22364 ||| VB
the  ||| S:22364 E:22368 ||| DT
role  ||| S:22368 E:22373 ||| NN
of  ||| S:22373 E:22376 ||| IN
SPARC  ||| S:22376 E:22382 ||| NNP
in  ||| S:22382 E:22385 ||| IN
cell  ||| S:22385 E:22390 ||| NN
motility  ||| S:22390 E:22399 ||| NNS
but  ||| S:22399 E:22411 ||| CC
also  ||| S:22411 E:22416 ||| RB
reveal  ||| S:22416 E:22423 ||| VB
how  ||| S:22423 E:22427 ||| WRB
SPARC  ||| S:22427 E:22433 ||| NNP
mediates  ||| S:22433 E:22442 ||| VBD
cell-ECM  ||| S:22442 E:22451 ||| JJ
and  ||| S:22451 E:22455 ||| CC
cell-cell  ||| S:22455 E:22473 ||| JJ
interactions  ||| S:22473 E:22486 ||| NNS
to  ||| S:22486 E:22489 ||| TO
promote  ||| S:22489 E:22497 ||| VB
cell  ||| S:22497 E:22502 ||| NN
motility ||| S:22502 E:22510 ||| NN
.  ||| S:22510 E:22520 ||| .
We  ||| S:22520 E:22523 ||| PRP
showed  ||| S:22523 E:22530 ||| VBD
in  ||| S:22530 E:22533 ||| IN
the  ||| S:22533 E:22537 ||| DT
present  ||| S:22537 E:22545 ||| JJ
study  ||| S:22545 E:22551 ||| NN
that  ||| S:22551 E:22556 ||| IN
there  ||| S:22556 E:22562 ||| EX
are  ||| S:22562 E:22566 ||| VBP
no  ||| S:22566 E:22569 ||| DT
overt  ||| S:22569 E:22583 ||| JJ
differences  ||| S:22583 E:22595 ||| NNS
in  ||| S:22595 E:22598 ||| IN
cell  ||| S:22598 E:22603 ||| NN
proliferation  ||| S:22603 E:22617 ||| NN
and  ||| S:22617 E:22621 ||| CC
type  ||| S:22621 E:22626 ||| NN
I  ||| S:22626 E:22628 ||| PRP
collagen  ||| S:22628 E:22637 ||| VBP
gel  ||| S:22637 E:22649 ||| JJ
contraction  ||| S:22649 E:22661 ||| NN
between  ||| S:22661 E:22669 ||| IN
control  ||| S:22669 E:22677 ||| NN
and  ||| S:22677 E:22681 ||| CC
SPARC-null  ||| S:22681 E:22692 ||| JJ
dermal  ||| S:22692 E:22707 ||| JJ
fibroblasts ||| S:22707 E:22718 ||| NN
.  ||| S:22718 E:22720 ||| .
Wound  ||| S:22720 E:22726 ||| JJ
contraction  ||| S:22726 E:22738 ||| NN
depends  ||| S:22738 E:22746 ||| VBZ
on  ||| S:22746 E:22749 ||| IN
migration  ||| S:22749 E:22759 ||| NN
of  ||| S:22759 E:22770 ||| IN
fibroblasts  ||| S:22770 E:22782 ||| NN
into  ||| S:22782 E:22787 ||| IN
the  ||| S:22787 E:22791 ||| DT
wound  ||| S:22791 E:22797 ||| JJ
site  ||| S:22797 E:22802 ||| NN
where  ||| S:22802 E:22808 ||| WRB
they  ||| S:22808 E:22813 ||| PRP
lay  ||| S:22813 E:22817 ||| VBD
down  ||| S:22817 E:22822 ||| RP
their  ||| S:22822 E:22836 ||| PRP$
own  ||| S:22836 E:22840 ||| JJ
collagen-rich  ||| S:22840 E:22854 ||| JJ
matrix  ||| S:22854 E:22861 ||| NNS
[  ||| S:22861 E:22863 ||| -LRB-
2  ||| S:22863 E:22865 ||| LS
]  ||| S:22865 E:22867 ||| -RRB-
.  ||| S:22867 E:22869 ||| .
Northern  ||| S:22869 E:22878 ||| JJ
analysis  ||| S:22878 E:22887 ||| NN
of  ||| S:22887 E:22890 ||| IN
wound  ||| S:22890 E:22904 ||| JJ
biopsies  ||| S:22904 E:22913 ||| NNS
showed  ||| S:22913 E:22920 ||| VBD
that  ||| S:22920 E:22925 ||| DT
production  ||| S:22925 E:22936 ||| NN
of  ||| S:22936 E:22939 ||| IN
type  ||| S:22939 E:22944 ||| NN
I  ||| S:22944 E:22946 ||| PRP
collagen  ||| S:22946 E:22955 ||| VBP
and  ||| S:22955 E:22967 ||| CC
fibronectin  ||| S:22967 E:22979 ||| NN
by  ||| S:22979 E:22982 ||| IN
the  ||| S:22982 E:22986 ||| DT
null  ||| S:22986 E:22991 ||| JJ
mice ||| S:22991 E:22995 ||| NNS
,  ||| S:22995 E:22997 ||| ,
at  ||| S:22997 E:23000 ||| IN
the  ||| S:23000 E:23004 ||| DT
beginning  ||| S:23004 E:23014 ||| NN
of  ||| S:23014 E:23017 ||| IN
wound  ||| S:23017 E:23031 ||| JJ
healing ||| S:23031 E:23038 ||| NN
,  ||| S:23038 E:23040 ||| ,
was  ||| S:23040 E:23044 ||| VBD
lower  ||| S:23044 E:23050 ||| JJR
than  ||| S:23050 E:23055 ||| IN
that  ||| S:23055 E:23060 ||| DT
by  ||| S:23060 E:23063 ||| IN
the  ||| S:23063 E:23067 ||| DT
wild-type  ||| S:23067 E:23077 ||| JJ
mice ||| S:23077 E:23081 ||| NNS
.  ||| S:23081 E:23091 ||| .
Subsequently ||| S:23091 E:23103 ||| RB
,  ||| S:23103 E:23105 ||| ,
the  ||| S:23105 E:23109 ||| DT
wound  ||| S:23109 E:23115 ||| NN
in  ||| S:23115 E:23118 ||| IN
the  ||| S:23118 E:23122 ||| DT
null  ||| S:23122 E:23127 ||| JJ
mice  ||| S:23127 E:23132 ||| NNS
was  ||| S:23132 E:23136 ||| VBD
fully  ||| S:23136 E:23142 ||| RB
invaded  ||| S:23142 E:23158 ||| VBD
by  ||| S:23158 E:23161 ||| IN
fibroblasts  ||| S:23161 E:23173 ||| NN
and  ||| S:23173 E:23177 ||| CC
expression  ||| S:23177 E:23188 ||| NN
of  ||| S:23188 E:23191 ||| IN
type  ||| S:23191 E:23196 ||| NN
I  ||| S:23196 E:23198 ||| PRP
collagen  ||| S:23198 E:23207 ||| VBP
and  ||| S:23207 E:23219 ||| CC
fibronectin  ||| S:23219 E:23231 ||| NN
by  ||| S:23231 E:23234 ||| IN
the  ||| S:23234 E:23238 ||| DT
SPARC-null  ||| S:23238 E:23249 ||| JJ
mice  ||| S:23249 E:23254 ||| NNS
was  ||| S:23254 E:23258 ||| VBD
as  ||| S:23258 E:23261 ||| IN
abundant  ||| S:23261 E:23270 ||| JJ
as  ||| S:23270 E:23273 ||| IN
that  ||| S:23273 E:23286 ||| DT
by  ||| S:23286 E:23289 ||| IN
the  ||| S:23289 E:23293 ||| DT
wild-type  ||| S:23293 E:23303 ||| JJ
mice ||| S:23303 E:23307 ||| NNS
.  ||| S:23307 E:23309 ||| .
Wound  ||| S:23309 E:23315 ||| JJ
contraction  ||| S:23315 E:23327 ||| NN
takes  ||| S:23327 E:23333 ||| VBZ
place  ||| S:23333 E:23339 ||| NN
when  ||| S:23339 E:23344 ||| WRB
a  ||| S:23344 E:23354 ||| DT
wound  ||| S:23354 E:23360 ||| JJ
site  ||| S:23360 E:23365 ||| NN
is  ||| S:23365 E:23368 ||| VBZ
filled  ||| S:23368 E:23375 ||| VBN
with  ||| S:23375 E:23380 ||| IN
fibroblasts  ||| S:23380 E:23392 ||| NN
and  ||| S:23392 E:23396 ||| CC
ECM  ||| S:23396 E:23400 ||| NNP
[  ||| S:23400 E:23402 ||| -LRB-
2  ||| S:23402 E:23404 ||| LS
]  ||| S:23404 E:23406 ||| -RRB-
.  ||| S:23406 E:23408 ||| .
Thus ||| S:23408 E:23412 ||| RB
,  ||| S:23412 E:23422 ||| ,
it  ||| S:23422 E:23425 ||| PRP
is  ||| S:23425 E:23428 ||| VBZ
likely  ||| S:23428 E:23435 ||| RB
that  ||| S:23435 E:23440 ||| IN
consistent  ||| S:23440 E:23451 ||| JJ
with  ||| S:23451 E:23456 ||| IN
the  ||| S:23456 E:23460 ||| DT
in  ||| S:23460 E:23463 ||| IN
vitro  ||| S:23463 E:23469 ||| JJ
study  ||| S:23469 E:23475 ||| NN
wound  ||| S:23475 E:23489 ||| NN
contraction  ||| S:23489 E:23501 ||| NN
in  ||| S:23501 E:23504 ||| IN
the  ||| S:23504 E:23508 ||| DT
SPARC-null  ||| S:23508 E:23519 ||| JJ
mice  ||| S:23519 E:23524 ||| NNS
is  ||| S:23524 E:23527 ||| VBZ
not  ||| S:23527 E:23531 ||| RB
compromised ||| S:23531 E:23542 ||| VBN
.  ||| S:23542 E:23566 ||| .
Conclusions  ||| S:23566 E:23586 ||| NNS
The  ||| S:23586 E:23590 ||| DT
delay  ||| S:23590 E:23596 ||| NN
in  ||| S:23596 E:23599 ||| IN
granulation  ||| S:23599 E:23611 ||| JJ
tissue  ||| S:23611 E:23618 ||| NN
formation  ||| S:23618 E:23628 ||| NN
and  ||| S:23628 E:23632 ||| CC
healing  ||| S:23632 E:23640 ||| NN
of  ||| S:23640 E:23651 ||| IN
excision  ||| S:23651 E:23660 ||| JJ
wounds  ||| S:23660 E:23667 ||| NNS
in  ||| S:23667 E:23670 ||| IN
SPARC-null  ||| S:23670 E:23681 ||| JJ
mice ||| S:23681 E:23685 ||| NNS
,  ||| S:23685 E:23687 ||| ,
and  ||| S:23687 E:23691 ||| CC
the  ||| S:23691 E:23695 ||| DT
defect  ||| S:23695 E:23702 ||| NN
in  ||| S:23702 E:23705 ||| IN
wound  ||| S:23705 E:23719 ||| JJ
closure  ||| S:23719 E:23727 ||| NN
in  ||| S:23727 E:23730 ||| IN
in  ||| S:23730 E:23733 ||| IN
vitro  ||| S:23733 E:23739 ||| JJ
assays  ||| S:23739 E:23746 ||| NNS
indicate  ||| S:23746 E:23755 ||| VBP
that  ||| S:23755 E:23760 ||| IN
SPARC  ||| S:23760 E:23766 ||| NNP
plays  ||| S:23766 E:23772 ||| VBZ
a  ||| S:23772 E:23774 ||| DT
role  ||| S:23774 E:23787 ||| NN
in  ||| S:23787 E:23790 ||| IN
wound  ||| S:23790 E:23796 ||| JJ
healing  ||| S:23796 E:23804 ||| NN
through  ||| S:23804 E:23812 ||| IN
its  ||| S:23812 E:23816 ||| PRP$
effect  ||| S:23816 E:23823 ||| NN
on  ||| S:23823 E:23826 ||| IN
cell  ||| S:23826 E:23831 ||| NN
migration ||| S:23831 E:23840 ||| NN
.  ||| S:23840 E:23842 ||| .
Cell  ||| S:23842 E:23855 ||| NN
migration  ||| S:23855 E:23865 ||| NN
is  ||| S:23865 E:23868 ||| VBZ
crucial  ||| S:23868 E:23876 ||| JJ
not  ||| S:23876 E:23880 ||| RB
only  ||| S:23880 E:23885 ||| RB
to  ||| S:23885 E:23888 ||| TO
wound  ||| S:23888 E:23894 ||| VB
healing  ||| S:23894 E:23902 ||| NN
but  ||| S:23902 E:23906 ||| CC
also  ||| S:23906 E:23911 ||| RB
to  ||| S:23911 E:23922 ||| TO
a  ||| S:23922 E:23924 ||| DT
wide  ||| S:23924 E:23929 ||| JJ
variety  ||| S:23929 E:23937 ||| NN
of  ||| S:23937 E:23940 ||| IN
normal  ||| S:23940 E:23947 ||| JJ
or  ||| S:23947 E:23950 ||| CC
abnormal  ||| S:23950 E:23959 ||| JJ
biological  ||| S:23959 E:23970 ||| JJ
phenomena  ||| S:23970 E:23988 ||| JJ
such  ||| S:23988 E:23993 ||| JJ
as  ||| S:23993 E:23996 ||| IN
embryogenesis ||| S:23996 E:24009 ||| NN
,  ||| S:24009 E:24011 ||| ,
leukocyte  ||| S:24011 E:24021 ||| JJ
immigration  ||| S:24021 E:24033 ||| NN
into  ||| S:24033 E:24038 ||| IN
areas  ||| S:24038 E:24044 ||| NNS
of  ||| S:24044 E:24055 ||| IN
insult ||| S:24055 E:24061 ||| NN
,  ||| S:24061 E:24063 ||| ,
and  ||| S:24063 E:24067 ||| CC
tumor  ||| S:24067 E:24073 ||| NN
cell  ||| S:24073 E:24078 ||| NN
invasion ||| S:24078 E:24086 ||| NN
.  ||| S:24086 E:24088 ||| .
SPARC-null  ||| S:24088 E:24099 ||| JJ
mice  ||| S:24099 E:24104 ||| NNS
and  ||| S:24104 E:24108 ||| CC
their  ||| S:24108 E:24122 ||| PRP$
cells  ||| S:24122 E:24128 ||| NNS
should  ||| S:24128 E:24135 ||| MD
provide  ||| S:24135 E:24143 ||| VB
a  ||| S:24143 E:24145 ||| DT
useful  ||| S:24145 E:24152 ||| JJ
system  ||| S:24152 E:24159 ||| NN
to  ||| S:24159 E:24162 ||| TO
investigate  ||| S:24162 E:24174 ||| VB
how  ||| S:24174 E:24178 ||| WRB
a  ||| S:24178 E:24188 ||| DT
matricellular  ||| S:24188 E:24202 ||| JJ
protein  ||| S:24202 E:24210 ||| NN
regulates  ||| S:24210 E:24220 ||| VBZ
pleiotropic  ||| S:24220 E:24232 ||| JJ
functions  ||| S:24232 E:24250 ||| NNS
through  ||| S:24250 E:24258 ||| IN
cell  ||| S:24258 E:24263 ||| NN
migration  ||| S:24263 E:24273 ||| NNS
and  ||| S:24273 E:24277 ||| CC
how  ||| S:24277 E:24281 ||| WRB
its  ||| S:24281 E:24285 ||| PRP$
absence  ||| S:24285 E:24293 ||| NN
alters  ||| S:24293 E:24308 ||| VBZ
biological  ||| S:24308 E:24319 ||| JJ
processes ||| S:24319 E:24328 ||| NNS
.  ||| S:24328 E:24352 ||| .
Materials  ||| S:24352 E:24362 ||| NNS
and  ||| S:24362 E:24366 ||| CC
Methods  ||| S:24366 E:24393 ||| NNP
Animals  ||| S:24393 E:24411 ||| NNPS
SPARC-null  ||| S:24411 E:24422 ||| JJ
mice  ||| S:24422 E:24427 ||| NNS
and  ||| S:24427 E:24431 ||| CC
control  ||| S:24431 E:24439 ||| VB
wild-type  ||| S:24439 E:24449 ||| JJ
mice  ||| S:24449 E:24454 ||| NNS
used  ||| S:24454 E:24459 ||| VBN
in  ||| S:24459 E:24472 ||| IN
this  ||| S:24472 E:24477 ||| DT
study  ||| S:24477 E:24483 ||| NN
were  ||| S:24483 E:24488 ||| VBD
generated  ||| S:24488 E:24498 ||| VBN
and  ||| S:24498 E:24502 ||| CC
maintained  ||| S:24502 E:24513 ||| VBN
on  ||| S:24513 E:24516 ||| IN
a  ||| S:24516 E:24518 ||| DT
mixed  ||| S:24518 E:24534 ||| JJ
genetic  ||| S:24534 E:24542 ||| JJ
background  ||| S:24542 E:24553 ||| NN
( ||| S:24553 E:24554 ||| -LRB-
F2 ||| S:24554 E:24556 ||| NNP
)  ||| S:24556 E:24558 ||| -RRB-
of  ||| S:24558 E:24561 ||| IN
129SvEv  ||| S:24561 E:24569 ||| CD
×  ||| S:24569 E:24571 ||| CD
C57BL ||| S:24571 E:24576 ||| CD
/ ||| S:24576 E:24577 ||| CD
6j  ||| S:24577 E:24580 ||| CD
as  ||| S:24580 E:24593 ||| IN
described  ||| S:24593 E:24603 ||| VBN
previously  ||| S:24603 E:24614 ||| RB
[  ||| S:24614 E:24616 ||| -LRB-
14  ||| S:24616 E:24619 ||| CD
]  ||| S:24619 E:24621 ||| -RRB-
.  ||| S:24621 E:24651 ||| .
Wound  ||| S:24651 E:24657 ||| FW
healing  ||| S:24657 E:24665 ||| FW
assays  ||| S:24665 E:24682 ||| FW
Two-  ||| S:24682 E:24687 ||| FW
to  ||| S:24687 E:24690 ||| TO
3-month-old  ||| S:24690 E:24702 ||| CD
male  ||| S:24702 E:24707 ||| JJ
mice  ||| S:24707 E:24712 ||| NNS
were  ||| S:24712 E:24717 ||| VBD
anesthetized  ||| S:24717 E:24740 ||| JJ
intraperitoneally  ||| S:24740 E:24758 ||| NN
with  ||| S:24758 E:24763 ||| IN
avertin  ||| S:24763 E:24771 ||| NNS
( ||| S:24771 E:24772 ||| -LRB-
0.5  ||| S:24772 E:24776 ||| CD
g ||| S:24776 E:24777 ||| CD
/ ||| S:24777 E:24778 ||| CD
kg  ||| S:24778 E:24781 ||| JJ
body  ||| S:24781 E:24786 ||| NN
weight ||| S:24786 E:24792 ||| NN
) ||| S:24792 E:24793 ||| -RRB-
.  ||| S:24793 E:24805 ||| .
The  ||| S:24805 E:24809 ||| DT
hair  ||| S:24809 E:24814 ||| NN
on  ||| S:24814 E:24817 ||| IN
the  ||| S:24817 E:24821 ||| DT
back  ||| S:24821 E:24826 ||| RB
was  ||| S:24826 E:24830 ||| VBD
cut  ||| S:24830 E:24834 ||| VBN
and  ||| S:24834 E:24838 ||| CC
full-thickness  ||| S:24838 E:24853 ||| JJ
25  ||| S:24853 E:24856 ||| CD
mm  ||| S:24856 E:24869 ||| CD
oblong  ||| S:24869 E:24876 ||| NNS
or  ||| S:24876 E:24879 ||| CC
30  ||| S:24879 E:24882 ||| CD
mm  ||| S:24882 E:24885 ||| CD
circular  ||| S:24885 E:24894 ||| CD
wounds ||| S:24894 E:24900 ||| NNS
,  ||| S:24900 E:24902 ||| ,
including  ||| S:24902 E:24912 ||| VBG
panniculus  ||| S:24912 E:24933 ||| JJ
carnosus ||| S:24933 E:24941 ||| NN
,  ||| S:24941 E:24943 ||| ,
were  ||| S:24943 E:24948 ||| VBD
made ||| S:24948 E:24952 ||| VBN
.  ||| S:24952 E:24954 ||| .
Wounds  ||| S:24954 E:24961 ||| NNS
were  ||| S:24961 E:24966 ||| VBD
neither  ||| S:24966 E:24974 ||| DT
dressed  ||| S:24974 E:24982 ||| NN
nor  ||| S:24982 E:24996 ||| CC
sutured ||| S:24996 E:25003 ||| NN
.  ||| S:25003 E:25005 ||| .
Mice  ||| S:25005 E:25010 ||| NNS
were  ||| S:25010 E:25015 ||| VBD
caged  ||| S:25015 E:25021 ||| JJ
individually  ||| S:25021 E:25034 ||| NN
and  ||| S:25034 E:25038 ||| CC
progression  ||| S:25038 E:25050 ||| NN
of  ||| S:25050 E:25063 ||| IN
wound  ||| S:25063 E:25069 ||| JJ
repair  ||| S:25069 E:25076 ||| NN
was  ||| S:25076 E:25080 ||| VBD
monitored  ||| S:25080 E:25090 ||| VBN
daily ||| S:25090 E:25095 ||| RB
.  ||| S:25095 E:25125 ||| .
Histology  ||| S:25125 E:25145 ||| NNP
Five  ||| S:25145 E:25150 ||| CD
full-thickness  ||| S:25150 E:25165 ||| JJ
6  ||| S:25165 E:25167 ||| CD
mm  ||| S:25167 E:25170 ||| CD
circular  ||| S:25170 E:25179 ||| CD
wounds  ||| S:25179 E:25186 ||| NNS
were  ||| S:25186 E:25191 ||| VBD
made  ||| S:25191 E:25196 ||| VBN
on  ||| S:25196 E:25209 ||| IN
the  ||| S:25209 E:25213 ||| DT
back  ||| S:25213 E:25218 ||| NN
of  ||| S:25218 E:25221 ||| IN
an  ||| S:25221 E:25224 ||| DT
anesthetized  ||| S:25224 E:25237 ||| JJ
mouse  ||| S:25237 E:25243 ||| NN
by  ||| S:25243 E:25246 ||| IN
a  ||| S:25246 E:25248 ||| DT
procedure  ||| S:25248 E:25258 ||| NN
similar  ||| S:25258 E:25276 ||| JJ
to  ||| S:25276 E:25279 ||| TO
that  ||| S:25279 E:25284 ||| WDT
described  ||| S:25284 E:25294 ||| VBD
above ||| S:25294 E:25299 ||| RB
.  ||| S:25299 E:25301 ||| .
The  ||| S:25301 E:25305 ||| DT
6  ||| S:25305 E:25307 ||| CD
mm  ||| S:25307 E:25310 ||| CD
diameter  ||| S:25310 E:25319 ||| CD
wounds  ||| S:25319 E:25336 ||| NNS
provided  ||| S:25336 E:25345 ||| VBD
stable  ||| S:25345 E:25352 ||| JJ
wound  ||| S:25352 E:25358 ||| NN
beds  ||| S:25358 E:25363 ||| NNS
appropriate  ||| S:25363 E:25375 ||| JJ
for  ||| S:25375 E:25379 ||| IN
collection  ||| S:25379 E:25390 ||| NN
of  ||| S:25390 E:25403 ||| IN
wound  ||| S:25403 E:25409 ||| JJ
tissues  ||| S:25409 E:25417 ||| NNS
for  ||| S:25417 E:25421 ||| IN
histological  ||| S:25421 E:25434 ||| JJ
analysis ||| S:25434 E:25442 ||| NN
.  ||| S:25442 E:25444 ||| .
Mice  ||| S:25444 E:25449 ||| NNS
were  ||| S:25449 E:25464 ||| VBD
sacrificed  ||| S:25464 E:25475 ||| VBN
by  ||| S:25475 E:25478 ||| IN
CO2  ||| S:25478 E:25482 ||| CD
asphyxia  ||| S:25482 E:25491 ||| CD
2 ||| S:25491 E:25492 ||| CD
,  ||| S:25492 E:25494 ||| ,
4 ||| S:25494 E:25495 ||| CD
,  ||| S:25495 E:25497 ||| ,
6 ||| S:25497 E:25498 ||| CD
,  ||| S:25498 E:25500 ||| ,
and  ||| S:25500 E:25504 ||| CC
10  ||| S:25504 E:25507 ||| CD
days  ||| S:25507 E:25512 ||| NNS
after  ||| S:25512 E:25528 ||| IN
wounding ||| S:25528 E:25536 ||| NN
.  ||| S:25536 E:25538 ||| .
An  ||| S:25538 E:25541 ||| DT
area  ||| S:25541 E:25546 ||| NN
7  ||| S:25546 E:25548 ||| CD
to  ||| S:25548 E:25551 ||| TO
8  ||| S:25551 E:25553 ||| CD
mm  ||| S:25553 E:25556 ||| NN
in  ||| S:25556 E:25559 ||| IN
diameter ||| S:25559 E:25567 ||| NN
,  ||| S:25567 E:25569 ||| ,
which  ||| S:25569 E:25575 ||| WDT
included  ||| S:25575 E:25594 ||| VBD
the  ||| S:25594 E:25598 ||| DT
uninjured  ||| S:25598 E:25608 ||| JJ
epithelial  ||| S:25608 E:25619 ||| JJ
margins ||| S:25619 E:25626 ||| NNS
,  ||| S:25626 E:25628 ||| ,
was  ||| S:25628 E:25632 ||| VBD
removed ||| S:25632 E:25639 ||| VBN
,  ||| S:25639 E:25641 ||| ,
bisected  ||| S:25641 E:25660 ||| VBG
in  ||| S:25660 E:25663 ||| IN
the  ||| S:25663 E:25667 ||| DT
midtransversal  ||| S:25667 E:25682 ||| JJ
plane ||| S:25682 E:25687 ||| NN
,  ||| S:25687 E:25689 ||| ,
fixed  ||| S:25689 E:25695 ||| VBN
in  ||| S:25695 E:25698 ||| IN
10 ||| S:25698 E:25700 ||| CD
%  ||| S:25700 E:25702 ||| NN
formalin  ||| S:25702 E:25721 ||| NNS
( ||| S:25721 E:25722 ||| -LRB-
Buffered  ||| S:25722 E:25731 ||| NNP
Formalde-Fresh ||| S:25731 E:25745 ||| NNP
,  ||| S:25745 E:25747 ||| ,
Fisher  ||| S:25747 E:25754 ||| NNP
Scientific ||| S:25754 E:25764 ||| NNP
,  ||| S:25764 E:25766 ||| ,
Fair  ||| S:25766 E:25771 ||| NNP
Lawn ||| S:25771 E:25775 ||| NNP
,  ||| S:25775 E:25787 ||| ,
NJ ||| S:25787 E:25789 ||| NNP
)  ||| S:25789 E:25791 ||| -RRB-
and  ||| S:25791 E:25795 ||| CC
embedded  ||| S:25795 E:25804 ||| VBN
in  ||| S:25804 E:25807 ||| IN
paraffin ||| S:25807 E:25815 ||| NN
.  ||| S:25815 E:25817 ||| .
Sections  ||| S:25817 E:25826 ||| NNS
( ||| S:25826 E:25827 ||| -LRB-
6  ||| S:25827 E:25829 ||| CD
μm ||| S:25829 E:25831 ||| CD
)  ||| S:25831 E:25833 ||| -RRB-
were  ||| S:25833 E:25838 ||| VBD
cut  ||| S:25838 E:25852 ||| VBN
from  ||| S:25852 E:25857 ||| IN
both  ||| S:25857 E:25862 ||| DT
faces  ||| S:25862 E:25868 ||| VBZ
of  ||| S:25868 E:25871 ||| IN
bisected  ||| S:25871 E:25880 ||| JJ
tissues  ||| S:25880 E:25888 ||| NNS
and  ||| S:25888 E:25892 ||| CC
stained  ||| S:25892 E:25900 ||| NN
with  ||| S:25900 E:25915 ||| IN
hematoxylin  ||| S:25915 E:25927 ||| NN
and  ||| S:25927 E:25931 ||| CC
eosin ||| S:25931 E:25936 ||| NN
.  ||| S:25936 E:25966 ||| .
RNA  ||| S:25966 E:25970 ||| NNP
analysis  ||| S:25970 E:25989 ||| NN
Circular ||| S:25989 E:25997 ||| NNP
,  ||| S:25997 E:25999 ||| ,
full-thickness  ||| S:25999 E:26014 ||| JJ
dorsal  ||| S:26014 E:26021 ||| JJ
cutaneous  ||| S:26021 E:26031 ||| JJ
biopsies  ||| S:26031 E:26040 ||| NNS
of  ||| S:26040 E:26053 ||| IN
6  ||| S:26053 E:26055 ||| CD
mm  ||| S:26055 E:26058 ||| CD
diameter  ||| S:26058 E:26067 ||| NNS
were  ||| S:26067 E:26072 ||| VBD
made  ||| S:26072 E:26077 ||| VBN
on  ||| S:26077 E:26080 ||| IN
the  ||| S:26080 E:26084 ||| DT
backs  ||| S:26084 E:26090 ||| NNS
of  ||| S:26090 E:26093 ||| IN
anesthetized  ||| S:26093 E:26106 ||| JJ
mice  ||| S:26106 E:26121 ||| NNS
and  ||| S:26121 E:26125 ||| CC
wound  ||| S:26125 E:26131 ||| JJ
sites ||| S:26131 E:26136 ||| NNS
,  ||| S:26136 E:26138 ||| ,
including  ||| S:26138 E:26148 ||| VBG
the  ||| S:26148 E:26152 ||| DT
uninjured  ||| S:26152 E:26162 ||| JJ
epithelial  ||| S:26162 E:26183 ||| JJ
margins ||| S:26183 E:26190 ||| NNS
,  ||| S:26190 E:26192 ||| ,
were  ||| S:26192 E:26197 ||| VBD
excised  ||| S:26197 E:26205 ||| CD
2 ||| S:26205 E:26206 ||| CD
,  ||| S:26206 E:26208 ||| ,
4 ||| S:26208 E:26209 ||| CD
,  ||| S:26209 E:26211 ||| ,
and  ||| S:26211 E:26215 ||| CC
6  ||| S:26215 E:26217 ||| CD
days  ||| S:26217 E:26222 ||| NNS
post  ||| S:26222 E:26227 ||| NN
wounding  ||| S:26227 E:26236 ||| VBZ
as  ||| S:26236 E:26249 ||| RB
described  ||| S:26249 E:26259 ||| VBN
above ||| S:26259 E:26264 ||| IN
.  ||| S:26264 E:26266 ||| .
Control ||| S:26266 E:26273 ||| NNP
,  ||| S:26273 E:26275 ||| ,
unwounded  ||| S:26275 E:26285 ||| FW
dorsal  ||| S:26285 E:26292 ||| FW
skin  ||| S:26292 E:26297 ||| FW
( ||| S:26297 E:26298 ||| -LRB-
0  ||| S:26298 E:26300 ||| CD
day ||| S:26300 E:26303 ||| NN
)  ||| S:26303 E:26315 ||| -RRB-
was  ||| S:26315 E:26319 ||| VBD
also  ||| S:26319 E:26324 ||| RB
isolated ||| S:26324 E:26332 ||| VBN
.  ||| S:26332 E:26334 ||| .
The  ||| S:26334 E:26338 ||| DT
harvested  ||| S:26338 E:26348 ||| JJ
tissues  ||| S:26348 E:26356 ||| NNS
were  ||| S:26356 E:26361 ||| VBD
frozen  ||| S:26361 E:26378 ||| VBN
immediately  ||| S:26378 E:26390 ||| RB
in  ||| S:26390 E:26393 ||| IN
liquid  ||| S:26393 E:26400 ||| JJ
nitrogen ||| S:26400 E:26408 ||| NN
.  ||| S:26408 E:26410 ||| .
Total  ||| S:26410 E:26416 ||| JJ
RNA  ||| S:26416 E:26420 ||| NNP
was  ||| S:26420 E:26424 ||| VBD
isolated  ||| S:26424 E:26443 ||| VBN
using  ||| S:26443 E:26449 ||| VBG
guanidine  ||| S:26449 E:26459 ||| JJ
thiocyanate  ||| S:26459 E:26471 ||| JJ
extraction  ||| S:26471 E:26482 ||| NN
and  ||| S:26482 E:26486 ||| CC
15  ||| S:26486 E:26489 ||| CD
μg  ||| S:26489 E:26492 ||| NN
of  ||| S:26492 E:26495 ||| IN
the  ||| S:26495 E:26509 ||| DT
total  ||| S:26509 E:26515 ||| JJ
RNA  ||| S:26515 E:26519 ||| NNP
was  ||| S:26519 E:26523 ||| VBD
analyzed  ||| S:26523 E:26532 ||| VBN
by  ||| S:26532 E:26535 ||| IN
Northern  ||| S:26535 E:26544 ||| NNP
hybridization  ||| S:26544 E:26558 ||| VBD
as  ||| S:26558 E:26571 ||| RB
described  ||| S:26571 E:26581 ||| VBN
previously  ||| S:26581 E:26592 ||| RB
[  ||| S:26592 E:26594 ||| -LRB-
16  ||| S:26594 E:26597 ||| CD
]  ||| S:26597 E:26599 ||| -RRB-
.  ||| S:26599 E:26601 ||| .
cDNA  ||| S:26601 E:26606 ||| JJ
probes  ||| S:26606 E:26613 ||| NNS
used  ||| S:26613 E:26618 ||| VBN
in  ||| S:26618 E:26631 ||| IN
hybridization  ||| S:26631 E:26645 ||| NN
were  ||| S:26645 E:26650 ||| VBD
human  ||| S:26650 E:26656 ||| JJ
fibronectin  ||| S:26656 E:26668 ||| NNS
[  ||| S:26668 E:26670 ||| -LRB-
33  ||| S:26670 E:26673 ||| CD
]  ||| S:26673 E:26675 ||| -RRB-
,  ||| S:26675 E:26677 ||| ,
α1 ||| S:26677 E:26679 ||| NNP
( ||| S:26679 E:26680 ||| -LRB-
I ||| S:26680 E:26681 ||| PRP
)  ||| S:26681 E:26693 ||| -RRB-
collagen  ||| S:26693 E:26702 ||| NN
[  ||| S:26702 E:26704 ||| -LRB-
34  ||| S:26704 E:26707 ||| CD
]  ||| S:26707 E:26709 ||| -RRB-
,  ||| S:26709 E:26711 ||| ,
or  ||| S:26711 E:26714 ||| CC
cytokeratin  ||| S:26714 E:26726 ||| CD
14  ||| S:26726 E:26729 ||| CD
cDNA  ||| S:26729 E:26734 ||| NNS
( ||| S:26734 E:26735 ||| -LRB-
Hung  ||| S:26735 E:26740 ||| NNP
Tseng ||| S:26740 E:26745 ||| NNP
,  ||| S:26745 E:26757 ||| ,
unpublished  ||| S:26757 E:26769 ||| JJ
results ||| S:26769 E:26776 ||| NNS
) ||| S:26776 E:26777 ||| -RRB-
.  ||| S:26777 E:26779 ||| .
The  ||| S:26779 E:26783 ||| DT
same  ||| S:26783 E:26788 ||| JJ
Northern  ||| S:26788 E:26797 ||| JJ
hybridization  ||| S:26797 E:26821 ||| JJ
filters  ||| S:26821 E:26829 ||| NNS
were  ||| S:26829 E:26834 ||| VBD
reprobed  ||| S:26834 E:26843 ||| VBN
with  ||| S:26843 E:26848 ||| IN
glyceraldehyde-3-phosphate  ||| S:26848 E:26885 ||| CD
dehydrogenase  ||| S:26885 E:26899 ||| NNS
( ||| S:26899 E:26900 ||| -LRB-
GAPDH ||| S:26900 E:26905 ||| NNP
)  ||| S:26905 E:26907 ||| -RRB-
cDNA ||| S:26907 E:26911 ||| JJ
.  ||| S:26911 E:26913 ||| .
The  ||| S:26913 E:26917 ||| DT
amounts  ||| S:26917 E:26925 ||| NNS
of  ||| S:26925 E:26928 ||| IN
transcripts  ||| S:26928 E:26950 ||| NNS
were  ||| S:26950 E:26955 ||| VBD
quantified  ||| S:26955 E:26966 ||| VBN
by  ||| S:26966 E:26969 ||| IN
PhosphoImager  ||| S:26969 E:26983 ||| NNP
( ||| S:26983 E:26984 ||| -LRB-
Molecular  ||| S:26984 E:26994 ||| NNP
Dynamics ||| S:26994 E:27002 ||| NNPS
)  ||| S:27002 E:27004 ||| -RRB-
and  ||| S:27004 E:27018 ||| CC
normalized  ||| S:27018 E:27029 ||| JJ
to  ||| S:27029 E:27032 ||| TO
GAPDH  ||| S:27032 E:27038 ||| NNP
transcript ||| S:27038 E:27048 ||| NN
.  ||| S:27048 E:27050 ||| .
Two  ||| S:27050 E:27054 ||| CD
independent  ||| S:27054 E:27076 ||| JJ
experiments  ||| S:27076 E:27088 ||| NNS
gave  ||| S:27088 E:27093 ||| VBD
similar  ||| S:27093 E:27101 ||| JJ
hybridization  ||| S:27101 E:27115 ||| JJ
patterns ||| S:27115 E:27123 ||| NNS
.  ||| S:27123 E:27153 ||| .
Isolation  ||| S:27153 E:27163 ||| NN
of  ||| S:27163 E:27166 ||| IN
primary  ||| S:27166 E:27174 ||| JJ
dermal  ||| S:27174 E:27181 ||| NNS
fibroblasts  ||| S:27181 E:27203 ||| VBP
Primary  ||| S:27203 E:27211 ||| JJ
dermal  ||| S:27211 E:27218 ||| JJ
fibroblasts  ||| S:27218 E:27230 ||| NN
were  ||| S:27230 E:27235 ||| VBD
prepared  ||| S:27235 E:27244 ||| VBN
from  ||| S:27244 E:27249 ||| IN
3  ||| S:27249 E:27251 ||| CD
day  ||| S:27251 E:27265 ||| NN
old  ||| S:27265 E:27269 ||| JJ
newborn  ||| S:27269 E:27277 ||| JJ
mice ||| S:27277 E:27281 ||| NNS
.  ||| S:27281 E:27283 ||| .
Mice  ||| S:27283 E:27288 ||| NNS
were  ||| S:27288 E:27293 ||| VBD
euthanized  ||| S:27293 E:27304 ||| VBN
by  ||| S:27304 E:27307 ||| IN
cervical  ||| S:27307 E:27326 ||| JJ
dislocation  ||| S:27326 E:27338 ||| NN
and  ||| S:27338 E:27342 ||| CC
sterilized  ||| S:27342 E:27353 ||| VBN
with  ||| S:27353 E:27358 ||| IN
70 ||| S:27358 E:27360 ||| CD
%  ||| S:27360 E:27362 ||| NN
ethanol ||| S:27362 E:27369 ||| NN
.  ||| S:27369 E:27371 ||| .
Skin  ||| S:27371 E:27376 ||| NN
was  ||| S:27376 E:27390 ||| VBD
removed ||| S:27390 E:27397 ||| VBN
,  ||| S:27397 E:27399 ||| ,
washed  ||| S:27399 E:27406 ||| VBN
with  ||| S:27406 E:27411 ||| IN
phosphate  ||| S:27411 E:27421 ||| FW
buffered  ||| S:27421 E:27430 ||| FW
saline  ||| S:27430 E:27437 ||| FW
( ||| S:27437 E:27438 ||| -LRB-
PBS ||| S:27438 E:27441 ||| NNP
) ||| S:27441 E:27442 ||| -RRB-
,  ||| S:27442 E:27444 ||| ,
and  ||| S:27444 E:27458 ||| CC
incubated  ||| S:27458 E:27468 ||| JJ
overnight  ||| S:27468 E:27478 ||| JJ
in  ||| S:27478 E:27481 ||| IN
0.25 ||| S:27481 E:27485 ||| CD
%  ||| S:27485 E:27487 ||| NN
trypsin  ||| S:27487 E:27495 ||| NN
in  ||| S:27495 E:27498 ||| IN
PBS  ||| S:27498 E:27502 ||| NNP
at  ||| S:27502 E:27505 ||| IN
4°C ||| S:27505 E:27508 ||| CD
.  ||| S:27508 E:27510 ||| .
The  ||| S:27510 E:27524 ||| DT
dermis  ||| S:27524 E:27531 ||| NN
was  ||| S:27531 E:27535 ||| VBD
separated  ||| S:27535 E:27545 ||| VBN
from  ||| S:27545 E:27550 ||| IN
the  ||| S:27550 E:27554 ||| DT
epidermis  ||| S:27554 E:27564 ||| NN
and  ||| S:27564 E:27568 ||| CC
subjected  ||| S:27568 E:27578 ||| VBN
to  ||| S:27578 E:27591 ||| TO
further  ||| S:27591 E:27599 ||| RBR
incubation  ||| S:27599 E:27610 ||| JJ
overnight  ||| S:27610 E:27620 ||| JJ
in  ||| S:27620 E:27623 ||| IN
200  ||| S:27623 E:27627 ||| CD
U ||| S:27627 E:27628 ||| NNP
/ ||| S:27628 E:27629 ||| NNP
ml  ||| S:27629 E:27632 ||| NN
of  ||| S:27632 E:27635 ||| IN
crude  ||| S:27635 E:27651 ||| JJ
collagenase  ||| S:27651 E:27663 ||| NNS
( ||| S:27663 E:27664 ||| -LRB-
Sigma ||| S:27664 E:27669 ||| NNP
,  ||| S:27669 E:27671 ||| ,
St.  ||| S:27671 E:27675 ||| NNP
Louis ||| S:27675 E:27680 ||| NNP
,  ||| S:27680 E:27682 ||| ,
MO ||| S:27682 E:27684 ||| NNP
)  ||| S:27684 E:27686 ||| -RRB-
in  ||| S:27686 E:27689 ||| IN
Dulbecco ||| S:27689 E:27697 ||| NNP
's  ||| S:27697 E:27700 ||| POS
modified  ||| S:27700 E:27719 ||| JJ
Eagle ||| S:27719 E:27724 ||| NNP
's  ||| S:27724 E:27727 ||| POS
medium  ||| S:27727 E:27734 ||| NN
( ||| S:27734 E:27735 ||| -LRB-
DMEM ||| S:27735 E:27739 ||| NNP
)  ||| S:27739 E:27741 ||| -RRB-
( ||| S:27741 E:27742 ||| -LRB-
Life  ||| S:27742 E:27747 ||| NNP
Technologies  ||| S:27747 E:27760 ||| NNPS
Inc. ||| S:27760 E:27764 ||| NNP
,  ||| S:27764 E:27776 ||| ,
Gaithersburg ||| S:27776 E:27788 ||| NNP
,  ||| S:27788 E:27790 ||| ,
MD ||| S:27790 E:27792 ||| NNP
)  ||| S:27792 E:27794 ||| -RRB-
at  ||| S:27794 E:27797 ||| IN
37°C ||| S:27797 E:27801 ||| CD
.  ||| S:27801 E:27803 ||| .
Small  ||| S:27803 E:27809 ||| JJ
cell  ||| S:27809 E:27814 ||| NN
aggregates  ||| S:27814 E:27825 ||| NNS
were  ||| S:27825 E:27840 ||| VBD
separated  ||| S:27840 E:27850 ||| VBN
from  ||| S:27850 E:27855 ||| IN
large  ||| S:27855 E:27861 ||| JJ
tissue  ||| S:27861 E:27868 ||| NN
fragments  ||| S:27868 E:27878 ||| NNS
by  ||| S:27878 E:27881 ||| IN
gravitation  ||| S:27881 E:27903 ||| JJ
sedimentation  ||| S:27903 E:27917 ||| NN
for  ||| S:27917 E:27921 ||| IN
10  ||| S:27921 E:27924 ||| CD
minutes  ||| S:27924 E:27932 ||| NNS
at  ||| S:27932 E:27935 ||| IN
room  ||| S:27935 E:27940 ||| NN
temperature ||| S:27940 E:27951 ||| NN
.  ||| S:27951 E:27953 ||| .
The  ||| S:27953 E:27967 ||| DT
supernatant  ||| S:27967 E:27979 ||| NN
was  ||| S:27979 E:27983 ||| VBD
carefully  ||| S:27983 E:27993 ||| RB
removed ||| S:27993 E:28000 ||| VBN
,  ||| S:28000 E:28002 ||| ,
and  ||| S:28002 E:28006 ||| CC
cells  ||| S:28006 E:28012 ||| NNS
were  ||| S:28012 E:28027 ||| VBD
collected  ||| S:28027 E:28037 ||| VBN
by  ||| S:28037 E:28040 ||| IN
centrifugation  ||| S:28040 E:28055 ||| NN
and  ||| S:28055 E:28059 ||| CC
plated  ||| S:28059 E:28066 ||| NN
in  ||| S:28066 E:28069 ||| IN
DMEM  ||| S:28069 E:28074 ||| NNP
containing  ||| S:28074 E:28095 ||| VBG
10 ||| S:28095 E:28097 ||| CD
%  ||| S:28097 E:28099 ||| NN
FBS  ||| S:28099 E:28103 ||| NNP
( ||| S:28103 E:28104 ||| -LRB-
Hyclone ||| S:28104 E:28111 ||| NNP
,  ||| S:28111 E:28113 ||| ,
Logan ||| S:28113 E:28118 ||| NNP
,  ||| S:28118 E:28120 ||| ,
UT ||| S:28120 E:28122 ||| NNP
)  ||| S:28122 E:28124 ||| -RRB-
for  ||| S:28124 E:28128 ||| IN
48  ||| S:28128 E:28131 ||| CD
hours ||| S:28131 E:28136 ||| NNS
.  ||| S:28136 E:28138 ||| .
The  ||| S:28138 E:28142 ||| DT
cells  ||| S:28142 E:28148 ||| NNS
were  ||| S:28148 E:28163 ||| VBD
then  ||| S:28163 E:28168 ||| RB
re-plated  ||| S:28168 E:28178 ||| JJ
twice  ||| S:28178 E:28184 ||| RB
to  ||| S:28184 E:28187 ||| TO
deplete  ||| S:28187 E:28195 ||| VB
from  ||| S:28195 E:28200 ||| IN
the  ||| S:28200 E:28204 ||| DT
culture  ||| S:28204 E:28212 ||| NN
the  ||| S:28212 E:28226 ||| DT
residual  ||| S:28226 E:28235 ||| JJ
keratinocytes  ||| S:28235 E:28249 ||| NN
that  ||| S:28249 E:28254 ||| WDT
do  ||| S:28254 E:28257 ||| VBP
not  ||| S:28257 E:28261 ||| RB
survive  ||| S:28261 E:28269 ||| VB
re-plating  ||| S:28269 E:28280 ||| JJ
in  ||| S:28280 E:28293 ||| IN
10 ||| S:28293 E:28295 ||| CD
%  ||| S:28295 E:28297 ||| NN
FBS-DMEM ||| S:28297 E:28305 ||| NN
.  ||| S:28305 E:28307 ||| .
The  ||| S:28307 E:28311 ||| DT
fibroblasts  ||| S:28311 E:28323 ||| NN
were  ||| S:28323 E:28328 ||| VBD
checked  ||| S:28328 E:28336 ||| VBN
for  ||| S:28336 E:28340 ||| IN
their  ||| S:28340 E:28356 ||| PRP$
spindle  ||| S:28356 E:28364 ||| FW
shaped  ||| S:28364 E:28371 ||| FW
morphology  ||| S:28371 E:28382 ||| FW
( ||| S:28382 E:28383 ||| -LRB-
passage  ||| S:28383 E:28391 ||| NN
one ||| S:28391 E:28394 ||| CD
)  ||| S:28394 E:28396 ||| -RRB-
and  ||| S:28396 E:28400 ||| CC
used  ||| S:28400 E:28405 ||| VBN
for  ||| S:28405 E:28419 ||| IN
future  ||| S:28419 E:28426 ||| JJ
experiments ||| S:28426 E:28437 ||| NNS
.  ||| S:28437 E:28439 ||| .
Twenty  ||| S:28439 E:28446 ||| CD
fibroblast  ||| S:28446 E:28457 ||| CD
preparations  ||| S:28457 E:28470 ||| NNS
were  ||| S:28470 E:28485 ||| VBD
made  ||| S:28485 E:28490 ||| VBN
from  ||| S:28490 E:28495 ||| IN
10  ||| S:28495 E:28498 ||| CD
wild-type  ||| S:28498 E:28508 ||| JJ
or  ||| S:28508 E:28511 ||| CC
SPARC-null  ||| S:28511 E:28522 ||| JJ
mice ||| S:28522 E:28526 ||| NNS
.  ||| S:28526 E:28528 ||| .
In  ||| S:28528 E:28531 ||| IN
all  ||| S:28531 E:28545 ||| DT
experiments ||| S:28545 E:28556 ||| NNS
,  ||| S:28556 E:28558 ||| ,
wild-type  ||| S:28558 E:28568 ||| JJ
and  ||| S:28568 E:28572 ||| CC
SPARC-null  ||| S:28572 E:28583 ||| JJ
cells  ||| S:28583 E:28589 ||| NNS
at  ||| S:28589 E:28592 ||| IN
identical  ||| S:28592 E:28612 ||| JJ
passage  ||| S:28612 E:28620 ||| NN
numbers  ||| S:28620 E:28628 ||| NNS
(  ||| S:28628 E:28629 ||| -LRB-
< ||| S:28629 E:28630 ||| SYM
5 ||| S:28630 E:28631 ||| LS
)  ||| S:28631 E:28633 ||| -RRB-
were  ||| S:28633 E:28638 ||| VBD
used ||| S:28638 E:28642 ||| VBN
.  ||| S:28642 E:28672 ||| .
In  ||| S:28672 E:28675 ||| IN
vitro  ||| S:28675 E:28681 ||| JJ
wound-healing  ||| S:28681 E:28695 ||| JJ
and  ||| S:28695 E:28699 ||| CC
cell  ||| S:28699 E:28704 ||| NN
migration  ||| S:28704 E:28724 ||| NNS
assays  ||| S:28724 E:28741 ||| VBP
Both  ||| S:28741 E:28746 ||| DT
wild-type  ||| S:28746 E:28756 ||| JJ
and  ||| S:28756 E:28760 ||| CC
SPARC-null  ||| S:28760 E:28771 ||| JJ
primary  ||| S:28771 E:28779 ||| JJ
dermal  ||| S:28779 E:28796 ||| JJ
fibroblasts  ||| S:28796 E:28808 ||| NN
were  ||| S:28808 E:28813 ||| VBD
seeded  ||| S:28813 E:28820 ||| VBN
in  ||| S:28820 E:28823 ||| IN
6-well  ||| S:28823 E:28830 ||| CD
plates  ||| S:28830 E:28837 ||| NNS
( ||| S:28837 E:28838 ||| -LRB-
5  ||| S:28838 E:28840 ||| CD
×  ||| S:28840 E:28842 ||| CD
10  ||| S:28842 E:28855 ||| CD
5cells ||| S:28855 E:28861 ||| CD
/ ||| S:28861 E:28862 ||| CD
well ||| S:28862 E:28866 ||| RB
) ||| S:28866 E:28867 ||| -RRB-
,  ||| S:28867 E:28869 ||| ,
and  ||| S:28869 E:28873 ||| CC
grown  ||| S:28873 E:28879 ||| VBN
to  ||| S:28879 E:28882 ||| TO
confluence  ||| S:28882 E:28893 ||| VB
overnight  ||| S:28893 E:28903 ||| JJ
in  ||| S:28903 E:28906 ||| IN
DMEM  ||| S:28906 E:28921 ||| NNP
containing  ||| S:28921 E:28932 ||| VBG
10 ||| S:28932 E:28934 ||| CD
%  ||| S:28934 E:28936 ||| NN
FBS ||| S:28936 E:28939 ||| NNP
.  ||| S:28939 E:28941 ||| .
Monolayers  ||| S:28941 E:28952 ||| NNP
were  ||| S:28952 E:28957 ||| VBD
wounded  ||| S:28957 E:28965 ||| VBN
using  ||| S:28965 E:28971 ||| VBG
a  ||| S:28971 E:28973 ||| DT
1  ||| S:28973 E:28975 ||| CD
ml  ||| S:28975 E:28988 ||| CD
plastic  ||| S:28988 E:28996 ||| JJ
micropipette  ||| S:28996 E:29009 ||| JJ
tip  ||| S:29009 E:29013 ||| NN
and  ||| S:29013 E:29017 ||| CC
incubated  ||| S:29017 E:29027 ||| NN
at  ||| S:29027 E:29030 ||| IN
37°C  ||| S:29030 E:29035 ||| CD
in  ||| S:29035 E:29038 ||| IN
DMEM  ||| S:29038 E:29053 ||| NNP
containing  ||| S:29053 E:29064 ||| VBG
10 ||| S:29064 E:29066 ||| CD
%  ||| S:29066 E:29068 ||| NN
FBS  ||| S:29068 E:29072 ||| NNP
or  ||| S:29072 E:29075 ||| CC
in  ||| S:29075 E:29078 ||| IN
DMEM  ||| S:29078 E:29083 ||| NNP
containing  ||| S:29083 E:29094 ||| VBG
10 ||| S:29094 E:29096 ||| CD
%  ||| S:29096 E:29098 ||| NN
FBS  ||| S:29098 E:29102 ||| NNP
and  ||| S:29102 E:29116 ||| CC
SPARC  ||| S:29116 E:29122 ||| NNP
protein  ||| S:29122 E:29130 ||| NN
purified  ||| S:29130 E:29139 ||| NN
from  ||| S:29139 E:29144 ||| IN
human  ||| S:29144 E:29150 ||| JJ
platelets  ||| S:29150 E:29160 ||| NNS
( ||| S:29160 E:29161 ||| -LRB-
48  ||| S:29161 E:29164 ||| CD
μg ||| S:29164 E:29166 ||| CD
/ ||| S:29166 E:29167 ||| CD
ml ||| S:29167 E:29169 ||| NNS
;  ||| S:29169 E:29181 ||| :
Calbiochem ||| S:29181 E:29191 ||| NNP
,  ||| S:29191 E:29193 ||| ,
La  ||| S:29193 E:29196 ||| NNP
Jolla ||| S:29196 E:29201 ||| NNP
,  ||| S:29201 E:29203 ||| ,
CA ||| S:29203 E:29205 ||| NNP
) ||| S:29205 E:29206 ||| -RRB-
.  ||| S:29206 E:29208 ||| .
At  ||| S:29208 E:29211 ||| IN
various  ||| S:29211 E:29219 ||| JJ
time  ||| S:29219 E:29224 ||| NN
points ||| S:29224 E:29230 ||| NNS
,  ||| S:29230 E:29232 ||| ,
cells  ||| S:29232 E:29248 ||| NNS
were  ||| S:29248 E:29253 ||| VBD
rinsed  ||| S:29253 E:29260 ||| VBN
with  ||| S:29260 E:29265 ||| IN
PBS  ||| S:29265 E:29269 ||| NNP
and  ||| S:29269 E:29273 ||| CC
visualized  ||| S:29273 E:29284 ||| NN
for  ||| S:29284 E:29288 ||| IN
migration  ||| S:29288 E:29298 ||| NN
of  ||| S:29298 E:29311 ||| IN
cells  ||| S:29311 E:29317 ||| NNS
into  ||| S:29317 E:29322 ||| IN
denuded  ||| S:29322 E:29330 ||| JJ
space  ||| S:29330 E:29336 ||| NN
by  ||| S:29336 E:29339 ||| IN
a  ||| S:29339 E:29341 ||| DT
phase-contrast  ||| S:29341 E:29356 ||| JJ
microscope ||| S:29356 E:29366 ||| NN
.  ||| S:29366 E:29378 ||| .
The  ||| S:29378 E:29382 ||| DT
assays  ||| S:29382 E:29389 ||| NN
were  ||| S:29389 E:29394 ||| VBD
performed  ||| S:29394 E:29404 ||| VBN
in  ||| S:29404 E:29407 ||| IN
triplicate  ||| S:29407 E:29418 ||| NN
in  ||| S:29418 E:29421 ||| IN
two  ||| S:29421 E:29425 ||| CD
separate  ||| S:29425 E:29444 ||| JJ
experiments ||| S:29444 E:29455 ||| NNS
.  ||| S:29455 E:29457 ||| .
To  ||| S:29457 E:29460 ||| TO
investigate  ||| S:29460 E:29472 ||| VB
cell  ||| S:29472 E:29477 ||| NN
motility ||| S:29477 E:29485 ||| NN
,  ||| S:29485 E:29487 ||| ,
monolayers  ||| S:29487 E:29498 ||| VBG
of  ||| S:29498 E:29511 ||| IN
dermal  ||| S:29511 E:29518 ||| JJ
fibroblasts  ||| S:29518 E:29530 ||| NN
were  ||| S:29530 E:29535 ||| VBD
prepared  ||| S:29535 E:29544 ||| VBN
and  ||| S:29544 E:29548 ||| CC
wounded  ||| S:29548 E:29556 ||| VBN
as  ||| S:29556 E:29559 ||| RB
described  ||| S:29559 E:29579 ||| VBN
above ||| S:29579 E:29584 ||| IN
.  ||| S:29584 E:29586 ||| .
The  ||| S:29586 E:29590 ||| DT
wounded  ||| S:29590 E:29598 ||| JJ
monolayers  ||| S:29598 E:29609 ||| NN
were  ||| S:29609 E:29614 ||| VBD
incubated  ||| S:29614 E:29624 ||| VBN
at  ||| S:29624 E:29627 ||| IN
37°C  ||| S:29627 E:29632 ||| CD
in  ||| S:29632 E:29645 ||| IN
DMEM  ||| S:29645 E:29650 ||| NNP
containing  ||| S:29650 E:29661 ||| VBG
10 ||| S:29661 E:29663 ||| CD
%  ||| S:29663 E:29665 ||| NN
FBS  ||| S:29665 E:29669 ||| NN
with  ||| S:29669 E:29674 ||| IN
or  ||| S:29674 E:29677 ||| CC
without  ||| S:29677 E:29685 ||| IN
mitomycin  ||| S:29685 E:29695 ||| JJ
C  ||| S:29695 E:29697 ||| NNP
( ||| S:29697 E:29698 ||| -LRB-
10  ||| S:29698 E:29711 ||| CD
μg ||| S:29711 E:29713 ||| CD
/ ||| S:29713 E:29714 ||| CD
ml ||| S:29714 E:29716 ||| NN
,  ||| S:29716 E:29718 ||| ,
Sigma ||| S:29718 E:29723 ||| NNP
,  ||| S:29723 E:29725 ||| ,
St  ||| S:29725 E:29728 ||| NNP
Louis ||| S:29728 E:29733 ||| NNP
,  ||| S:29733 E:29735 ||| ,
MO ||| S:29735 E:29737 ||| NNP
)  ||| S:29737 E:29739 ||| -RRB-
to  ||| S:29739 E:29742 ||| TO
block  ||| S:29742 E:29748 ||| VB
mitosis ||| S:29748 E:29755 ||| NNS
.  ||| S:29755 E:29757 ||| .
Migration  ||| S:29757 E:29777 ||| NNP
of  ||| S:29777 E:29780 ||| IN
cells  ||| S:29780 E:29786 ||| NNS
into  ||| S:29786 E:29791 ||| IN
denuded  ||| S:29791 E:29799 ||| JJ
areas  ||| S:29799 E:29805 ||| NNS
was  ||| S:29805 E:29809 ||| VBD
monitored  ||| S:29809 E:29819 ||| VBN
for  ||| S:29819 E:29823 ||| IN
up  ||| S:29823 E:29826 ||| RB
to  ||| S:29826 E:29829 ||| TO
48  ||| S:29829 E:29842 ||| CD
hours ||| S:29842 E:29847 ||| NNS
.  ||| S:29847 E:29877 ||| .
Incorporation  ||| S:29877 E:29891 ||| NNP
of  ||| S:29891 E:29894 ||| IN
3H-thymidine  ||| S:29894 E:29917 ||| NNP
Wild-type  ||| S:29917 E:29927 ||| NNP
and  ||| S:29927 E:29931 ||| CC
SPARC-null  ||| S:29931 E:29942 ||| JJ
dermal  ||| S:29942 E:29949 ||| JJ
fibroblasts  ||| S:29949 E:29961 ||| NN
were  ||| S:29961 E:29976 ||| VBD
plated  ||| S:29976 E:29983 ||| VBN
in  ||| S:29983 E:29986 ||| IN
96-well  ||| S:29986 E:29994 ||| CD
plates  ||| S:29994 E:30001 ||| NNS
( ||| S:30001 E:30002 ||| -LRB-
1  ||| S:30002 E:30004 ||| CD
×  ||| S:30004 E:30006 ||| CD
10  ||| S:30006 E:30009 ||| CD
4cells ||| S:30009 E:30015 ||| CD
/ ||| S:30015 E:30016 ||| CD
well ||| S:30016 E:30020 ||| RB
)  ||| S:30020 E:30022 ||| -RRB-
and  ||| S:30022 E:30036 ||| CC
cultured  ||| S:30036 E:30045 ||| JJ
overnight  ||| S:30045 E:30055 ||| JJ
in  ||| S:30055 E:30058 ||| IN
DMEM  ||| S:30058 E:30063 ||| NNP
containing  ||| S:30063 E:30074 ||| VBG
10 ||| S:30074 E:30076 ||| CD
%  ||| S:30076 E:30078 ||| NN
FBS ||| S:30078 E:30081 ||| NNP
.  ||| S:30081 E:30083 ||| .
The  ||| S:30083 E:30087 ||| DT
cells  ||| S:30087 E:30103 ||| NNS
were  ||| S:30103 E:30108 ||| VBD
then  ||| S:30108 E:30113 ||| RB
washed  ||| S:30113 E:30120 ||| VBD
three  ||| S:30120 E:30126 ||| CD
times  ||| S:30126 E:30132 ||| NNS
with  ||| S:30132 E:30137 ||| IN
DMEM  ||| S:30137 E:30142 ||| NNP
without  ||| S:30142 E:30150 ||| IN
FBS  ||| S:30150 E:30154 ||| NNP
and  ||| S:30154 E:30168 ||| CC
incubated  ||| S:30168 E:30178 ||| NN
with  ||| S:30178 E:30183 ||| IN
3H-thymidine  ||| S:30183 E:30196 ||| NNP
( ||| S:30196 E:30197 ||| -LRB-
1  ||| S:30197 E:30199 ||| CD
μCi ||| S:30199 E:30202 ||| JJ
/ ||| S:30202 E:30203 ||| CD
ml ||| S:30203 E:30205 ||| NNS
;  ||| S:30205 E:30207 ||| :
NEN ||| S:30207 E:30210 ||| NNP
,  ||| S:30210 E:30212 ||| ,
Boston ||| S:30212 E:30218 ||| NNP
,  ||| S:30218 E:30220 ||| ,
MA ||| S:30220 E:30222 ||| NNP
)  ||| S:30222 E:30234 ||| -RRB-
in  ||| S:30234 E:30237 ||| IN
DMEM  ||| S:30237 E:30242 ||| NNP
containing  ||| S:30242 E:30253 ||| VBG
10 ||| S:30253 E:30255 ||| CD
%  ||| S:30255 E:30257 ||| NN
FBS  ||| S:30257 E:30261 ||| NN
for  ||| S:30261 E:30265 ||| IN
time  ||| S:30265 E:30270 ||| NN
periods  ||| S:30270 E:30278 ||| NNS
varying  ||| S:30278 E:30296 ||| VBG
between  ||| S:30296 E:30304 ||| IN
0  ||| S:30304 E:30306 ||| CD
and  ||| S:30306 E:30310 ||| CC
30  ||| S:30310 E:30313 ||| CD
hours ||| S:30313 E:30318 ||| NNS
.  ||| S:30318 E:30320 ||| .
Due  ||| S:30320 E:30324 ||| JJ
to  ||| S:30324 E:30327 ||| TO
the  ||| S:30327 E:30331 ||| DT
problem  ||| S:30331 E:30339 ||| NN
of  ||| S:30339 E:30342 ||| IN
cell  ||| S:30342 E:30347 ||| NN
death  ||| S:30347 E:30363 ||| NN
( ||| S:30363 E:30364 ||| -LRB-
> ||| S:30364 E:30365 ||| CD
80 ||| S:30365 E:30367 ||| CD
% ||| S:30367 E:30368 ||| NN
)  ||| S:30368 E:30370 ||| -RRB-
in  ||| S:30370 E:30373 ||| IN
serum-free  ||| S:30373 E:30384 ||| JJ
medium ||| S:30384 E:30390 ||| NN
,  ||| S:30390 E:30392 ||| ,
cell  ||| S:30392 E:30397 ||| NN
cycle  ||| S:30397 E:30413 ||| NN
synchronization  ||| S:30413 E:30429 ||| NN
of  ||| S:30429 E:30432 ||| IN
the  ||| S:30432 E:30436 ||| DT
dermal  ||| S:30436 E:30443 ||| JJ
fibroblasts  ||| S:30443 E:30455 ||| NN
in  ||| S:30455 E:30458 ||| IN
serum-free  ||| S:30458 E:30479 ||| JJ
medium  ||| S:30479 E:30486 ||| NN
was  ||| S:30486 E:30490 ||| VBD
not  ||| S:30490 E:30494 ||| RB
performed  ||| S:30494 E:30504 ||| VBN
prior  ||| S:30504 E:30510 ||| RB
to  ||| S:30510 E:30513 ||| TO
3H-thymidine  ||| S:30513 E:30526 ||| CD
assays ||| S:30526 E:30532 ||| NNS
.  ||| S:30532 E:30544 ||| .
DNA-bound  ||| S:30544 E:30554 ||| NNP
3H-thymidine  ||| S:30554 E:30567 ||| NNP
was  ||| S:30567 E:30571 ||| VBD
immobilized  ||| S:30571 E:30583 ||| VBN
on  ||| S:30583 E:30586 ||| IN
glass  ||| S:30586 E:30592 ||| NN
fiber  ||| S:30592 E:30608 ||| NN
filter  ||| S:30608 E:30615 ||| NN
paper  ||| S:30615 E:30621 ||| NN
( ||| S:30621 E:30622 ||| -LRB-
Packard ||| S:30622 E:30629 ||| NNP
,  ||| S:30629 E:30631 ||| ,
Meriden ||| S:30631 E:30638 ||| NNP
,  ||| S:30638 E:30640 ||| ,
CT ||| S:30640 E:30642 ||| NNP
)  ||| S:30642 E:30644 ||| -RRB-
with  ||| S:30644 E:30649 ||| IN
the  ||| S:30649 E:30653 ||| DT
aid  ||| S:30653 E:30657 ||| NN
of  ||| S:30657 E:30660 ||| IN
an  ||| S:30660 E:30673 ||| DT
automated  ||| S:30673 E:30683 ||| JJ
cell  ||| S:30683 E:30688 ||| NN
harvester  ||| S:30688 E:30698 ||| NNS
( ||| S:30698 E:30699 ||| -LRB-
Tomtec ||| S:30699 E:30705 ||| NNP
,  ||| S:30705 E:30707 ||| ,
Orange ||| S:30707 E:30713 ||| NNP
,  ||| S:30713 E:30715 ||| ,
CT ||| S:30715 E:30717 ||| NNP
)  ||| S:30717 E:30719 ||| -RRB-
and  ||| S:30719 E:30723 ||| CC
the  ||| S:30723 E:30737 ||| DT
tritium  ||| S:30737 E:30745 ||| NN
incorporation  ||| S:30745 E:30759 ||| NNS
was  ||| S:30759 E:30763 ||| VBD
determined  ||| S:30763 E:30774 ||| VBN
by  ||| S:30774 E:30777 ||| IN
scintillation  ||| S:30777 E:30801 ||| JJ
counting ||| S:30801 E:30809 ||| NN
.  ||| S:30809 E:30811 ||| .
Experiments  ||| S:30811 E:30823 ||| NNS
were  ||| S:30823 E:30828 ||| VBD
performed  ||| S:30828 E:30838 ||| VBN
in  ||| S:30838 E:30841 ||| IN
triplicate  ||| S:30841 E:30852 ||| NN
with  ||| S:30852 E:30867 ||| IN
cells  ||| S:30867 E:30873 ||| NNS
derived  ||| S:30873 E:30881 ||| VBN
from  ||| S:30881 E:30886 ||| IN
two  ||| S:30886 E:30890 ||| CD
different  ||| S:30890 E:30900 ||| JJ
dermal  ||| S:30900 E:30907 ||| JJ
fibroblast  ||| S:30907 E:30928 ||| JJ
preparations ||| S:30928 E:30940 ||| NNS
.  ||| S:30940 E:30970 ||| .
Collagen  ||| S:30970 E:30979 ||| JJ
gel  ||| S:30979 E:30983 ||| JJ
contraction  ||| S:30983 E:30995 ||| NN
assay  ||| S:30995 E:31011 ||| VBD
A  ||| S:31011 E:31013 ||| DT
standard  ||| S:31013 E:31022 ||| JJ
procedure  ||| S:31022 E:31032 ||| NN
[  ||| S:31032 E:31034 ||| -LRB-
11  ||| S:31034 E:31037 ||| CD
]  ||| S:31037 E:31039 ||| -RRB-
for  ||| S:31039 E:31043 ||| IN
collagen  ||| S:31043 E:31052 ||| JJ
disc  ||| S:31052 E:31067 ||| NN
contraction  ||| S:31067 E:31079 ||| NN
was  ||| S:31079 E:31083 ||| VBD
followed  ||| S:31083 E:31092 ||| VBN
with  ||| S:31092 E:31097 ||| IN
minor  ||| S:31097 E:31103 ||| JJ
modifications ||| S:31103 E:31116 ||| NNS
.  ||| S:31116 E:31128 ||| .
Briefly ||| S:31128 E:31135 ||| RB
,  ||| S:31135 E:31137 ||| ,
6-well  ||| S:31137 E:31144 ||| CD
tissue  ||| S:31144 E:31151 ||| NN
culture  ||| S:31151 E:31159 ||| NN
plates  ||| S:31159 E:31166 ||| NNS
were  ||| S:31166 E:31171 ||| VBD
made  ||| S:31171 E:31186 ||| VBN
non-adhesive  ||| S:31186 E:31199 ||| JJ
with  ||| S:31199 E:31204 ||| IN
a  ||| S:31204 E:31206 ||| DT
coating  ||| S:31206 E:31214 ||| NN
of  ||| S:31214 E:31217 ||| IN
1 ||| S:31217 E:31218 ||| CD
%  ||| S:31218 E:31220 ||| NN
agarose  ||| S:31220 E:31228 ||| NNS
( ||| S:31228 E:31229 ||| -LRB-
Sea-Kem  ||| S:31229 E:31237 ||| NNP
LE ||| S:31237 E:31239 ||| NNP
,  ||| S:31239 E:31251 ||| ,
FMC  ||| S:31251 E:31255 ||| NNP
BioProducts ||| S:31255 E:31266 ||| NNP
,  ||| S:31266 E:31268 ||| ,
Rockland ||| S:31268 E:31276 ||| NNP
,  ||| S:31276 E:31278 ||| ,
MD ||| S:31278 E:31280 ||| NNP
) ||| S:31280 E:31281 ||| -RRB-
.  ||| S:31281 E:31283 ||| .
One  ||| S:31283 E:31287 ||| CD
volume  ||| S:31287 E:31294 ||| NN
of  ||| S:31294 E:31297 ||| IN
a  ||| S:31297 E:31299 ||| DT
solution  ||| S:31299 E:31318 ||| NN
of  ||| S:31318 E:31321 ||| IN
3  ||| S:31321 E:31323 ||| CD
mg ||| S:31323 E:31325 ||| CD
/ ||| S:31325 E:31326 ||| CD
ml  ||| S:31326 E:31329 ||| CD
bovine  ||| S:31329 E:31336 ||| JJ
type  ||| S:31336 E:31341 ||| NN
I  ||| S:31341 E:31343 ||| PRP
collagen  ||| S:31343 E:31352 ||| VBP
( ||| S:31352 E:31353 ||| -LRB-
Vitrogen™ ||| S:31353 E:31362 ||| NNP
,  ||| S:31362 E:31364 ||| ,
Celtrix  ||| S:31364 E:31382 ||| NNP
Corp. ||| S:31382 E:31387 ||| NNP
,  ||| S:31387 E:31389 ||| ,
Palo  ||| S:31389 E:31394 ||| NNP
Alto ||| S:31394 E:31398 ||| NNP
,  ||| S:31398 E:31400 ||| ,
CA ||| S:31400 E:31402 ||| NNP
)  ||| S:31402 E:31404 ||| -RRB-
was  ||| S:31404 E:31408 ||| VBD
combined  ||| S:31408 E:31417 ||| VBN
with  ||| S:31417 E:31422 ||| IN
1 ||| S:31422 E:31423 ||| CD
/ ||| S:31423 E:31424 ||| CD
6  ||| S:31424 E:31426 ||| CD
volume  ||| S:31426 E:31433 ||| NN
of  ||| S:31433 E:31436 ||| IN
7X  ||| S:31436 E:31449 ||| NNP
DMEM  ||| S:31449 E:31454 ||| NNP
and  ||| S:31454 E:31458 ||| CC
sufficient  ||| S:31458 E:31469 ||| JJ
1X  ||| S:31469 E:31472 ||| NNP
DMEM  ||| S:31472 E:31477 ||| NNP
added  ||| S:31477 E:31483 ||| VBD
to  ||| S:31483 E:31486 ||| TO
yield  ||| S:31486 E:31492 ||| VB
a  ||| S:31492 E:31494 ||| DT
final  ||| S:31494 E:31510 ||| JJ
collagen  ||| S:31510 E:31519 ||| NN
concentration  ||| S:31519 E:31533 ||| NN
of  ||| S:31533 E:31536 ||| IN
0.75  ||| S:31536 E:31541 ||| CD
mg ||| S:31541 E:31543 ||| CD
/ ||| S:31543 E:31544 ||| CD
ml ||| S:31544 E:31546 ||| NNS
.  ||| S:31546 E:31548 ||| .
A  ||| S:31548 E:31550 ||| DT
suspension  ||| S:31550 E:31561 ||| NN
of  ||| S:31561 E:31574 ||| IN
mouse  ||| S:31574 E:31580 ||| JJ
dermal  ||| S:31580 E:31587 ||| JJ
fibroblasts  ||| S:31587 E:31599 ||| NN
at  ||| S:31599 E:31602 ||| IN
2  ||| S:31602 E:31604 ||| CD
×  ||| S:31604 E:31606 ||| CD
10  ||| S:31606 E:31609 ||| CD
6cell ||| S:31609 E:31614 ||| CD
/ ||| S:31614 E:31615 ||| CD
ml  ||| S:31615 E:31618 ||| NN
in  ||| S:31618 E:31621 ||| IN
DMEM  ||| S:31621 E:31626 ||| NNP
was  ||| S:31626 E:31640 ||| VBD
added  ||| S:31640 E:31646 ||| VBN
to  ||| S:31646 E:31649 ||| TO
9  ||| S:31649 E:31651 ||| CD
volumes  ||| S:31651 E:31659 ||| NNS
of  ||| S:31659 E:31662 ||| IN
the  ||| S:31662 E:31666 ||| DT
type  ||| S:31666 E:31671 ||| NN
1  ||| S:31671 E:31673 ||| CD
collagen  ||| S:31673 E:31682 ||| NN
solution ||| S:31682 E:31690 ||| NN
,  ||| S:31690 E:31692 ||| ,
and  ||| S:31692 E:31706 ||| CC
FBS  ||| S:31706 E:31710 ||| NNP
added  ||| S:31710 E:31716 ||| VBD
to  ||| S:31716 E:31719 ||| TO
provide  ||| S:31719 E:31727 ||| VB
a  ||| S:31727 E:31729 ||| DT
concentration  ||| S:31729 E:31743 ||| NN
of  ||| S:31743 E:31746 ||| IN
2 ||| S:31746 E:31747 ||| CD
%  ||| S:31747 E:31749 ||| NN
FBS  ||| S:31749 E:31753 ||| NN
in  ||| S:31753 E:31756 ||| IN
the  ||| S:31756 E:31770 ||| DT
final  ||| S:31770 E:31776 ||| JJ
solution ||| S:31776 E:31784 ||| NN
.  ||| S:31784 E:31786 ||| .
The  ||| S:31786 E:31790 ||| DT
resulting  ||| S:31790 E:31800 ||| JJ
cell  ||| S:31800 E:31805 ||| NN
suspension  ||| S:31805 E:31816 ||| NN
was  ||| S:31816 E:31830 ||| VBD
dispensed  ||| S:31830 E:31840 ||| VBN
into  ||| S:31840 E:31845 ||| IN
agarose-coated  ||| S:31845 E:31860 ||| JJ
wells  ||| S:31860 E:31866 ||| NNS
( ||| S:31866 E:31867 ||| -LRB-
2  ||| S:31867 E:31869 ||| CD
ml ||| S:31869 E:31871 ||| NNS
/ ||| S:31871 E:31872 ||| VBP
well ||| S:31872 E:31876 ||| RB
)  ||| S:31876 E:31878 ||| -RRB-
and  ||| S:31878 E:31892 ||| CC
gelled  ||| S:31892 E:31899 ||| NN
for  ||| S:31899 E:31903 ||| IN
2  ||| S:31903 E:31905 ||| CD
hours  ||| S:31905 E:31911 ||| NNS
at  ||| S:31911 E:31914 ||| IN
37°C ||| S:31914 E:31918 ||| CD
.  ||| S:31918 E:31920 ||| .
DMEM  ||| S:31920 E:31925 ||| NNP
( ||| S:31925 E:31926 ||| -LRB-
2  ||| S:31926 E:31928 ||| CD
ml ||| S:31928 E:31930 ||| CD
)  ||| S:31930 E:31932 ||| -RRB-
with  ||| S:31932 E:31937 ||| IN
2 ||| S:31937 E:31938 ||| CD
%  ||| S:31938 E:31940 ||| NN
FBS  ||| S:31940 E:31944 ||| NNP
was  ||| S:31944 E:31958 ||| VBD
subsequently  ||| S:31958 E:31971 ||| RB
added  ||| S:31971 E:31977 ||| VBD
to  ||| S:31977 E:31980 ||| TO
the  ||| S:31980 E:31984 ||| DT
wells  ||| S:31984 E:31990 ||| NNS
and  ||| S:31990 E:31994 ||| CC
the  ||| S:31994 E:31998 ||| DT
gels  ||| S:31998 E:32003 ||| NN
were  ||| S:32003 E:32008 ||| VBD
gently  ||| S:32008 E:32025 ||| RB
detached  ||| S:32025 E:32034 ||| VBN
from  ||| S:32034 E:32039 ||| IN
the  ||| S:32039 E:32043 ||| DT
walls  ||| S:32043 E:32049 ||| NNS
to  ||| S:32049 E:32052 ||| TO
float  ||| S:32052 E:32058 ||| VB
the  ||| S:32058 E:32062 ||| DT
collagen  ||| S:32062 E:32071 ||| JJ
disks ||| S:32071 E:32076 ||| NNS
.  ||| S:32076 E:32078 ||| .
The  ||| S:32078 E:32092 ||| DT
collagen ||| S:32092 E:32100 ||| JJ
/ ||| S:32100 E:32101 ||| CD
cell  ||| S:32101 E:32106 ||| NN
mixtures  ||| S:32106 E:32115 ||| NNS
were  ||| S:32115 E:32120 ||| VBD
incubated  ||| S:32120 E:32130 ||| VBN
in  ||| S:32130 E:32133 ||| IN
humidified  ||| S:32133 E:32144 ||| JJ
air  ||| S:32144 E:32158 ||| NN
at  ||| S:32158 E:32161 ||| IN
37°C  ||| S:32161 E:32166 ||| NNP
and  ||| S:32166 E:32170 ||| CC
contraction  ||| S:32170 E:32182 ||| NN
was  ||| S:32182 E:32186 ||| VBD
monitored  ||| S:32186 E:32196 ||| VBN
for  ||| S:32196 E:32200 ||| IN
72  ||| S:32200 E:32203 ||| CD
hours ||| S:32203 E:32208 ||| NNS
.  ||| S:32208 E:32210 ||| .
The  ||| S:32210 E:32224 ||| DT
assay  ||| S:32224 E:32230 ||| NN
was  ||| S:32230 E:32234 ||| VBD
performed  ||| S:32234 E:32244 ||| VBN
three  ||| S:32244 E:32250 ||| CD
times ||| S:32250 E:32255 ||| NNS
,  ||| S:32255 E:32257 ||| ,
each  ||| S:32257 E:32262 ||| DT
in  ||| S:32262 E:32265 ||| IN
triplicate ||| S:32265 E:32275 ||| NN
.  ||| S:32275 E:32277 ||| .
The  ||| S:32277 E:32291 ||| DT
area  ||| S:32291 E:32296 ||| NN
of  ||| S:32296 E:32299 ||| IN
gels  ||| S:32299 E:32304 ||| NN
was  ||| S:32304 E:32308 ||| VBD
calculated  ||| S:32308 E:32319 ||| VBN
from  ||| S:32319 E:32324 ||| IN
the  ||| S:32324 E:32328 ||| DT
average  ||| S:32328 E:32336 ||| JJ
diameter  ||| S:32336 E:32345 ||| NN
of  ||| S:32345 E:32358 ||| IN
the  ||| S:32358 E:32362 ||| DT
experiments  ||| S:32362 E:32374 ||| NNS
and  ||| S:32374 E:32378 ||| CC
expressed  ||| S:32378 E:32388 ||| VBN
as  ||| S:32388 E:32391 ||| IN
a  ||| S:32391 E:32393 ||| DT
percentage  ||| S:32393 E:32404 ||| NN
of  ||| S:32404 E:32407 ||| IN
the  ||| S:32407 E:32421 ||| DT
initial  ||| S:32421 E:32429 ||| JJ
area ||| S:32429 E:32433 ||| NN
.  ||| S:32433 E:32466 ||| .
Abbreviations  ||| S:32466 E:32488 ||| NNP
DMEM ||| S:32488 E:32492 ||| NNP
,  ||| S:32492 E:32494 ||| ,
Dulbecco ||| S:32494 E:32502 ||| NNP
's  ||| S:32502 E:32505 ||| POS
modified  ||| S:32505 E:32514 ||| JJ
Eagle ||| S:32514 E:32519 ||| NNP
's  ||| S:32519 E:32522 ||| POS
medium ||| S:32522 E:32528 ||| NN
;  ||| S:32528 E:32530 ||| :
ECM ||| S:32530 E:32533 ||| NNP
,  ||| S:32533 E:32543 ||| ,
extracellular  ||| S:32543 E:32557 ||| JJ
matrix ||| S:32557 E:32563 ||| NN
;  ||| S:32563 E:32565 ||| :
FBS ||| S:32565 E:32568 ||| NNP
,  ||| S:32568 E:32570 ||| ,
fetal  ||| S:32570 E:32576 ||| JJ
bovine  ||| S:32576 E:32583 ||| JJ
serum ||| S:32583 E:32588 ||| NN
;  ||| S:32588 E:32590 ||| :
GAPDH ||| S:32590 E:32595 ||| NNP
:  ||| S:32595 E:32605 ||| :
glyceraldehyde-3-phosphate  ||| S:32605 E:32632 ||| CD
dehydrogenase ||| S:32632 E:32645 ||| NNS
;  ||| S:32645 E:32647 ||| :
PBS ||| S:32647 E:32650 ||| NNP
,  ||| S:32650 E:32652 ||| ,
phosphate  ||| S:32652 E:32670 ||| FW
buffered  ||| S:32670 E:32679 ||| FW
saline ||| S:32679 E:32685 ||| FW
;  ||| S:32685 E:32687 ||| :
SPARC ||| S:32687 E:32692 ||| NNP
,  ||| S:32692 E:32694 ||| ,
secreted  ||| S:32694 E:32703 ||| JJ
protein  ||| S:32703 E:32711 ||| NN
acidic  ||| S:32711 E:32718 ||| NNS
and  ||| S:32718 E:32722 ||| CC
rich  ||| S:32722 E:32727 ||| JJ
in  ||| S:32727 E:32738 ||| IN
cysteine ||| S:32738 E:32746 ||| NN
,  ||| S:32746 E:32748 ||| ,
also  ||| S:32748 E:32753 ||| RB
known  ||| S:32753 E:32759 ||| VBN
as  ||| S:32759 E:32762 ||| IN
osteonectin  ||| S:32762 E:32774 ||| NN
and  ||| S:32774 E:32778 ||| CC
BM-40 ||| S:32778 E:32783 ||| NNP
;  ||| S:32783 E:32785 ||| :
SD ||| S:32785 E:32787 ||| NNP
,  ||| S:32787 E:32789 ||| ,
standard  ||| S:32789 E:32806 ||| JJ
deviation ||| S:32806 E:32815 ||| NN
.  ||| S:32815 E:32832 ||| .
